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1 Introduction 
 
The first paramyxovirus (PMV) outbreak in reptiles was documented in Switzerland in 
1976, where a farm of Fer-de-lance snakes (Bothrops atrox) suffered from respiratory 
disease and death. The virus isolated during that outbreak was Fer de Lance Virus 
(FDLV), named after the species of snake affected. Clark et al. (1979) isolated this 
virus in cell culture and consequently several reports documented the occurrence of 
PMV infections in other snake families.  
Like all other PMV, ferlaviruses are enveloped and form envelope glycolproteins 
fusion (F) and haemagglutin neuraminidase (HN) which have an essential role in the 
viral immunogenicity and pathogenecity. These glycoproteins play multiple roles in 
virus entry and the exit from its host. 
Kurath et al. (2004) successfully sequenced the full genome of FDLV and detected a 
unique gene named unknown gene (U) which is absent in all other genera of 
Paramyxovirinae. Based on phylogenetic analyses and the unique genome 
characterization, Kurath (2009) proposed the classification of this new group of 
viruses into a novel genus Ferlavirus within the subfamily Paramyxovirinae with 
FDLV as the type species. 
Ferlaviruses are important disease causing agents of reptiles including snakes, 
tortoises, and lizards. Earlier publications (Ahne et al., 1999; Franke et al., 2001) 
have characterized many PMV isolates and displayed inconsistent clustering of 
members of the genus Ferlavirus. In these publications, two to three distinct genetic 
variants were detected respectively, while several isolates clustered as “intermediate 
isolates”. A later study by Marschang et al. (2009) resolved this inconsistency by 
suggesting a revised grouping; sensu lato subgroups A and B. Recent studies by 
Abbas et al. (2011) and Papp et al. (2013) based on partial sequences of L, HN, and 
U genes, detected the first two representatives of a third subgroup C within the 
Ferlavirus genus.  
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The objectives of this study were to establish standard diagnostic methods for the 
detection of ferlaviruses in several snake families including Boidae, Pythonidae, 
Colubridae, and Viperidae, evaluate the nested RT-PCR method described by Ahne 
et al. (1999) targeting a partial sequence of the L gene and its efficiency as a 
standard diagnostic method, characterize novel types of viruses and increase our 
knowledge of their phylogenetic relationships and host specificity.   
Several methods were used in order to optimize the sensitivity and specificity of the 
detection methods for ferlaviruses. Virus characterization and comparison were 
carried out based on partial sequences of L, HN, and U genes. In addition, the 
complete sequences of the surface glycoprotein encoding genes of nine ferlaviruses 
isolated from six snakes, two lizards, and a tortoise were amplified and compared. In 
addition, the complete set of the sequence motifs of F and HN genes were compared 
to detect the relation and the degree of similarity among genetically different 
ferlavirus isolates. 
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2 Literature review 
      2.1 Taxonomy of Paramyxoviruses (PMV) 
 
The order Mononegavirales includes four families: Bornaviridae, Filoviridae, 
Paramyxoviridae, and Rhabdoviridae classified based on several criteria including 
genome size, virion morphology, replication site, host range, pathogenic potential 
and growth in cell culture (Easton and Ring, 2010) besides some other properties 
including genome organization and phylogenetic analyses (Wang et al., 2011). The 
common aspect which unites these enveloped viruses is the presence of a negative 
sense, single strand (ss) RNA genome in a helical nucleocapsid. This order of 
viruses comprises the agents of a wide range of diseases affecting humans, animals, 
and plants (Easton and Ring, 2010).  
The family Paramyxoviridae has been classified into two subfamilies: the 
Paramyxovirinae which is currently divided into seven genera; Ferlavirus, 
Aquaparamyxovirus, Rubulavirus, Avulavirus, Morbillivirus, Respirovirus, and 
Henipavirus and the Pneumovirinae which is divided into Pneumovirus and 
Metapneumovirus (ICTV, 2011)1 based on the biological activities of the proteins, the 
organization of the genome, morphologic criteria and the sequence relatedness of 
the encoded proteins (Lamb and Kolakofsky, 2001).  
The Paramyxoviridae include a number of well-known disease-causing viruses that 
occur only in vertebrates. This family includes measles virus, respiratory syncytial 
virus, parainfluenza viruses, mumps virus, Newcastle disease virus, rinderpest virus, 
Hendra virus, and Nipah virus (Lamb and Kolakofsky, 2001; Wang et al., 2011) 
(Table 1.1). 
 
                                            
1
 http://www.ictvonline.org/virusTaxonomy.asp?version=2011&bhcp=1 
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Table 1.1: list of genera of the family Paramyxoviridae 
 Genera of the family Paramyxoviridae, type species, total genome length, host range (Wang 
et al., 2011; Lamb & Jardetzky, 2007; Nylund et al., 2008). Abbreviations are as follows: 
HPIV-1: Human parainfluenza virus type 1, PIV-5: Parainfluenza virus type 5, SV-41: Simian 
virus 41, APMV-6: Avian paramyxovirus type 6, NDV:  New castle disease virus, nts: 
Nucleotides. 
 
 
 Genera Type species Total 
length 
in 
(nts) 
Haemagglutinin/ 
Neuraminidase 
Host range Examples 
P
a
ra
m
y
x
o
v
ir
in
a
e
 Rubulavirus Mumps virus 15,384 haemagglutinin 
/neuraminidase 
humans, 
canines, 
monkeys, 
swine 
 
PIV-5, SV-41 
Respirovirus Sendai virus 15,348 haemagglutinin 
/neuraminidase 
rodents, 
bovines, 
humans 
HPIV-1 
Avulavirus NDV 15,186 haemagglutinin/ 
neuraminidase 
avians  APMV-6 
Henipavirus Hendra virus 18,234 none bats, swine, 
horses, 
humans 
Nipah virus 
Morbillivirus Measles virus 15,894 haemagglutinin canines, 
bovines, 
humans, 
phocine, 
cetacean 
Canine distemper 
virus 
Aquaparamyx
ovirus 
Atlantic 
salmon PMV 
16,965 haemagglutinin/ 
neuraminidase 
fish Pacific salmon 
PMV 
Ferlavirus FDLV 15,378 haemagglutinin/ 
neuraminidase 
reptiles Gono GER95 
P
n
e
u
m
o
v
ir
in
a
e
 
Pneumovirus 
 
Human 
respiratory 
syncytial virus 
15,222 hemagglutinin 
was reported in 
pneumonia virus 
of mice (PVM) 
bovines, 
humans 
Bovine respiratory 
syncytial virus 
Metapneumov
irus 
Human 
metapneumovi
rus 
13,335 none humans Avian 
metapneumovirus 
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       2.2       Structure of Paramyxoviruses 
 
Paramyxoviridae are enveloped viruses 150 to 350 nm in diameter, spherical, 
although they can have pleiomorphic or filamentous forms (Lamb and Kolakofsky, 
2001; Jacobson, 2007). Surface glycoproteins fusion (F) and attachment proteins: 
haemagglutinin neuraminidase (HN), haemagglutinin (HA) or glycoprotein (G) usually 
form spikes that are inserted into the lipid bilayer envelope and extend about 8 to 12 
nm from the surface of the envelope. Underneath the envelope is another membrane 
associated matrix (M) protein. This protein is non-glycosylated and functions to 
stabilize the virion structure and associates with the inner face of the envelope (Fig 
1). The viral nucleocapsid has helical symmetry and contains non infectious, negative 
sense single-stranded RNA genome and nucleocapsid associated proteins (Wang et 
al., 2011; Lamb and Kolakofsky, 2001). 
 
 
 
 
 
 
 
 
 
 
                                  Figure 1: 3D image of of Pneumovirus reconstruction 
Source: University of Warwick, Pneumovirus 
Laboratory, UK. (http://biowiki.org/view/Fall09/FinalProject 
Paramyxoviridae, 07.06.12) 
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The nucleocapsid protein (N) protects the RNA genome from digestion by nucleases. 
This protein together with the large polymerase protein (L) and phosphoproteins (P) 
form a complex that has RNA-dependent RNA transcriptase activity (Lamb and 
Kolakofsky, 2001). 
The Paramyxoviridae genome varies in length among PMV genera from 13335 in 
Metapneumovirus (Human Metapneumovirus) to 18234 bp in Nipahvirus (Hendra 
virus) (Wang et al., 2011). Common in the genomes of members of Paramyxovirinae 
are six to ten transcriptional units listed in the order 3' N-P-M-F-HN-L 5'. N, P, M, F, 
and L are indicated as above. There is also diversity in genome length in PMV due to  
an unusual hallmark for some PMV (rule of six) where the N protein binds six 
nucleotides of RNA, therefore the genome length of these viruses are multiples of six 
nucleotides (nts). Nevertheless, most viruses in the order Mononigavirales do not fit 
to this rule (Easton and Ring, 2010). 
Common in members of Paramyxovirinae are “accessory” proteins, which are 
encoded generally by alternative transcriptional units, Open Reading Frames (ORFs) 
that overlap within the P gene (Lamb and Kolakofsky, 2001). During mRNA 
synthesis, glycine residue(s) are added into its editing site in a planned pattern which 
will in turn shift the translational reading frame to an alternative reading frame(s). 
This will in turn lead to the translation of new proteins as (P, V, W, Y1, Y2) (Lamb 
and Kolakofsky, 2001). These proteins play a role in the inhibition of interferon 
induction and signaling which in turn activate transcription (Easton and Ring 2010). 
Moreover, Lamb and Kolakofsky (2001) addressed the role of these proteins in 
organizing viral RNA synthesis. 
 
2.3   Replication strategy of paramyxoviruses 
Members of the Paramyxoviridae typically attach to receptors on the plasma 
membrane of cells and fuse directly with the plasma membrane. These two actions 
seem to be mediated by HN, HA or G for attachment and the F protein for fusion 
(Easton and Ring, 2010).  
In the case of PMVs, e.g New castle disease virus (NDV), attachment of HN protein 
to the sialic acid binding sites on the plasma membrane of susceptible cells catalyze 
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the fusion protein into its fusogenic state through an association between HN and F 
proteins (Morrison, 2003). 
 Subsequent to this reorganization, the amino terminal end (N-terminus) of the F 
protein is able to interact with the cytoplasmic membrane of the target cell, while the 
carboxyl terminal end (C-terminus) of the same protein is anchored in the viral 
envelope. Further conformational changes of the F protein bring its two terminal 
sides in to closer proximity and that in turn brings both the target and the viral 
membrane closer and leads to membrane fusion (Lamb & Jardetzky, 2007; Morrison, 
2003).  
The viral envelope of PMV generally merges with the plasma membrane at neutral 
pH. Infected cells expressing viral glycoproteins can merge with neighboring cells 
causing syncytia formation, a feature of PMV infection (Klenk and Garten, 1995). 
Fusion of the viral envelope with cellular membranes results in the discharge of viral 
nucleocapsids into the cytoplasm where replication occurs. The positive-sense 
antigenome RNA is subsequently used as the template for the replication of the viral 
RNA. 
Transcription of mRNA starts at the 3' end of the template and is catalyzed by the 
RNA polymerase at the first transcription initiation signal sequence located next to 
the genome promoter and requires the N, P, and L proteins in addition to the genome 
as a template (Easton and Ring, 2010). 
Upon transcribing the gene, the polymerase adds a series of uridine residues at the 
5' end of the gene subsequent to the transcription termination codon and ceases 
transcription. Due to the presence of the termination signal and the short non-
transcribed intergenic region between gene start and gene stop, transcription 
produces mRNA in a chronological mode. The reinitiation of this procedure 
occasionally fails several times. Therefore, the transcription is arranged in a way to 
produce a gradient of transcription proteins with those genes closer to the promoter 
at the 3' end being expressed at higher levels than those located further away. Thus, 
L protein, coded at the 5' end of the genome, reaches the lowest level concentration, 
whereas the N protein, coded at the 3' end of the genome reaches the highest 
concentration. The new positive sense strand created is used further as a template 
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for new negative-sense genomes which can be assembled into new virus particles 
(Easton and Ring, 2010).  
Post translation, surface glycoproteins of viruses traverse a secretory pathway 
through the rough endoplasmic reticulum (ER) in a process called translocation. This 
process is directed by a short sequence known as signal peptide (SP) located at the 
N- terminus of the proteins (Hunter, 2001). These proteins undergo post translation 
modifications in the ER and Golgi apparatus and are subsequently transported to the 
cytoplasmic membrane of the infected cell, where assembly takes place (Easton and 
Ring, 2010). 
Several steps of virus assembly are mediated by matrix proteins starting from 
adherence of these proteins via their hydrophobic domains to regions of the 
cytoplasmic membrane, recruitment of nucleocapsids to these sites and 
reorganization of the nucleocapsids into structures with helical symmetry. Progeny 
virions are then set free by budding at the plasma membrane (Easton and Ring, 
2010). 
2.4   Viral proteins 
Members of the Paramyxovirinae encode 7-10 structural proteins (5-250 kilodalton 
(kDa))  in addition to 2-4 proteins encoded by additional genes which are encoded by 
overlapping ORFs of the P gene (Wang et al., 2011; Lamb and Kolakofsky, 2001). In 
general, viral proteins of all Paramyxovirinae genera are nucleocapsid associated 
proteins including: L, N, and P proteins and membrane associated proteins including: 
F, Attachment and M proteins. Among the genera of the subfamily Paramyxovirinae 
L, N, and M showed the highest sequence relation between the related proteins, 
while surface proteins are less conserved (Wang et al., 2011). 
 
The N protein (43-58 kDa) coats the genomic RNAs forming the helical structure and 
is essential for transcription and replication. The P protein (27-72 kDa) is 
phosphorylated and required for transcription and replication. The M protein, which is 
the major structural component of the PMV virion is important for particle 
morphogenesis and is considered the key determinant of virus assembly and 
budding in viruses of the family Paramyxoviridae. The L protein is the largest viral 
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protein measuring 200 to 260 kDa. It is highly conserved within the family 
Paramyxoviridae and is presumed to contain the major RNA dependent RNA-
Polymerase (RdRP) enzymatic activities in the nucleocapsid complex. This protein is 
responsible for transcription including capping and polyadenylation and replication of 
the viral RNA (Easton and Ring, 2010). 
Surface glycoproteins: an attachment protein and a fusion (F) protein are encoded in 
all Paramyxoviridae members and responsible for the steps starting from the first 
contact with the host cell membrane to the release of the viral genome into the 
cytoplasm. These proteins will be discusses in detail in the following sections (2.4.1 
and 2.4.2).  
Normally, the surface proteins are glycosylated during post-translation modification in 
the ER (Lamb and Kolakofsky, 2001), where an N-linked carbohydrate attaches 
covalently to asparagines based on the sequence motif NXT (Aspargine-X-
Threonine) or NXS (Aspargine-X-Serine), where X is any amino acid (aa) except 
proline or aspartic acid. In Simian Virus 5 (SV5), removal of oligosaccharides from 
the F1 subunit of the F protein of SV5 resulted in delayed intracellular transport and 
decreased stability of the protein (Panda et al., 2004). 
2.4.1       F protein  
F proteins of PMVs are glycosylated, heterodimer, pH independent and classified as 
type I glycoproteins (Lamb and Kolakofsky, 2001). Klenk and Garten (1994) have 
described the role the F protein of avian and mammalian PMV play in viral virulence 
which is mediated by the interaction between this protein and cellular proteases 
which regulate viral reproduction, host range and viral pathogenecity.  
The F proteins of PMV contain at their N-terminus a cleavable signal peptide that 
targets via their hydrophobic intermediate sequence the freshly translated 
polypeptide to the ER (Lamb and Kolakofsky, 2001). The signal peptide contains 
three different regions. The first is the positively charged N- terminus, the second is 
the highly hydrophobic intermediate motif and the third is the polar C- terminus which 
determines the signal peptide (SP) cleavage site (Von Heijne, 1985). Following 
translocation of these proteins into the lumen of the ER, the SP is cleaved from the 
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rest of the protein by a complex of enzymes known as signal peptidase to mature the 
protein (Hunter, 2001).  
Proteolytic cleavage is a common post translational modification of F protein (inactive 
precursor F0) to produce the active form of the glycoprotein (F1 and F2) (Klenk and 
Garten, 1994). Cleavage is carried out by intracellular enzymes (furin) which are 
provided by the infected cells. Interestingly, the cleavage efficiency and the cellular 
site where the cleavage is supposed to occur are strongly influenced by the 
sequences of the furin recognition site as has been shown in some NDV strains. For 
instance, if only a single basic aa is present at the furin recognition site, the inactive 
precursor F0 cannot be cleaved as usual by the protease enzymes provided in the 
Golgi apparatus. This protein can then alternatively be cleaved by extra enzymes 
(tryptase Clara) in the respiratory tract (Klenk and Garten, 1994). Therefore, such 
infections are restricted to the respiratory tract and cannot induce systemic infections. 
In comparison, PMV encoded F proteins with the furin recognition site R-X-K-R/R (R: 
arginine; K: lysine, X: any aa) can be cleaved in the trans Golgi apparatus and thus 
induce systemic infection and death (Klenk and Garten, 1995). Post cleavage, 
disulfide linked F1 and F2 fusogenically active subunits are formed (Scheid and 
Choppin, 1974). The newly formed fusion peptide (FP) positioned at the amino 
terminus of the F1 inserts into the target membrane initiating its fusion (Hernandez et 
al., 1996; Morrison, 2003). The hydrophobic domain FP is a distinctive feature for 
most fusion glycoproteins (Hernandez et al., 1996). The sequence of FP can regulate 
syncytia formation (Gething et al., 1986).  
F proteins of PMVs consist of repeat patterns of seven aa, positioned from a~g and 
called heptad repeats (HR). Amino acids of each HR are positioned to form helical 
wheels in the α helices coiled coil structure. Residues at positions a and d of each 
wheel are usually hydrophobic and form the interior hydrophobic core of the coiled 
coil. When leucine residues are predominant at the a positions of the HRs, this 
motive is recognized as a leucine zipper motif (LZ) where leucine residues form the 
teeth of the zipper. This motif provides a bonding force in the analogous α helices 
with a hydrophobic interior allowing the motif to fasten together (Franke et al., 2006; 
Joshi et al., 1998; and2). Two HR were predicted for the F protein of SV5; HRA, 
which is located at the C- terminus of the FP and HRB, which is located at the N- 
                                            
2
 http://encyclopedia.thefreedictionary.com/Leucine+zipper 
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terminus of the tansmembrane domain (TM). Both are mapped to the protein 
anchored subunit F1 (Joshi et al., 1998). The hydrophobic TM domain (around 20 
residues) is located near the C- terminus of the protein. Once the TM domain is 
synthesized, the translocation machinery of the polypeptide chain into the ER stops. 
TM domain anchors the protein in the membrane, leaving a short cytoplasmic tail (20 
– 40 aa) at the C- terminus of the protein in the cytoplasm and the rest of the protein 
extracellular (equivalent to ER lumen/ virion surface/ cell surface) which is typical for 
type I orientation proteins (Lamb and Kolakofsky, 2001). 
Residue substitutions and mutations within several domains of the F protein including 
cleavage site (CS), FP, HRs, LZ, and TM can influence activation of this protein 
(Watanabe et al., 1992; Reitter et al., 1995; Sergel-Germano et al., 1994; Morrison et 
al., 2003; Bosch et al., 1989).  
The crystal structure of NDV uncleaved F protein was resolved by Morrison 2003, 
showing homotrimers which are intertwined with each other, each consisting of head, 
neck, and long stalk. The stalk in that 3 dimensional (3D) diagram is made up of 
coiled coil trimers that consist of HRI and HRII.  
Current studies characterizing ferlavirus glycoproteins are limited. Franke et al. 
(2006) characterized and compared portions of the F gene from fourteen PMV of 
reptilian origin and predicted conserved domains along this gene. Based on the 
entire sequence of F gene of both FDLV and Gono GER85, a universal model of F 
protein was predicted by Franke et al. (2006). 
2.4.2         Attachment protein (HN, H or G) 
HN glycoproteins are the main antigenic factor of PMV (Lamb and Kolakovfsky, 
2001) The attachment protein has different names based on its activities; for instance 
haemagglutinin (HA) when it lacks neuraminidase, but agglutinates red blood cells 
(RBCs), as for morbilliviruses, or glycoprotein (G) when it has neither function like in 
henipaviruses, or haemagglutinin-neuraminidase (HN) when it performs both actions 
as in avula-, respiro- and rubulaviruses (Chua et al., 2000; Morrison, 1988; Lamb and 
Kolakovfsky, 2001). Merz et al. (1981) documented that the two different functions 
may occur at one sialic acid site, while Morrison and Portner (1991) have 
documented that both activities may occur at two distinct sialic acid sites. Regarding 
the HN protein of NDV, Lamb and Kolakovfsky (2001) have suggested that both 
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functions may happen at one site. The attachment protein is pH dependent; the 
acidic atmosphere is favorable for hemagglutination, and neuraminidase activity 
(Lamb & Kolakofsky, 2001). Beside these two functions, HN protein functions to 
trigger the fusion process (Zaitsev et al., 2004; Yuan et al., 2011). 
Morrison (1988) has compared the protein sequences of attachment proteins of 
several paramyxoviruses (sendai virus, simianvirus type 5, NDV, and 
parainfluenzavirus type 3) and found two short but very conserved regions. The first 
contained the sequence NRKSCS (N: aspargine; S: serine; C: cysteine) and the 
second contained the sequence GAEGR (G: glycine; A: alanine; E: glutamic acid). 
The conservation of these regions has directed Morrison to suggest the potential 
importance of these sites to the HN protein functionality and structure. Mirza et al. 
(1994) have studied the effect of several mutations introduced by site directed 
mutagenesis for the motif NRKSCS, on the several functions assigned to this protein 
and found that any mutation for each of the four aa residues (N-R-K-S) of this motif 
reduced the neuraminidase dramatically.  
Several reports have demonstrated the structures of many PMV attachment proteins 
which consist of a transmembrane domain, stem and head (Lamb and Kolakofsky, 
2001; Yuan et al., 2011). Some reports demonstrated the presence of a cytoplasmic 
tail at the N- terminus of the proitein in addition to the previous components in the HN 
protein structure (Chanock et al., 2001).   
The transmembrane domain is the single hydrophobic domain located close to the N- 
terminus that is non cleavable and works as both signal and anchorage motif (Lamb 
and Kolakofsky, 2001). This motif functions to target the freshly translated poly 
peptide chain to the ER and ensuring their translocation. This process will in turn 
bring the TM domain in the lipid bilayer, leaving the N- terminus of the protein 
including the cytoplasmic tail (as for the low pathogenic parainfluenzavirus type-3 
PIV-3) in the cytoplasm and the C- terminus of the protein extracellular which is 
typical for type II protein orientation (Chanock et al., 2001).  
The head was proposed to contain neuraminidase domains where the sialic acid 
binding sites were located while the stalk was predicted to have specific sites that 
were important for triggering the F protein. Therefore, mutations in this region, 
depending on their exact localization, might either affect fusion activation only or 
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might in addition have a double affect on fusion and neuraminidase activity (Yuan et 
al., 2011). 
2.5   Paramyxoviruses in reptiles 
Reptile PMV are important disease etiological factors of snakes and have been 
isolated from both private and zoological collections (Jacobson, 2007). The first 
documentation of a PMV outbreak in reptiles was from Zurich in Switzerland in 1976, 
with an explosive respiratory disease in farmed Fer-de-lance snakes (Bothrops atrox) 
(Fölsch and Leloup, 1976). The causative agent of that outbreak was FDLV, named 
after the infected snakes and isolated by Clark et al. (1979). In that study, Clark 
suggested that FDLV is of ectothermic vertebrate origin based on several 
observations, including low temperature requirement for replication (the optimum 
range of 25-30 Cº), efficient replication in all reptilian cell types and lack of antigenic 
relation to all known mammalian and avian Myxoviruses. Consequent cases were 
reported in several snake families including Elaphidae, Colubridae, Boidae and 
Pythonidae (Ahne et al., 1987; Essbauer and Ahne, 2001; Marschang et al., 2009; 
Abbas et al., 2011). Kurath et al. (2004) sequenced the full genome of FDLV and 
found the presence of the unique unknown gene (U) between the N and P genes. 
Kurath et al. (2004) also found other criteria when comparing the sequences of the 
complete genome of FDLV with other established PMVs including low levels of 
sequence identity (ICTV, 2011). All previously mentioned characteristics supported 
grouping of described PMV of reptilian origin in the new genus Ferlavirus within the 
subfamily Paramyxovirinae with FDLV as the type species (Kurath et al., 2004, 2009; 
Marschang, 2011).  
In snakes, the target organ for ferlaviruses seems to be the lung. In general, PMV 
infections should be considered in snakes with respiratory distress, anorexia, 
emaciation, lethargy and sudden death (Jacobson et al., 2007). However, ill snakes 
can display neural symptoms like head tremor, weak muscles, opisthotonus 
(stargazing), and flaccid paralysis (Fölsch and Leloup, 1976; Jacobson et al., 1981;).  
Gross post mortem examination often reveals exudative pneumonia with pulmonary 
lesions, congestive and haemorrhagic lungs, enlarged pancreas/ liver and 
fibrinonecrotic exudate in the coelomic cavity which often form aggregates or clumps 
(Stacy and Pessier, 2007).   
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Microscopically, histologic changes are often observed in affected lungs including 
hyperplasia of respiratory epithelial cells and variable diffuse interstitial infiltrates of 
lymphocytes, heterophiles, plasma cells and macrophages (Jacobson, 1992, 1997; 
Stacy and Pessier, 2007). In some cases, epithelial syncytial cell formation or 
intraepithelial eosinophilic intracytoplasmic inclusions are also formed (Homer et al., 
1995). While proliferative pneumonia is suggestive of PMV infection, other chronic 
non viral pneumonias including bacterial and parasitic pneumonias should be taken 
into acount (Homer et al., 1995).  
PMV infections have also been doccumented in lizards, though less frequently than 
in snakes (Jacobson, 2007). Antibody surveys of captive and wild-caught lizards 
often demonstrate high level antibody titres against PMV (Marschang et al., 2002; 
Gravendyck et al., 1998; Marschang et al., 2009). A paramyxo-like virus was first 
isolated from a false tegu (Callapistes maculatus), however, no clinical signs 
associated with the infection were reported (Ahne and Neubert, 1991). The first 
report documenting PMV infection associated with clinical signs was in an epidemic 
of proliferative pneumonia caused by PMV infection in a group of caiman lizards 
(Jacobson et al., 2001). A PMV was isolated from a clinically healthy wild caught 
mexican lizard (Marschang et al., 2002). In 2012, a case study documented the first 
detection of PMV in apparently healthy bearded dragons (Pogona vitticeps) from a 
rescue centre in Munich (Abbas et al., 2012). 
In chelonians, the information available on ferlavirus infections is even rarer 
(Essbauer and Ahne, 2001; Jacobson, 2007; Marschang et al., 2009). In one report, 
PMV were described in a group of Hermann’s (Testudo hermanni) and spur-thighed 
(T. graeca) tortoises in Switzerland associated with dermatitis (Zangger et al., 1991). 
In another case, a double infection of PMV and herpesvirus was detected in South 
Africa within a mixed group of tortoises during an epidemic (Oettle et al., 1990). The 
sole PMV isolate (Ther GER99) reported to date was obtained from a Hermann’s 
tortoise in Germany. The infection was associated with pneumonia. This isolate was 
identified as a ferlavirus based on morphological, biochemical and molecular 
characteristics (Marschang et al., 2009). In 2010(a), Papp et al. documented a 
ferlavirus infection in a leopard tortoise (Geochelone pardalis babcocki) with lethargy 
and respiratory distress. The viruses found in that animal differed on a genomic level 
15 
 
 
 
from that previously found in a Hermann’s tortoise highlighting the lack of species 
specificity within these viruses (Papp et al., 2010a). 
Concurrent infections have been documented along with ferlavirus infections in 
reptiles, mainly with at least two ferlavirus strains (Papp et al., 2010a&b) and 
infection with other viruses like reoviruses (Gravendyck et al., 1998; Marschang et 
al., 2002; Abbas et al., 2011), or with both reo- and adenoviruses (Abbas et al., 
2011). 
Hyndman et al. (2012) described a new PMV (Sunshine) from Australian pythons 
with neuroresperatory disease. Phylogenetic calculations of the complete genome 
has revealed clustering within the family Paramyxoviridae but could not be assigned 
to any of the subfamilies Paramyxovirinae or Pneumovirinae. This virus is quite 
distinct from the previously described ferlaviruses. 
Serological relatedness was documented via Haemagglutination inhibition (HI) by 
Blahak (1995) between snake PMVs and avian PMV serotypes 1 and 7 (aPMV). 
However no antigenic relatedness was observed between PMVs of reptile origin and 
members of mammalian and avian PMV serotypes (1,2,3,4,6,7,8,9) (Richter et al., 
1996). Cross reaction was noticed within PMVs of reptile origin when rabbit anti sera 
originally directed against neotropical virus (NTV), reacted as well against other PMV 
of reptile origin including NTV (Clark et al., 1979). A recent study has described cross 
reactivity within ferlaviruses (Rösler et al., 2013), where an antiserum originally 
directed against ferlavirus isolate Crot GER03 reacted similarly against all of the 
squamate and chelonid ferlaviruses. 
2.6   Taxonomy of ferlaviruses  
Previous studies compared ferlaviruses based on partial genome sequences: L and 
HN genes (Ahne et al., 1999) and L and F genes (Franke et al., 2001). While Ahne et 
al. (1999) proposed classification of these viruses into two subgroups designated A 
and B with intermediate isolates, Franke et al. (2001) suggested the classification 
into three clusters designated A, B and C. Unfortunately, Franke did not integrate 
isolates from the previous study, therefore, members of the three clusters did not 
correspond to those from Ahne et al. (1999). This inconsistency was resolved by 
Marschang et al. (2009) based on partial genome sequences (L, HN and U genes) 
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when comparing several PMV isolates from snakes, lizards, and a tortoise. All PMV 
of squamate origin (snakes and lizards) included in that study clustered into two 
subgroups designated A and B. The only chelonian PMV (Ther GER99) available, 
isolated from a Hermann’s tortoise, was found to cluster very close to the squamate 
PMVs based on partial L gene sequence. However, this virus could not be assigned 
to any of the known subgroups (A, B) within the proposed Ferlavirus genus 
(Marschang et al., 2009). 
A recent study by Abbas et al. (2011) based on partial genome sequences of the L, 
HN, and U genes of PMVs from a corn snake (Patherophis guttatus) revealed a new 
PMV type. This study incorperated information on almost all of the PMV included in 
the previous study by Marschang et al. (2009). The novel PMV showed moderate 
distances to all members of subgroups A and B suggesting a new classification; the 
first representatives of subgroup C within the newly accepted genus Ferlavirus. A 
new study from Papp et al. (2013), based on partial genome sequence of the L, HN, 
and U genes of a PMV from a masked water snake (Homalopsis buccata) has 
revealed the second representative of subgroup C. The exact taxonomic positions of 
these different clusters and whether they represent different species within the genus 
remains to be determined. The single chelonian isolate (Ther GER99) has 
consistently been shown to cluster within the genus Ferlavirus but as a sister group 
to the A, B, and C subgroups (Marschang et al., 2009; Abbas et al., 2011). 
Several studies (Ahne et al., 1999; Marschang et al., 2009; Franke et al., 2001) have 
shown that ferlaviruses are not species specific. In one study, PMVs from lizards 
were shown to be closely related to various snake isolates and did not form a 
separate cluster (Marschang et al., 2009); in another, two PMVs detected in a 
leopard tortoise clustered with those of squamate origin (Papp et al., 2010a), 
indicating no species specificity. 
2.7   Detection of Ferlaviruses 
Ferlaviruses have been isolated from both living animals (oral and cloacal swabs) 
(Pees et al., 2010) and from different tissues including kidney, small intestine, lung, 
trachea, liver, and heart (Blahak, 1994; Papp et al., 2010b; Abbas et al., 2011). The 
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most commonly used methods to detect ferlaviruses in reptiles are described in the 
following. 
Virus isolation in cell culture is the first method that was used for the detection of 
ferlaviruses. It has often been used for screening snakes, lizards, and tortoises for 
ferlaviruses (Marschang et al., 2009; Papp et al., 2010a&b; Abbas et al., 2011).  
Clark et al. (1979) isolated the first FDLV by inoculating lung suspension from a 
Bothrops that suffered a fatal infection into the embryonated eggs of the snake 
Cyclagras gigas. The homogenate of the infected embryo was then inoculated into a 
wide range of reptilian and mammalian cell lines and caused cytopathic effects (CPE) 
when incubated at 30 ºC.  
Reptile PMV can grow readily on several reptilian cell lines including iguana heart 
cells (IgH2) (Ahne et al., 1999), viper heart cells (VH2) (Clark et al., 1979; Richter et 
al., 1996), and rattlesnake fibroma cells (Jacobson et al., 1980), or on mammalian 
cell lines like vero cells (Mayr et al., 2000) and BHK/21 from Syrian hamster (Clark et 
al., 1979). They have also been propagated in embryonated gecko and chicken eggs 
(Clark et al., 1979). Depending on the cell type used, the CPE, which includes all 
morphological and pathological changes, varies from spindling and rounding of cells 
to giant cell formation followed by cell detachment and cell lysis (Clark et al., 1979; 
Franke et al., 2001). In some cases, CPE formation may take a long time; for that 
reason blind passages are of great importance for virus recovery (Origgi and Paré, 
2007).  
Nowadays and most commonly, diagnosis of PMV infection in reptiles is confirmed 
using reverse-transcription followed by PCR (RT-PCR). This molecular based 
technique is very sensitive. In order to obtain molecular information from PMVs of 
reptile origin, Ahne et al. (1999) described a nested RT-PCR protocol using synthetic 
oligonucleotide primers targeting portions of the L and HN genes.  
Subsequently, additional primer design was accomplished targeting portions of 
several genes in addition to the L gene. Franke et al. (2001) described a semi nested 
RT-PCR protocol targeting partial F gene sequence. Marschang et al. (2009) 
described new degenerate primers targeting partial sequances of the HN gene along 
with several primers targeting partial sequence of the U gene. Those primers 
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described in Ahne et al. (2009) have been further used for the detection and 
characterization of new ferlaviruses (Abbas et al., 2011; Papp et al., 2013).  
 A comparison of sequences of the L, HN, and U genes (Marschang et al., 2009) 
showed that the L gene was the most conserved gene, followed by the HN gene, 
while the U gene was the least conserved. Therefore, the protocol described by Ahne 
et al. (1999) targeting a partial sequence of the L gene has been established as a 
standard molecular diagnostic technique for the detection and characterization of 
ferlaviruses in reptiles (Franke et al., 2001; Kindemann et al., 2001; Marschang et al., 
2009; Abbas et al., 2011). 
HI testing is one of the serological tests that has been used to reveal the antigenic 
relationship between ferlaviruses and between these viruses and others including 
avian and mammalian PMV (Richter et al., 1996; Blahak, 1995; Rösler et al., 2013).  
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3     Materials  
     3.1     Laboratory equipment 
Table 3.1:  Equipment used for cell culture and virus isolation  
Name of article Resource Application 
Biosafety cabinet Heraeus Kendro Laboratory Products, Hanau. Sterile cabinet 
Fireboy S1000 Tecnorama, Fernwald Bunsen burner 
CO2-Incubator Binder Tuttlingen Incubator 
Sterile workbench Prettl, Bempflingen Laminar flow 
cabinet 
Inverted light microscope Leitz, Wetzlar Microscope 
 
Table 3.2:  Equipment used for processing diagnostic samples  
Name of article Resource Application 
Varifuge 3.2 RS,  Heraeus Osterode  Centrifuge 
Branson-250 Sonifier Ausrüstung 707 
Schwäbisch Gmünd 
Disruption of cell 
membranes 
 
Table 3.3: Equipment used for the extraction of viral RNA/ RT-PCR 
Name of article Resource Application 
Centrifuge 5415 R  Eppendorf, Wesseling Berzdorf Table centrifuge 
Centrifuge 5415 D  Eppendorf, Wesseling Berzdorf Table centrifuge 
Vortex Genie 2™  Bender & Hohlbein AG, Zurich 
(CH) 
Vortexer 
Dry Bath Incubator  Kisker, Steinfurt Heating block 
Peqlab Primus 35 Adv. Peqlab, Erlangen Thermal cycler 
Doppio Thermocycler  VWR, Darmstadt Thermal cycler 
Mastercycler Gradient  Eppendorf, Wesseling Berzdorf Thermal cycler 
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Table 3.4: Equipment used for gel electrophoresis/ Gel extraction 
Name of article Resource Application 
Sterile Surgical Blades, (Aesculap Ag, Tuttlingen) Gel extraction 
Consort 443, Electrophoresis Keutz, Reiskirchen Power supply 
EC-105,  Electrophoresis Biometra, Gottingen  Power supply 
Infinity  1000 Vilber 
Lourmat,Eberhardzell 
UV-transilluminator 
Agagel Mini G45/2- Gel 
chamber 
Biometra, Gottingen Gel electrophoresis 
 
3.2.      Cell lines 
Table 3.5: Description of cell lines used in experimental trials 
Cell type Reference 
No. 
Source Description 
Viper heart 
cells (VH2) 
ATCC, 
CCL-140 
American 
Type Culture 
Collection 
USA 
Established from the heart of a 
female Russells Viper (Vipera 
russelli) 
Iguana heart 
cells (IgH2)  
ATCC, 
CCL-108 
American 
Type Culture 
Collection 
USA 
Established from the heart of a 
green iguana (Iguana iguana) 
 
Table 3.6: Other materials used for different applications 
Name of article Source  application 
BD Falcon BD Falcon™ 
with vented cap (75 cm3), 
Becton Dickinson GmbH, 
Heidelberg 
Tissue Culture Flasks 
30mm diameter Cellstar®  Greiner Bio-One GmbH, 
Frickenhausen 
Tissue culture dishes 
BD FalconTM 15 ml 
polypropylene conical tubes 
BD Biosciences Discovery 
Labware, Heidelberg 
Sample preparation 
1000. 200, 10 μl Pipettes 
0.5 ml PCR Tubes 
Biozyme scientific GmbH, 
Oldendorf 
RNA preparation 
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3.3    Chemicals, reagents and solutions 
      3.3.1       Cell culture and virus isolation 
Water, deionised and filtered  
Milli-Q® water (Millipore GmbH, Eschborn) 
Dulbecco´s modified Eagle medium (DMEM) 
13.4 g/l DMEM medium, 4.5 g/l D-glucose, with L-glutamine, were all dissolved in 1 l 
Milli-QR water. 2.2 g/l NaHCO3 (Merck KGaA, Darmstadt) was added and the solution 
was stirred thoroughly until the ingredients were dissolved completely. After that, the 
medium was sterile filtered and kept at 4°C for future use. 
Amphotericin B 
The lyophelized Amphotericin B (Biochrom AG, Berlin, Germany) was suspended in 
5 ml Milli-Q® water. The final concentration of the stock solution was about 250 
µg/ml.  
Gentamicin sulfate solution 
640 U/mg Gentamicin sulfate (Biochrom AG, Berlin, Germany) dissolved in Milli-Q® 
water to achieve a concentration of approx. 3200 U/ml in the stock solution. 
Penicillin-G solution 
Penicillin-G (1664 U/mg) (Biochrom AG, Berlin, Germany) was dissolved in Milli-Q® 
water to achieve a concentration of about 100000 U/ml in the stock solution. 
Streptomycin sulfate solution 
Streptomycin sulfate (758 U/mg) (Biochrom AG, Berlin, Germany) was dissolved in 
Milli-Q® water to achieve a concentration of about 190000U/ml in the stock solution. 
 
FBS 
Fetal bovine serum (FBS) (Biochrom AG, Berlin, Germany) 
Non essential amino acids (NEA) 
(Biochrom AG, Berlin, Germany)  
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Table 3.7: Maintenance medium Dulbecco´s modified Eagle medium (DMEM) for cell culture 
and virus isolation.  
Concentrations used for virus isolation are written in Italics 
Constituent  Volume in ml /500 ml DMEM Final 
Concentration  
FBS                                                  50 
10 
10 % (v/v) 
2%  (v/v) 
NEA 
 
5 
5 
 1% (v/v) 
 1% (v/v) 
Penicillin-G-solution   
 
2 
2 
200 U/ml 
200 U/ml 
Gentamycin sulfate-solution  
 
2 
2 
6.4 U/ml 
6.4 U/ml 
Streptomycin sulfate-solution  2 
2 
380 U/ml 
380 U/ml 
Amphotericin B-solution  
  
4 
4 
0.5 μg/ml 
0.5 μg/ml 
 
Table 3.8: Trypsin-versen (TV) solution 0.05 %    
The ingredients were dissolved in Milli-Q® water, adjusted with 1 M NaOH to pH 7.00, 
and sterile filtered and kept at -20 °C for future use.  
 
Ingredient /  Company Volume g/l Concentration 
KCl (Merck KgaA, Darmstadt) 0.20 3 mM) 
KH2PO4 (Merck KgaA, Darmstadt) 0.20 1 mM  
Na2HPO4x12 H2O (Merck KgaA, Darmstadt) 2.31 6 mM  
CaCl2 x 2 H2O (Merck KgaA, Darmstadt) 0.132 0.9 mM 
NaCl (Merck KGaA, Darmstad) 8.00 136 mM 
Trypsin-dry substance (Biochrom AG, Berlin) 0.5 1:250 U/mg 
Versen (Titriplex III) (Merck KgaA, Darmstadt) 1.25 3 mM  
Streptomycin sulfate (Biochrom AG, Berlin) 0.05 37900 U/l 
Penicillin-G (Biochrom AG, Berlin) 0.06 100000 U/l  
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3.3.2      Other materials used for processing clinical samples 
Table 3.9: DMEM supplemented with 2x antibiotic concentration (2x AB DMEM) used for 
processing diagnostic samples 
Constituent Volume in ml /500 
ml DMEM 
Final Concentration 
Penicillin-G-solution   4 400 U/ml 
Gentamycin sulfate-solution  4 12.8 U/ml 
Streptomycin sulfate solution  4 760 U/ml 
Amphotericin B-solution  8 1 μg/ml 
 
3.3.3     Extraction of viral RNA 
Nuclease-free water  
(QIAGEN Hilden, Germany) 
 
Diethylpyrocarbonate (DEPC) as nuclease free water  
10 ml DEPC (Fluka, Buchs SG, Switzerland) was dissolved in 90 ml of absolute 
ethanol to reach a concentration of 10% of the DEPC stock solution. This solution 
was placed in brown bottles and kept in the dark. A 1% working solution was made 
by mixing 1ml of the stock solution in 99 ml sterile Milli-Q® water. The mixture was 
then autoclaved at 120 °C for 30 min and stored at 4 °C until use. 
 
Silica-matrix 
60 g of Silicon dioxide (SiO2) (Sigma-Aldrich Chemie GmbH, Steinheim, Germany) 
was added to a measuring cylinder and filled with DEPC water up to 500 ml and 
mixed thoroughly. The cylinder was placed at room temperature for 24 hours to allow 
good sedimentation. Using a pipette, 430 ml of the supernatant were removed and 
discarded. The cylinder was again filled with DEPC water up to 500 ml to re-suspend 
the sedimented Silica particles. Following an additional sedimentation of 5 hours, 440 
ml of the supernatant were discarded. The pH of the solution was adjusted to 2.00 by 
the addition of 600 µl of 25 % HCl (6.85 M). The solution was shaken to re-suspend 
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the silica, and then aliquoted into 1.5 ml nuclease free tubes in 1 ml portions, 
autoclaved at 121 °C for 15 min and kept at room temperature in the dark. 
Tris-HCl 
12.1 g Tris-HCl (Carl Roth GmbH & Co, Karlsruhe, Germany) was dissolved in 1L 
Milli-Q® water and the pH of the solution was adjusted to 6.40 with 0.01 M HCl. The 
solution was stored at 4 °C. The final concentration of Tris- HCl solution was 0.1 M  
Ethylenediamine-tetraaceticacid (EDTA)  
7.44 g EDTA (Carl Roth GmbH & Co, Karlsruhe, Germany) was dissolved in 100 ml 
DEPC water to reach a final concentration of about 0.2 M. With 5N NaOH, the pH of 
the solution was adjusted to 8.00. The solution was then autoclaved at 120 °C for 30 
min and stored at 4 °C until use. 
Lysis buffer (LB) 
1 ml Triton X-100 (Sigma-Aldrich Chemie GmbH, Steinheim, Germany), 48 g 
Guanidinethiocyanate (Carl Roth GmbH & Co, Karlsruhe, Germany), 8.8 ml of 0.2 M 
EDTA (pH 8.0) and 40 ml 0.1 M Tris HCl (pH 6.40) were mixed together in a 250 ml-
glass beaker. The beaker was wrapped in aluminum foil and placed in a water bath 
(56 °C, 15 min) to dissolve the ingredients. The solution was then stored in the dark 
at room temperature for future use. 
Washing buffer (WB) 
48 g Guanidinethiocyanate and 40 ml 0.1 Tris HCl (pH 6.40) were mixed in a 250 ml-
glass beaker. The beaker was wrapped with aluminum foil and placed in a water bath 
(56 °C, 15 min) to dissolve the contents. The solution was stored in the dark at room 
temperature until use. 
70 % Ethanol 
35 ml of absolute ethanol Rotipuran® 99.8 % (Carl Roth GmbH & Co, Karlsruhe, 
Germany) and 15 ml Milli-Q® water were mixed in a nuclease free 50 ml tube. The 
tubes were then kept at room temperature. 
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RNase inhibitor 
RiboLockTM RNase Inhibitor 40 U/µl (Fermentas GmbH, St. Leon-Rot, Germany) was 
kept frozen at – 20 ºC until use. 
Acetone 
Acetone Rotipuran® 99.8 % (Carl Roth GmbH & Co, Karlsruhe, Germany) was kept in 
nuclease free 50 ml plastic tube and stored at room temperature. 
3.3.4:     Reverse transcription polymerase chain reaction (RT-PCR) 
Table 3.10: Chemicals and reagents used for RT-PCR (Fermentas, St. Leon-Roth) and long-
RT-PCR (Analytik Jena AG, Jena).  
Those used for long RT-PCR are written in Italics. 
Reagent  Volume/ 
25µl 
Final 
concentration 
10X Taq buffer (with KCl)  2.5 μl 1x 
10x PCR buffer long PCR, (with KCl and 
(NH4)2SO4 ) 
2.5 μl 1x 
25 mM MgCl2  2.5 μl 2.5 mM 
25 mM  MgCl2 solution long PCR 2.5 μl 2.5 mM 
primer 2.5 µl 1 µM 
dNTPs 2.5µl 0.2 mM 
dNTPs 3µl 0.24 mM 
40 U/μl  RiboLock™ RNase Inhibitor 0.15 μl 0.24 U/μl 
200 U/μl  RevertAid™ Reverse 
Transcriptase 
0.35 μl 2.8 U/μl 
5 U/μl  Taq DNA Polymerase  0.25 μl 0.05 U/μl 
5 u/μl  Innu Taq Long Range Polymerase 0.25 μl 0.05 U/μl 
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Primers 
Primers were ordered from biomers.net (Ulm, Germany). The stock solution (100 
pmol/μl) was then prepared by dissolving the lyophilized primers with the appropriate 
amount of Milli-QR water (calculated by the provider) into 1.5 ml RNase-free centrifuge 
tubes. The tubes were then vortexed for five seconds and allowed to stand on ice for 
15 min. Subsequently, the tubes were again shortly vortexed and centrifuged for five 
seconds to ensure the proper mixing of the primer components. The stock solution 
was tenfold diluted in Milli-QR water to achieve working solutions of 10 pmol/μl. The 
final concentration of the primers in the master mix was 1 μM.  
 
 
dNTPs 2´- Desoxynucleosid-5´-Triphosphat dATP, dCTP, dGTP, and dTTP (100 mM, 
Fermentas,St. Leon-Rot) 
A working solution (2 mM) was prepared from the stock solution (100 mM) by adding 
40 μl of each nucleotide of the stock solution to 1840 μl Milli-QR water. After mixing 
well, the solution was aliquoted and stored at -20° C until use. The final concentration 
of each dNTP in the master mix was 0.2 mM in the normal RT-PCR and 0.24 mM in 
the long RT-PCR. 
 
3.3.5 Gel electrophoresis 
1x TAE-buffer (Roth, Karlsruhe,Germany) 
 
The stock solution of 50x TAE buffer consisted of 242 g Tris, 57.1 ml acetic acid and 
100 ml 0.5 M EDTA, maintained at pH 8.00. To prepare the working solution (1x), 40 
ml 50x TAE buffer were diluted with 1960 ml Milli-QR water. 
 
 
Ethidium bromide solution (Roth, Karlsruhe,Germany)  
 
The working solution was prepared by dissolving 10 mg ethidium bromide in 10 ml 
aqua dest under the laminar flow cabinet. This solution was stored in the dark and 
handled carefully using nitrile gloves. 
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Table 3.11: Other chemicals used for gel electrophoresis 
  
Chemical/ Reagent Source 
Agarose Roth (Karlsruhe)/Germany 
6x Loading Dye  Fermentas (St. Leon-Roth),Germany 
GeneRuler™ 100 bp DNA Ladder  Fermentas (St. Leon-Roth),Germany 
GeneRuler™ DNA Ladder Mix  Fermentas (St. Leon-Roth),Germany 
 
3.3.6 Gel extraction 
Chemicals, regents and materials 
 
PeqGOLD Gel-Extraction Kit (PEQLAB, Erlangen). Detailed protocol: see methods 
section. 
3.4   Software programs for sequencing and phylogenetic analyses 
Table 3.12: Software programs for processing DNA sequences 
Program 
description  
Producer Application 
Staden Package 
version:1.7.0 
(2003.0) Pregap4 
and Gap4 
Andrew Withwham,  
(Bonfield et al., 1995) 
 
Genome assembly 
program: assembling, 
editing, correcting and 
aligning DNA sequence 
BioEdit 7.0.5.3 
(2005)  
Ibis therapeutics Carlsbad CA92008, 
(Hall, 1999) 
Alignment editor 
NCBI BLAST, 
BlastX and BlastN  
http://blast.ncbi.nlm.nih.gov/Blast.cgi 
 
Sequence analysis and 
source for additional 
sequences 
 
Table 3.13: Software programs for phylogenetic analyses 
Program description  Producer Application 
PHYLIP Package, 
Versions 3.64  
Felsenstein, University of 
Washington (Felsenstein, 
1989) 
 
Phylogenetic analysis 
Mega 5.05 (2011)  Tamura et al., 2011 Phylogenetic analysis 
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3.5   Processing of clinical samples  
     3.5.1       Samples 
During the period from 2009 until the end of 2011, a total of 495 clinical samples from 
251 snakes were tested for the occurrence of PMV by RT-PCR as described in the 
methods section. The snakes originated from private collections, mostly from 
Germany under cooperation with the Clinic for Birds and Reptiles, Leipzig University, 
and in a few cases from Hungary, Great Britain, Italy, and Denmark. All clinical 
samples (different organs, oral/ cloacal swabs, and tracheal washes) were collected 
by veterinary practitioners. List of samples: see supplementary data, Table 1. 
   3.5.2         Primers 
Table 3.14: Description of oligonucleotide primers for amplification of partial sequences of L, 
U, and HN genes of ferlaviruses 
Name  Sequence Position 
5’ in FDLV 
References 
L 5F GCAGAGATTTTCTCTTTCTT 9768 Ahne et al., 1999 
L 6R AGCTCTCATTTTGTATGTCAT 10394 Ahne et al., 1999 
L 7F TAGAGGCTGTTACTGCTGC 9811 Ahne et al., 1999 
L 8R CATCTTGGCAAATAATCTGCC 10376 Ahne et al., 1999 
U-cons Fwd-out ACCARYYATRRRCHTGYVRAR
ATG 
1571 Marschang et al., 
2009 
U-cons Rev-out GTTWGCCATTMTTACTGGATC
TC 
2254 Marschang et al., 
2009 
U-cons Rev-in ATCTCAGATACCTTTGATCCTA
AG 
2236 Marschang et al., 
2009 
U-cons Fwd-in RARATGATTAAAGAAAACCTAG
G 
1589 Marschang et al., 
2009 
HN 1F  AAATCCTGCAGTACCGTGGCA 7532 Ahne et al., 1999 
HN 2R  AGATATCTGTGTAAACTCCTG 8210 Ahne et al., 1999 
HN cons F1  AATGTYRTRGARGATGARAG 7583 Marschang et al., 
2009 
HN cons R2  CARGGYYYGTTMCCWGGYCT
YG 
8154 Marschang et al., 
2009 
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3.5.3             RT-PCR Positive controls 
09/05/03 Crot GER03 (Marschang et al., 2009) 
 
06/03/09 Pangut GER09 (Abbas et al., 2011) 
 
3.6        Materials used for optimization trials 
The established RT-PCR protocol from Ahne et al. (1999) targeting partial sequence 
of the L gene has been used as a standard diagnostic detection tool for PMV in 
reptiles. In order to increase the specificity of this protocol, multiple trials were 
performed targeting this L gene.  
3.6.1    Optimization trials of RT-PCR targeting a portion of the L gene  
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3.6.1.1 Chemicals and reagents used for optimization trials of the RT-PCR targeting a partial sequence of the L gene (Ahne 
et al., 1999). 
Table 3.15: RT-PCR matrix with different MgCl2 concentrations 
Reagent 1st round RT-PCR 2nd round RT-PCR Final concentration 
 volume in 25 µl total 
amount 
volume in 25 µl total amount  
Millipore water 9.25 μl 12.75 12.25 11.75 11.25 μl  
Taq-Buffer+KCl 10x  2.5 μl 2.5 μl 1x 
25 mM MgCl2 2.5 μl 1 μl 1.5 μl 2 μl 2.5 μl 1 
mM 
1.5 
mM 
2 
mM 
2.5 
mM 
2 mM DNTPs 2.5 μl 2.5 μl 0.2 mM 
10 pmol/μl Primer Farward 2.5 μl 2.5 μl 1 pmole/µl 
10 pmol/μl Primer reverse 2.5 μl 2.5 μl 1 pmole/µl 
5 u/μl Taq DNA-Polymerase 0. 25 μl 0. 25 μl 0.05 U/μl 
40 u/μl Ribolock inhibitor 0.15 μl  0.24 U/μl 
200 u/μl RT   
(ReverseTranscriptase) 
0. 35 μl 2.8 U/μl 
Template 2.5 µl of extracted viral RNA 
sample 
1µl of the 1st round RT-PCR 
products 
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3.6.1.2           Isolates 
All ferlavirus isolates were identified as PMV by syncytia formation on VH2, 
sensitivity to chloroform and by detection of the partial L gene sequence (RT-PCR- 
Ahne et al., 1999) followed by sequencing. 
Table 3.16: PMV isolates used for optimization trials.  
Isolate 
No/ year 
Isolate name 
  
Sub 
group 
Host Species 
common 
name 
Literature 
3319/95 Var GER95 A Varanus prasinus Emerald 
tree 
monitor 
Gravendycket 
al., 1998 & 
Marschang et 
al.,  2002 
28xpc/99 
 
Xeno USA99 A Xenosaurus 
platyceps 
Flathead 
knob-scaled 
lizard 
Marschang et 
al.,  2009 
9/5/03 Crot GER03 B Crotalus horridus Timber 
rattlesnake 
Marschang et 
al.,  2009 
936/00 
 
Dasy GER00 A Dasypeltis atra Montane 
egg-eating 
snake 
Marschang et 
al., 2009 
324/00 Igu GER00 B Iguana iguana Green 
iguana 
Marschang et 
al.,  2009 
5688/91 
 
Pangut 
GER91 
A Pantherophis 
guttatus 
Kornnatter Blahak, 1994 
1356/90 Crot GER90 B Crotalus 
catalinensis 
Santa 
Catalina 
Island 
Rattlesnake 
Blahak, 1994 
2766/90 Vip GER90 B Vipera 
palaestinae 
Palestine 
viper 
Blahak, 1994 
20/3/05 Orth GER05 B Orthriophis 
taeniurus 
Beauty 
snake 
Marschang et 
al.,  2009 
tPMV/99 Ther GER99 - Testudo hermanni Hermann’s 
tortoise 
Marschang et 
al.,  2009 
6/3/09 Pangut 
GER09 
C Pantherophis 
guttatus 
Corn 
snakes 
Abbas et al., 
2011 
 
3.6.1.3 Samples and positive control 
Optimization trials were carried out with samples (Table 3.17) that gave unspecific 
reactions in the original PCR and with samples that were positive for snake 
adenovirus (SnAdV-1). 
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Table 3.17: Diagnostic Samples used for the optimization trials.  
Some of the samples represent false positive/ unspecific products including bacteriaπ, 
adenovirusΩ, and some are PMV which were used as positive controlsPC.* products obtained 
after applying the RT-PCR protocol from Ahne et al. (1999) targeting partial L gene 
sequence. SnAdV1= Snake Adeno Virus Type 1. 
 
Samples Product length 
after sequencing* 
Sequencing result 
123/10  500 bp Acinetobacter baumanni 
104/4/11π 550 bp Enterobacter cloaca 
104/5/11π 550 bp Enterobacter cloaca 
101/1/11  550 bp Acinetobacter baumanni 
17/2/10  500 bp Pseudomonas putida 
61/11π 500 bp Pseudomonas aeroginosa 
AdVΩ  350 bp SnAdV1 
6/11 pc 550 PMV 
86/11 PC 550 PMV 
Pangut GER 09 PC 550 PMV 
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3.6.2    Designing new primers targeting partial sequence of the L gene of 
ferlavirus isolates 
3.6.2.1 Primers 
Table 3.18: Description of oligonucleotide primers designed for RT-PCR amplification of L 
gene and used for the optimization trials.  
Name  Sequence Position 5’ in FDLV 
PMV F1 out  GAYATHYTHTAYCCDGARTG 34 
PMV F2 in  CAYYTNRAYTCHCCDATHG 55 
PMV F3 in  CRTTYHTRACHTGGTT 524 
PMV R1 out  CKCATHTCHYWYTTRAT 544 
PMV R3   GTYADRAAYGRBYKRTDCCA 514 
PMV R2  AACCADGTYADRAAYG 524 
PMV R4 out  CTNCCYTCBACHACRTCRC 729 
PMV R5 out  CCNCCRTGYCTYTCYC 1238 
PMV R6 out  GGRTANACDGWRTCCCA 1462 
 
 
3.6.2.1: Isolates 
Nine ferlavirus isolates (Dasy GER00, Pangut GER91, Crot GER03, Igu GER00, Vip 
GER90, Crot GER90, Orth GER05, Pangut GER09, Ther GER99) as indicated in 
Table 3.16 were used for testing the new primers. 
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3.7   Materials used for amplification of full CDS of F and HN genes  
     3.7.1       Virus isolates 
Table 3.19: Description of ferlavirus isolates analyzed in this study 
Isolate 
No/ 
year 
Isolate name 
  
Sub 
group 
Host Species 
common 
name 
Literature 
3319/95 Var GER95 A Varanus prasinus Emerald 
tree 
monitor 
Gravendycket 
al., 1998 & 
Marschang et 
al.,  2002 
368/01 Pyth GER01 B Python regius Ball python Marschang et 
al.,  2009 
9/5/03 Crot GER03 B Crotalus horridus Timber 
rattlesnake 
Marschang et 
al.,  2009 
324/00 Igu GER00 B Iguana iguana Green 
iguana 
Marschang et 
al.,  2009 
1356/90 Crot GER90 B Crotalus 
catalinensis 
Santa 
Catalina 
Island 
Rattlesnake 
Blahak, 1994 
2766/90 Vip GER90 B Vipera 
palaestinae 
Palestine 
viper 
Blahak, 1994 
20/3/05 Orth GER05 B Orthriophis 
taeniurus 
Beauty 
snake 
Marschang et 
al.,  2009 
tPMV/99 Ther GER99 - Testudo hermanni Hermann’s 
tortoise 
Marschang et 
al.,  2009 
6/3/09 Pangut GER09 C Pantherophis 
guttatus 
Corn 
snakes 
Abbas et al., 
2011 
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3.7.2     Primers 
Table 3.20: Description of oligonucleotide primers designed for RT-PCR amplification of full 
CDS region of HN and F genes of nine ferlavirus isolates. 
 πPrimers were kindly provided by Tibor Papp, PhD, DVM. 
Name  Sequence Position 5’ in FDLV 
F-gen cons 68 F TTGATMAHCTWGAACARRTAGG 5089 
F gene 130 F CCRGTCAGYAMWGCRACAATGAT 5157 
F gene 257 F  CCATWRAYAARHTVARBACTG 5284 
F gene 1631 R  AKAAARCCKAGRTTRTTGTAD 6658 
OPMV F gene 274 F  ACTGAYATYASTGTVVTNGARGG 5301 
OPMV F gene 1502 R GCRATAGAGRYHGRAGMDKTYA 6518 
F-gene cons 5409F  GCMCARATMACRGCDGGRATTGC 5406 
F-gene cons 6324R  GGYTTRATYTGYAGVCCRTC 6316 
F-HN cons 6305F  GAYGGBCTRCARATYAARCC 6296 
F-HN cons 7837R GRGCTTGRCACATRGCYTG 7829 
F-HN cons 7837R  GRGCTTGRCACATRGCYTG 7829 
HN 7562 F tPMV GCTTATCTCTTATGTACTCATG 7565 
HN 8257 R tPMV CCAGATAACAATGTGACAGTGG 8262 
HN 7671 F tPMV GCTATAGGTACTCAGACAGG 7674 
HN 8119 R tPMV  GGTCTCTATCCAACTGATCC 8123 
HN middle 7984F  TCHCARGTRTGGCTHGGTGCAG 7974 
HN middle 8335R  TGACTATCWGCMACBCGYCC 8325 
HN gene 1303 Fπ GAYCCHATAAGAATAAGYTGG 8093 
L gene 1217 Rπ  CCRTGTCTCTCYCTRAAYCC 9943 
HN cons. 8421FWD  GAGYTHAGYCCTGCYACYYTRGG 8415 
HN cons. 9574 REV  TCATASACYTTATTACCDAG 9562 
HN gene 1351 Fπ  GGKAACRRBCCYTGYYCWGC 8141 
L gene 1184 Rπ  GARCARAAHACNGCATGYCC 9910 
HN 8060 F1 tort  GGTTGGCATGCCTTGGCACAG 8051 
HN 10280 R1 tort  GGATCGAAATCCATATCTTC 10258 
HN 8199 F2 tort  TGTATCACTGGTGTTTATAATG 8183 
HN 9970 R2 tort GATCCTCCGTGTCTCTCTC 9950 
F gene 5755 REV GCATTDATRTCRCCATCC 5735 
F gene 5881 REV GGRAARGACATCTCRAT 5831 
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Table 3.21: Software programs for surface protein analyses 
Program 
description  
Producer/ Reference Application 
GENtle  Magnus Manske at the 
University of Cologne, 
Germany/ Kyte & Doolittle, 
1982 
Prediction of hydrophobicity 
plots, leusine zipper (LZ) 
NetNGlyc 1.0 
(2002)  
Center for Biological Sequence 
Analysis (Denmark)3  
Prediction of glycolysation 
sites 
TMHMM Server 
2.0 (2009) 
Center for Biological Sequence 
Analysis (Denmark)/4 
 
Prediction of transmembrane 
domains 
SignalP V 2.0  Center for Biological Sequence 
Analysis (Denmark)/5 
Nielsen et al., 1997 
Prediction of signal peptides 
 
 
4.         Methods 
          4.1         Processing of diagnostic samples 
Swabs or tissue samples of examined snakes were placed in 15 ml tubes, immersed 
in 3 ml growth medium DMEM supplemented with 2x concentration of antibiotics 
(Table 3.9) and sonicated at an output level of 30 for 3 impulses for the destruction of 
cell membranes. For removal of bacteria and cell debris, samples were subsequently 
centrifuged at 3000xg for 15 min and kept at -4 ºC. 
4.2 Subculture and preparation of tissue culture dishes for virus 
isolation 
After discarding the DMEM from a complete cell monolayer flask (75 cm3) and 
washing with 5 ml trypsin, the cells were incubated with 1 ml trypsin at room 
                                            
3
 http://www.cbs.dtu.dk/services/NetNGlyc/ 
4
 http://www.cbs.dtu.dk/services/TMHMM/ 
5 http://www.cbs.dtu.dk/services/SignalP/ 
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temperature for 15 minutes. Subsequently, the flask was shaken by hand until the 
cells were detached. Afterward, 4 ml of growth medium was added to the subcultured 
cells. A glass pipette was used to separate the cells by pipetting them up and down 
several times. The cells were diluted at a ratio of 1:10, 1:5, or 1:2 during 
subcultivation (depending on the density of the cells) by transferring 0.5, 1, or 2.5 ml 
of the cell suspensionrinto 17 ml DMEM. To prepare tissue culture dishes the cell 
suspension was mixed 1:10 with DMEM in a cell reservoir to prepare 30 mm tissue 
culture dishes. 2 ml of this diluted suspension was added to all dishes. 1 day old 
dishes were used for virus isolation. All flasks and dishes were incubated at 28 °C 
with 5 % CO2. 
4.3              Virus isolation 
Virus isolation trials were carried out from all clinical samples on VH2 and IgH2. 200 
ml of the sample supernatant were inoculated onto one day old, medium-free tissue 
culture dishes, with about 70% confluent cell monolayers. Dishes were then 
incubated for 2 hours at 28 ºC with 5% CO2.. After incubation, 2 ml DMEM 
supplemented with 2% FBS, 1% NEA and antibiotics (Table 3.7) were added to each 
dish. One dish was always left uninoculated as a cell control. Inoculated cells were 
checked for the occurrence of CPE using a light microscope about every 2-3 days. 
Virus isolates were identified by the form of the CPE and resistance to chloroform. 
When CPE was seen, dishes were frozen at -80 ºC and thawed for another passage. 
When no CPE was seen, dishes were incubated for two weeks and then frozen for 
blind passaging. Subsequent to a freeze and thaw cycle, two further passages were 
carried out from each dish.  
   
Chloroform treatment 
Chloroform treatment was performed by mixing chloroform and virus suspension at a 
dilution of 1:10, followed by shaking vigorously for 1h and centrifugation at 10.000 
rpm for 10 min. The supernatant was then diluted 1:10 and inoculated into tissue 
culture dishes. 
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4.4             Extraction of viral RNA 
RNA – Preparation modified from Boom et al. (1990) 
1- 300 µl of the cell culture supernatant (see 4.3) or of the homogenous 
supernatant after processing the diagnostic samples (see 4.1), was mixed 
with 900 µl lysis buffer and 40 µl silica matrix in 2 ml tubes. The suspension 
was then incubated (lying on a table) at room temperature for 10 minutes 
and vortexed every 3 minutes.  
2-  The suspension was centrifuged (1 minute, 14000 rpm, 4°C) and the 
supernatant was discarded.  
3- The pellet was washed twice with 1000 µl washing buffer and 1000 µl 70% 
ethanol respectively. After each washing step, the pellet was vortexed, 
centrifuged (0.5 minute, 14000 rpm, 4°C) and the supernatant was 
discarded.  
4- The washing process was repeated once with aceton, followed by 
centrifugation for 3 minutes. The aceton was then decanted and the pellet 
dried (10 min. 56 °C) on a heating block. 
5- Following complete drying, 60 µl of nuclease-free water and 1 μl RNase-
inhibitor were added to the pellet, vortexed and incubated at 56°C for 15 
minutes. The tubes were then vortexed every 5 minutes, followed by 
centrifugation (3 min. 14000 rpm, 4°C). 
6- The supernatant was carefully removed with a micropipette (without any 
contact to the silica matrix) from each tube and transferred to a new 0.5 ml 
tube. This process was repeated once again and the supernatant stored 
immediately at -80 °C. 
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4.5          Methods used for RT-PCR 
4.5.1       RT-PCR protocol used for processing diagnostic samples 
Table 4.1: Nested RT-PCR protocol targeting partial sequence of the L (Ahne et al., 1999), 
HN, and U genes (Marschang et al., 2009) 
Reagent 1st round RT-PCR 2nd round RT-PCR Final 
concentration 
 volume in 25 µl 
total amount 
volume in 25 µl 
total amount 
Final 
concentration 
Millipore water 9.25 μl 11.25 μl  
10x Taq-buffer+KCl 2.5 μl 2.5 μl 1x 
25 mM MgCl2 2.5 μl 2.5 μl 2.5 mM 
2 mM dNTPs 2.5 μl 2.5 μl 0.2 mM 
10 pmol/μl primer 
forward 
2.5 μl 2.5 μl 1 pmole/µl 
10 pmol/μl primer 
reverse 
2.5 μl 2.5 μl 1 pmole/µl 
5 u/μl Taq DNA-
polymerase 
0. 25 μl 0. 25 μl 0.05 U/µl 
40 u/μl Ribolock 
inhibitor 
0.15 μl  0.24 U/µl 
200 u/μl RT (reverse 
transcriptase) 
0. 35 μl 2.8 U/µl 
Template 2.5 µl of extracted 
viral RNA sample 
1µl of the 1st round 
RT-PCR products 
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Table 4.2: Description of primer combinations, thermocycler programs and expected product 
lengths used for RT-PCR amplification of partial sequences of L, HN and U genes of 
ferlaviruses from diagnostic samples. 
PCR 
Name 
Primer PCR 
round I 
                                                                        
Fwd       Rev 
Thermocycler 
program 1st 
round 
Primer PCR 
round   II 
 
Fwd      Rev 
Thermocycler 
program 2nd 
round 
Expected 
Product 
length 
(bp) 
L 
gene 
 
L5F 
 
L6R  
42°C for 1 h 
95°C for 5 min. 
95°C for 30 
sec. 
45°C for 30 
sec. 
72°C for 2 min. 
72°C for 7 min. 
L7F L8R  
95°C for 2 min. 
95°C for 30 
sec. 
45°C for 30 
sec. 
72°C for 1 min. 
72°C for 5 min. 
626, 566 
HN 
gene 
HN 
1F 
HN 
2R 
HN 
cons 
F1 
HN 
cons 
R2 
678, 399 
 
U 
gene 
U-
cons 
Fwd-
out 
U-
cons 
Rev-
out 
U-
cons 
Rev-
in 
U-
cons 
Fwd-
in 
684, 648 
 
4.5.2     RT-PCRs used for the optimization trials  
4.5.2.1. Optimization trials for the detection of ferlavirus L gene 
In order to increase the specificity of the RT-PCR (Ahne et al., 1999), multiple trials 
were performed, both to lower the number of products with unexpected sizes as well 
as to increase the number of virus specific products of the expected size. RT-PCRs 
carried out in these trials targeted the L gene, as this gene is highly conserved and is 
therefore considered a good target for a group of genetically diverse viruses.  
Optimization trials were carried out with samples that gave unspecific reactions in the 
original PCR (3.5.1.3) as well as with positive controls (PC) (a ferlavirus isolate and 
two diagnostic samples verified by sequencing as PMV positive) and samples that 
were positive for other viruses frequently found in snakes, particularly a snake 
adenovirus (SnAdV-1). Optimization procedures included the use of multiple MgCl2 
concentrations. Three different annealing temperatures were used for each master 
mix. Differences were applied for the 2nd round of the RT-PCR only. The first round 
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was carried out as described by Papp et al. (2010). All primer combinations and 
thermo cycler programs are listed in Table 4.3. 
 
Primer combination/ thermocycler program 
The primer combination targeting partial L gene sequence described by Ahne et al., 
1999 (Table 2.4) and the corresponding thermo cycler programs were used for the 
optimization trials. In addition, MgCl2 concentrations were varied and each 
concentration was used with three different annealing temperatures, as listed in 
Table 3.15 
4.5.2.2 Designing new primers targeting partial L gene sequence 
As a second attempt to achieve a more specific assay for ferlaviruses, degenerate 
primers targeting a portion of the L gene were designed based on several members 
of each ferlavirus subgroup including; Var GER95 (subgroup A), Pyth GER01, Crot 
GER03, Igu GER00 (subgroup B), Pangut GER09 (subgroup C) and the Ther 
GER99. All information regarding these isolates is listed in Table 3.16. Extended 
portions of partial L gene sequences were obtained from these isolates and used for 
the alignments. Deduced amino acid sequences of L gene (514 aa) are indicated in 
supplementary data, Figure 1.  
 
RT-PCR protocol 
The primer combinations (Table 4.3) targeting partial L gene sequences were tested 
for six ferlaviruses as follows: Xeno USA99, Var GER95, Pangut GER 09, Ther 
GER99, Igu GER00, Dasy GER00. All information regarding these isolates is listed in 
Table 3.16. 
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Table 4.3: Description of primer combinations, thermo cycler programs and expected product 
lengths used for RT-PCR amplification of partial L gene.  
Abbreviations: *Composition of chemicals and thermo cycler programs used in the RT-PCR 
protocol were the same as those used by Ahne et al. (1999) and Marschang et al. (2009) 
(Table 4.1, 4.2). π The sequences of all primers are listed in Table 3.18. 
PCR 
Name 
Primer PCR 
round I
π
 
Fwd      Rev 
Thermocycler 
program 1
st
 
round* 
Primer PCR 
round   II
π
 
Fwd     Rev 
Thermocycler 
program 2
nd
 
round* 
Expected 
Product 
length (bp) 
A F2  in R5 out  
 
42°C for 1 h 
95°C for 5 min. 
95°C for 30 sec. 
45°C for 30 sec. 
72°C for 2 min. 
72°C for 7 min. 
F3 in R4 out  
 
95°C for 2 min. 
95°C for 30 sec. 
45°C for 30 sec. 
72°C for 1 min. 
72°C for 5 min. 
190 
B F2 in R6 out F3 in R5 out 929 
C F1 out R6 out F3 in R5 929 
D F1 out R1 out F2 in R2 451 
E F1 out R1 out F2 in R3 441 
F F1 out R2 F2 in R3 441 
G F1 out R5 out F2 in R4 out 656 
H F1 out R5 out F3 in R4 out 190 
I F1 out R6 out  F2 in R4 out 656 
 
4.5.3 Methods used for the amplification of the full CDS of F and HN 
genes  
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Table 4.4: RT-PCR protocol utilized for the amplification of full CDS of surface proteins 
 Those written in Italics were used for long RT-PCR. 
 1
st round RT-
PCR 
2nd round RT-
PCR 
 
Reagent volume in 25 µl 
total amount 
volume in 25 µl 
total amount 
Final 
concentration 
Millipore water 9.25 μl 
8.75 μl 
11.25 μl 
10.75 µl 
 
10x Taq-Puffer+KCl 
10x PCR Buffer long PCR 
2.5 μl 
2.5 μl 
2.5 μl 
2.5 μl 
1x 
1x 
25 mM MgCl2 
25mM MgCl2 long 
PCR 
2.5 μl 
2.5 μl 
2.5 μl 
2.5 μl 
2.5 mM 
2.5 mM 
2 mM dNTPs 2.5 μl 
3 µl 
2.5 μl 
3 µl 
0.2 mM 
o.24 mM 
10 pmol/μl primer forward 2.5 μl 2.5 μl 1 µM 
10 pmol/μl primer reverse 2.5 μl 2.5 μl 1 µM 
5 u/μl Taq DNA-
polymerase 
5 u/μl Innu Taq long 
range polymerase 
0. 25 μl 
0. 25 μl 
0. 25 μl 
0. 25 μl 
0.05 U/µl 
0.05 U/µl 
40 u/μl Ribolock inhibitor 0.15 μl  0.24 U/µl 
200 u/μl RT   (reverse 
transcriptase) 
0. 35 μl 2.8 U/µl 
Template 2.5 µl of 
extracted viral 
RNA sample 
1µl of the 1st 
round RT-PCR 
products 
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Table 4.5:  Description of Synthetic oligonucleotide primer combinations, thermal cycler 
programs and expected product lengths used for RT-PCR amplification of full CDS region of 
HN and F genes of nine ferlavirus isolates. 
Abbreviations: Ɨ gap of about 400bp at the end of the HN gene. ¡ gap of about 10 bp. ±   a 
genomic region lying at the end of the F gene and at the beginning of the HN genes.. Ǐ PCR 
targets the beginning of the F gene. Primers have been described in earlier publications; 
ǂAhne et al. (1999), ∞ Marschang et al. (1999) 
PCR 
Name 
Primer PCR round I 
Fwd              Rev 
Primer PCR round II 
Fwd               Rev 
Modification 
applied to the RT-
PCR (Ahne et al., 
1999) 
Expected 
product 
length 
(bp) 
F gene I  130F 1631 R 274F 1502R  
PCR; 95Cº/45 sec. 
Annealing;45Cº/45 
sec. Elongation 
72Cº/2 min. for 
both rounds.  
 
1501,1228 
F gene II 257 F 1631 R 274F 1502R 1374,1228 
F gene III 130F 1631 R 257F 1502R 1501,1245 
F gene VI 257 F 1631 R 274F 1631 R 1374,1357 
F 
subgroup 
`C`  
257 F 1631 R 5409F 6324R 1501, 915 
F-HN
± 
 257 F HN cons R2∞ F-HN 6305 F 7837R Annealing; 44 Cº/ 
45 sec. Elongation; 
72Cº/ 3 min. for 
both 1
st
 and 2
nd 
rounds. 
2870, 
1532 
HN gene  HN 
1F
ǂ
 
HN R2
ǂ
 HN cons 
F1∞ 
HN cons R2∞ RT-PCR has been 
applied without 
modifications. 
678, 571 
HN 10 bp
¡  7984 
F 
8335 R 1 round PCR with 
45 cycles 
PCR; 95 C°/ 1 min. 
Annealing; 45Cº/ 
45 sec.Elongation; 
72 Cº/ 3 min. 
351 
HN gap
Ɨ 
400 bp  
HN 
1351 
F 
L 1184 R 8421F 9574R PCR; 95 C°/ 1 min. 
Elongation;72 Cº/ 
3 min. for both 
rounds 
1769, 
1147 
HN tPMV 
gap  
HN 
7562 
F 
HN 8257 R HN 7671 F 
t. 
HN 8119 R t. RT-PCR has been 
applied without 
modifications. 
697, 448 
HN-L   HN 
1303F 
L 1217R HN 1351F L 1184R Annealing; 45Cº/ 
45 sec.  
Elongation; 72Cº/ 
3 min. for both 
rounds. 
1847, 
1769 
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PCR 
Name 
Primer PCR round I 
Fwd              Rev 
Primer PCR round II 
Fwd               Rev 
Modification 
applied to the RT-
PCR (Ahne et al., 
1999) 
Expected 
product 
length 
(bp) 
HN-L 
tortoise  
HN 
8060 
F1 
tort 
L 10280 R1 
tort 
HN 8199 
F2 tort 
L 9970 R2 tort Annealing; 45Cº/ 
45 sec.  
Elongation; 72Cº/ 
3 min. for both 
rounds. 
2207, 
1767 
F gene 
left side
Ǐ
 
U 
cons. 
F in∞ 
F 
5755R 
F 
5881R 
1 round PCR with 45 cycles  Annealing; 
45Cº/45 sec. 
Elongation; 72Cº/4 
min.  
750  
 
4.6 Gel electrophoresis 
1.5% agarose solution was prepared by dissolving 1.5 g agarose in 100 ml 1x TAE-
buffer followed by heating in a microwave for about 2 min. After heating, the solution 
was supplemented with 5 μl of the ethidium bromide solution and mixed by gentle 
shaking. The mixture was then poured into the gel chamber provided with a comb 
and left to solidify for about 20 minutes at room temperature. After drying, the comb 
was removed and the gel was placed in the gel chamber and immersed in 1x TAE-
buffer. 2 µl Loading dye (6x) was mixed with 8 µl of each of the DNA samples and 
pipetted into the gel slots. 3 µl of DNA size ladder (100 bp DNA ladder or DNA ladder 
mix, based on the expected length of the products) was added to at least two side 
slots of each row. Gel electrophoresis was run for about 20-30 min at about 110 V, 
the gel was then visualized with a 320 nm UV-transilluminator. 
4.7 Gel extraction 
With the use of surgical blades, the bands of the fourfold volume of PCR II amplicons 
were incised accurately under visualization on the UV-transilluminator (the whole 
process should not exceed more than 30 seconds). Each band was put in a 2 ml 
microcentrifuge tube (previously weighed and numbered). 
Gel extraction was carried out according to the protocol provided by the manufacturer 
for the peqGOLD Gel-Extraction Kit (PEQLAB Biotechnology GmbH, Erlangen, 
Germany) as follows: 
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1. After supplying each gel slice with an equal amount of Binding Buffer , the tubes 
were incubated on a heating block at 65°C, (vortexing every 3 min) until the gel was 
totally dissolved. The pH of the solution was controlled based on its color; if it was 
orange or red instead of yellow, about 5 μl of 5 M Na-Acetate were added and 
vortexed immediately. 
 
2. 700 µl of the solution was then pipetted onto PerfectBind DNA columns with a 
membrane for adsorption of DNA, which were plugged into collection tubes. The 
tubes were centrifuged (always for 1 min at 10,000 rpm) and the flow-through was 
discarded. If the solution was more than 700 µl, the process was repeated using the 
same collection tubes and columns. 
 
3. Columns were washed once with 300 μl Binding Buffer and twice with 300 µl 
Wash Buffer supplemented with EtOH. Prior to centrifuging (1 min at 10,000 rpm), 
the columns were incubated for about 3 min at room temperature. 
 
4. For drying the columns, a further centrifugation step (same conditions as above) 
was applied. The collection tubes were then discarded and the columns were placed 
into fresh 1.5 ml microcentrifuge tubes. 
 
5. For elution of the DNA from the membrane, 15 μl Elution Buffer was added 
(exactly on the membrane), the tubes were then incubated for about 3 min at room 
temperature. After that, the tubes and the membrane were centrifuged for 1 min at 
5,000 rpm. This elution step was repeated once to get a final volume of about 30 µl of 
the extracted DNA which was stored at -4ºC until sequencing.  
 
All steps used for gel electrophoresis were carried out with all extracted DNA 
samples to determine the efficiency of the gel purification, by mixing 2 μl of each 
purified sample with 8 μl 1x concentration loading dye. 
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4.8 Sequencing 
Purified DNA samples were diluted (1:2-1:20), based on the strength of the band 
visualized on the UV-transilluminator. For sequencing, 15 μl of the diluted samples 
and 20 μl of the corresponding primer were sent to a commercial lab (Eurofins, 
Ebersberg).  
 
Analyses of sequences  
The raw sequences were first downloaded from the website of the company 
http://www.eurofinsdna.com/de/home.html and processed using the ABI Sequence 
Analysis Programme 5.1.1 (Applied Biosystems, Foster City, USA). Sequences were 
further edited, joined and aligned using several software programs (all programs 
involved are mentioned in Table 3.12). Identity matrices were generated by the 
BioEdit program (Hall, 1999)  
Phylogenetic calculations were carried out using the unweighted pair group method 
with the arithmetic mean (UPGMA), maximum likelihood (ML), maximum parsimony 
(MP) and minimum evolution (ME) trees calculated using Mega 5.05 (Tamura et al., 
2011) model; ML and distance based Fitch trees using the PHYLIP Package 
(Felsenstein, 1989) model (Table 3.13). Protein analysis was carried out using 
several programs (Table 3.21), under the supervision of Prof. Pfitzner from the 
Institute for Genetics, Subinstitute for General Virology of the University of 
Hohenheim. 
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5  Results 
5.1     Prevalence of ferlaviruses in diagnostic samples 
5.1.1  RT-PCR/ sequencing analyses 
Molecular diagnostics based on L gene RT-PCR verified by sequencing revealed 
ferlavirus positive results (566 bp products) from 19 samples (3.83% of the 495 
screened) originating from 15 snakes (5.97% of the 251 snakes tested). All ferlavirus 
positive snakes were from the families Colubridae and Pythonidae (Table 5.1.1), 
while no ferlaviruses were detected from other snake families (supplementary data, 
Table 1 in Appendix). Ferlavirus was detected in 8 dead snakes (Col-1,-2, Pyt-1a,b,c, 
Pyt-3,4,5) and from 6 live animals (Pyt-2, Col-1a,b,c,d,e,f). Col-1 and the live animals 
tested (except Pyt-2) came from one enclosure (Abbas et al., 2011). 
In the dead snakes, the following tissues tested positive by RT-PCR (number 
positive/number tested): intestine (3/7), lung (5/6), kidney (2/7), pancreas (1/4), liver 
(1/1). Heart (0/1), and head (0/1) were negative (Table 5.1.1). Among the ferlavirus 
positive snakes intestine, kidney and lung were all examined 5 times and all three 
were positive in one case (Col-1) (20%). Only lung was positive in three cases (Pyt1-
a,b,c) (60%) while the other two organs were negative in these cases. In our study, 
PMV was only detected in the pancreas and not in any other tissues once (7.14% of 
the 14 snakes that tested positive) in a dead royal python (Pyt-3). 
The RT-PCRs targeting the HN and U genes were carried out on all L gene positive 
samples which were confirmed by sequencing. Positive products (399bp) were 
obtained from 14 samples (73.68% of the 19 ferlavirus positive samples) for the HN 
gene and from 10 samples (648bp) (52.63%) for the U gene.  
All specific size RT-PCR amplicons obtained for all three genes (L, HN, and U) were 
sent for sequencing by a commercial company (MWG Operon, Ebersberg) and then 
processed as described in the Methods section (4.8). Ten RT-PCR partial L gene, 
nine partial HN gene and eight partial U gene sequences were identical to each other 
representing subgroup C (Pangut-GER09) (HQ148084–HQ148087). Three 
amplicons from Pyt-1a~c were identical to the previously described Crot-GER03 
(Subgroup B), (Acc No: GQ277611). Another three products from Pyt-5 were also 
identical to one another and to Igu GER00 (Subgroup B), (Acc No: GQ277617). The 
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three amplicons representing partial sequences of L, HN and U genes obtained from 
Col-2 belonged to the new subgroup C (Hobuc HUN09) (Acc No JX186193-
JX186195) (Papp et al., 2013). The partial RT-PCR L gene obtained from Pyt-4 was 
99% similar to Crot GER03 (GQ277611) (Subgroup B) (Table 5.1.1).  
An RT-PCR targeting partial L gene sequence revealed a positive signal from the 
throat and cloacal swab of Pyt-2 (an Indian python). Sequencing resulted in a product 
of 234 bp as sequence data from the rest of RT-PCR product was not reliable. The 
partial L gene RT-PCR obtained from this sample was 97% identical to FDLV 
(AY141760.2) (Subgroup A).  
5.1.2 Virus isolation 
Virus isolation attempts were carried out for all samples. Ferlaviruses were isolated 
on VH2 from three snakes (Col-1, -1a, Pyt-4) (20%), all of which were also positive in 
the RT-PCR from original samples and from RNA prepared from the virus isolates. 
Infection rates with ferlaviruses obtained from isolation and RT-PCR results of all 
tested snakes were 5.97% (15 of the 251 tested snakes) (Table 5.1.2). 
Of those animals that tested ferlavirus positive by RT-PCR, reoviruses were isolated 
in four cases (26.66%) (Col-1, -1a,b,c) while AdVs were isolated twice (13.33%) (Col-
1&1a). Of those found negative for ferlaviruses by RT-PCR, reoviruses were isolated 
from five animals that originated from two groups of snakes owned consecutively by 
the same owner (14/5, 10, 13/09 and 54/3, 4/09) (Supplementary data, Table 1). 
Multiple viral infections with three viruses (PMV, AdV, and reoviruses) were detected 
in two animals (Col-1, 1a) which belonged to a group of captive corn snakes of the 
same enclosure. These viruses were isolated in the first case from the intestine of a 
dead animal and in the second case from a swab of a live snake which belong to a 
group of 13 survivals which were swabbed one month later.  Unknown viruses were 
isolated on VH2 in two cases (Lab No; 3/2/09 and 106/09) that tested negative for 
ferlavirsues by RT-PCR (L gene) and in three cases (Lab No; 56/10, 60/10 and 
157/10) that tested positive for ferlaviruses by RT-PCR and revealed no significant 
results after sequencing (supplementary data, Table 1 in Appendix). 
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Applying an end-point dilution technique followed by plaque purification, a pure 
ferlavirus isolate was obtained from Col-1a, as confirmed by RT PCR. While applying 
the same techniques in conjunction with chloroform treatment, a pure AdV isolate 
was obtained from the same sample (Abbas et al., 2011). Syncytial cell formation 
and cytolysis were the hallmark for the CPE caused by the ferla- and the reoviruses. 
As compared to ferlaviruses in cell culture, which grew slowly forming small syncytial 
cells (Figure 2), the reoviruses grew quickly, forming giant syncytial cells (Figure 3). 
Virus isolates forming fusogenic CPE and sensitive to chloroform were further 
identified as PMV by RT-PCR (Ahne et al., 2009), whereas isolates forming 
fusogenic CPE and resistant to chloroform were further identified as reoviruses using 
a reovirus specific RT-PCR (Wellehan et al., 2009). The AdV caused a CPE 
consisting of fast detachment of cells with developement of small round cells and 
was identified by PCR (Wellehan et al., 2004) (Figure 4).  
All orthoreoviruses isolated from Pantherophis guttatus were identical to one another 
and to orthoreovirus 55/02 (E4309703) based on nested RT-PCR targeting partial 
sequence of the RDRP gene. The adenovirus isolated from the dead Pantherophis 
guttatus (Col-1) was 100% similar to Snake AdV type 2 (FJ 012163) based on partial 
DNA dependent DNA polymerase gene sequences while the AdV isolated from the 
live snake Col-1a of the same species revealed 100% similarity to Snake AdV type 1 
(DQ106414).  
Figure 2.  Cytopathic effects (CPE) of a ferlavirus isolate from corn snakes. 
(A): Negative control VH2. (B): 2nd passage of ferlavirus isolate from the intestine of Col-1 on 
VH2 cells 4 days post inoculation (Magnification: 400x). The cytopathic effect (CPE) 
consisted of the development of syncytial cells and cytolysis. 
 
        
 
A B 
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Figure 3.  Cytopathic effects (CPE) of a reovirus isolate from corn snakes. 
(A): Negative control VH2. (B): 2nd passage of reovirus isolate from oral/ cloacal swab from 
(Col-1a) on VH2 cells 7 days post inoculation (Magnification: 400x). The cytopathic effect 
(CPE) consisted of the development of giant multinuclear syncytial cells and cytolysis. 
 
       
 
 
Figure 4. Cytopathic effects (CPE) of an AdV isolate from corn snakes. 
(A): Negative control IgH2. (B): 4th passage of an AdV isolate from oral/ cloacal swab from 
corn snake Col-1a on IgH2 3 days post inoculation (Magnification: 400x). (CPE) consisted of 
rounding and detachment of some cells. 
 
   
 
 
 
 
 
 
 
 
 
B A 
B A 
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Table 5.1.1: PMV positive diagnostic samples. 
Abbreviations: *, **: indicate animals are from the same owner and enclosure; o/cl. swab = oral and cloacal swabs, +: positive, –: negative, 
AdV= adenovirus, Ref1.= case reported in: Abbas et al. (2011), Ref2 =case reported in Papp et al. (2013). R Sequencing of PCR products from 
all reovirus isolates revealed identical partial RDRP gene sequences to the orthoreovirus isolate 55/02 (Wellehan et al., 2009). 
 
 
 
 
  
Lab. 
No. 
 
Species Case 
history 
Tissue tested PMV  RT-PCR Nucleotide identity 
of partial L gene 
sequences 
Virus isolation Comments/ further 
findings (other PCRs) 
L
 g
e
n
e
  
H
N
G
e
n
e
 
U
 g
e
n
e
  
C
o
l-
1
* 
 
6
/3
/0
9
 
 C
o
rn
 s
n
a
k
e
 
(P
a
n
th
e
ro
p
h
is
 
g
u
tt
a
ti
s
) 
 
 
A snake died 
in a new 
collection. 
Ref1 
 
dyspnoea 
and vomitus 
noticed prior 
to death 
Lung  + + -  
Pangut GER09 
 
OrthoreovirusR Accompanying two 
animals were negative 
for PMV.   Kidney + + + PMV, 
orthoreovirus 
Intestine + + + PMV, 
orthoreovirus, 
SnAdV-2 
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Lab. 
No. 
 
Species Case 
history 
Tissue tested PMV  RT-PCR Nucleotide identity 
of partial L gene 
sequences 
Virus isolation Comments/ further 
findings (other PCRs) 
C
o
l-
1
a
* 
1
4
/2
/0
9
 
 
Swabs taken 
one month 
later from 13 
survivors 
of the same 
group. Ref1 
O/cl. swab + + + All had the same 
PMV, a new type 
designated Pangut-
GER09 
 
PMV, 
orthoreovirus, 
SnAdV-1  
Tested positive for AdV 
by PCR 
C
o
l-
1
b
* 
1
4
/3
/0
9
 O/cl. swab + + + orthoreovirus 
 
Tested positive for AdV 
by PCR 
C
o
l-
1
c
* 
1
4
/6
/0
9
 
 
O/cl. swab + + + orthoreovirus Seven snakes from this 
group tested negative for 
the presence of PMV 
(14/1, 14/4, 14/5, 14/7, 
14/9, 14/10, 14/13). 
Reovirus was isolated 
from three of those 
tested negative (14/5, 
14/10, 14/13). 
 
C
o
l-
1
d
* 
1
4
/8
/0
9
 
 
O/cl. swab + + +           - 
C
o
l-
1
e
* 
1
4
/1
1
/0
9
 
 
O/cl. swab + + +           - 
C
o
l-
1
f*
 
1
4
/1
2
/0
9
 
 
O/cl. swab + + +           - 
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Lab. 
No. 
 
Species Case 
history 
Tissue tested PMV  RT-PCR Nucleotide identity 
of partial L gene 
sequences 
Virus isolation Comments/ further 
findings (other PCRs) 
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Lab. 
No. 
 
Species Case 
history 
Tissue tested PMV  RT-PCR Nucleotide identity 
of partial L gene 
sequences 
Virus isolation Comments/ further 
findings (other PCRs) 
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PCR 
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Table 5.1.2: Infection rates in respect to all tested viruses (ferla-, reo- and adenoviruses) 
obtained from isolation and/ or (RT-) PCR results of all tested snakes. 
Abbreviations: *: case reported in Abbas et al., (2011), **: case repoted in Papp et al., 2013
  
Number of snakes infected with the following viruses Infection 
rate  
 Ferlavirus Reovirus SnAdV 
Three snakes with 
triple infection* 
 Col-1, 1a, 1b Col-1, 1a, 1b  Col-1, 1a, 1b 
 
1.19% 
Three snakes with 
double infection* 
Col-1c, Pyt-5 
 
Col-1c, 54/4/09 
(Abbas et al., 
2011) 
Pyt-5, 
54/4/09 
(Abbas et al., 
2011) 
 
1.19% 
Fourteen snakes with 
single infection 
Ten snakes: 
Col-1d, e, f, 
Col-2**, Pyt-
1a~c, Pyt-3&4 
and Pyt2 
Four snakes: 
14/ 5,10&13/09 
and 54/3/09 
 5.57% 
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5.1.3  Phylogenetic analyses 
Six different partial L gene sequences were obtained from 19 RT-PCR products. The 
RT-PCR product obtained from Pyt-2 (234 bp) was not included in the phylogenetic 
analyses. Three of these produtcs (from Pyt-1a~Pyt-1c, Pyt-4, and Pyt-5) cluster to 
subgroup B while the rest (from Col -1; Col -1a~col-1e; Pyt-3 and Col-2) cluster into 
one branch forming the new subgroup C within the Ferlavirus genus (Figure 5A). This 
figure shows the same topology as in earlier publications (Abbas et al., 2011; Papp et 
al., 2013) where the ferlaviruses clustered into three closely related subgroups 
forming a seperate genus (Marschang et al., 2009; Kurath et al., 2004). Within this 
genus, the first two representatives of the novel subgroup C clustered together.  
Phylogenetic calculations based on partial L gene sequence were carried out using 
several methods within the Mega program 5.05 as mentioned previously (Table 
3.13). In all methods used, the two isolates Pangut GER09 and Hobuc HUN09 
clustered together within the Ferlavirus genus supported with significant bootstrap 
values (61-83%). Depending on the method applied, this subgroup sometimes 
clustered close to subgroup B isolates, supported with low bootstrap values (39-
53%). In one method (ML) this subgroup clustered as its own branch, the proposed 
subgroup C supported with high bootstrap values (95%) (Figure 5B).  
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Figure 5A: Phylogenetic tree (Maximum likelihood analysis) based on partial L gene 
sequences 456 nucleotides (nt). 
Bootstrap values were calculated for 500 replicates. Bootstrap values 60% and higher are 
indicated beside the nodes, while the branches with lower values are shown with 
checkerboard lines. Clinical samples from this study are printed in italics. GenBank 
accession numbers: FDLV (NC_005084), Crot GER03 (GQ277611), Dasy GER00 
(GQ277613), GonoGER 85 (AF349404), Igu GER00 (GQ277617), NTV (AF286045), Orth 
GER05 (GQ277616), Xeno USA99 (GQ277614), Pyth GER01 (GQ277612), Pangut GER09 
(HQ148084), Hobuc HUN09 (JX186195), Ther GER99 (GQ277615).  Avian PMV-6 
(AY029299), NDV = Newcastle disease virus (AF375823), Hendra virus (AF017149), Nipah 
virus (NC_002728), HPIV-1 (AF457102), Sendai (NC_001552), Canine distemper virus 
(AF378705),  Measles virus (AF266289), Mumps virus (NC_002200), SV-41 = Simian virus 
41 (NC_006428)  and Tupaia paramyxovirus (AF079780). 
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Figure 5B: Phylogenetic tree (Maximum likelihood analysis) based on partial L gene 463 
nucleotides (nt). 
 Bootstrap values were calculated for 500 replicates. Values of 60% and higher are indicated 
beside the nodes, while the branches with lower values are shown with checkerboard lines. 
Clinical samples from this study are printed in italics. GenBank accession numbers: FDLV 
(NC_005084), Crot GER03 (GQ277611), Dasy GER00 (GQ277613), GonoGER 85 
(AF349404), Igu GER00 (GQ277617), NTV (AF286045), Orth GER05 (GQ277616), Xeno 
USA99 (GQ277614), Pyth GER01 (GQ277612), Pangut GER09 (HQ148084), Hobuc HUN09 
(JX186195), Ther GER99 (GQ277615).  Avian PMV-6 (AY029299), NDV = Newcastle 
disease virus (AF375823), Hendra virus (AF017149), Nipah virus (NC_002728), HPIV-1 
(AF457102), Sendai (NC_001552), Canine distemper virus (AF378705),  Measles virus 
(AF266289), Mumps virus (NC_002200), SV-41 = Simian virus 41 (NC_006428)  and Tupaia 
paramyxovirus (AF079780). 
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5.1.4    Evaluation of the nested RT-PCR method (Ahne et al., 1999) 
targeting the ferlavirus partial L gene and its efficiency as a standard 
diagnostic method 
A product of approximately 566bp was obtained from a total of 61 samples from 50 
animals. (For more details, see supplementary data, Table (1) in Appendix). The size 
range of these products was between 500 and 600 bp. All products within this size 
range were submitted for sequencing. No sequence was obtained from 49.18% (30 
samples of the 61 reactive samples). The sequence obtained from 7 samples 
(11.47%) was bacterial in origin. Amplicons from an additional five samples (8.19%) 
were non specific, while 19 samples (31.14%) had ferlavirus specific sequences. 
Unspecific products of the expected size but not specific sequence made up 29.23% 
of the apparently positive samples (8 samples of the 27 that resulted in expected size 
products).  
      In order to increase the specificity of the RT-PCR multiple trials were performed 
targeting the highly conserved L gene. 
5.2         Optimization trials  
5.2.1      Optimization trials for the nested RT-PCR (Ahne et al., 1999) 
targeting a portion of the L gene. 
Despite the changes in the annealing temperature (45, 48 and 51) and in the MgCl2 
concentrations (1, 1.5, 2, and 2.5) mM, all of the samples that had resulted in 
unspecific products in the original RT-PCR (listed in Table 3.17) also resulted in 
unspecific products in the adjusted RT-PCRs. The AdV positive sample gave false 
positive specific size products (~566 bp) with all three annealing temperatures used 
when concentrations of 2 and 2.5 mM MgCl2 were used. However, when lower MgCl2 
concentrations were used with all three annealing temperatures, this sample gave 
unspecific size amplicons (350 bp of the DNA polymerase gene) which is the 
predicted size length when applying the AdV PCR (Wellehan et al., 2004). No signals 
were detected for negative controls (NC) in any of the trials. All three samples used 
as PC showed the specific size amplicon (566 bp) for all applications except for 
sample No 10 which showed either too faint or no amplicons when using 2.5 mM 
MgCl2 at 45 and 51 ºC annealing temperatures and 2 mM MgCl2 at 48 ºC annealing 
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temperature. All RT-PCR results of these trials are shown in the following figures 
(Figure 6.1- 6.3). 
Sensitivity testing using ferlavirus isolates from cell culture showed that the RT-PCR 
using the new primers had a lower sensitivity than the original PCR. This PCR was 
therefore discarded as a possible alternative diagnostic method. 
Figure 6.1: RT PCR targeting a portion of the L gene modified from Ahne et al. (1999) using 
an annealing temperature of 45 ºC with four different concentrations of MgCl2; (A) 1 mM, (B) 
1.5 mM, (C) 2 mM, (D) 2.5 mM. 
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Figure 6.2:  RT PCR targeting a portion of the L gene modified from Ahne et al. (1999) using 
an annealing temperature of 48 ºC with four different concentrations of MgCl2; (A) 1 mM, (B) 
1.5 mM, (C) 2 mM, (D) 2.5 mM. 
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Figure 6.3:  RT PCR targeting a portion of the L gene modified from Ahne et al. (1999) using 
an annealing temperature of 51 ºC with four different concentrations of MgCl2; (A) 1 mM, (B) 
1.5 mM, (C) 2 mM, (D) 2.5 mM.  
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5.2.2: Designing new primers targeting partial L gene sequence 
The following isolates: Dasy GER00, Pangut GER91, Crot GER03, Igu GER00, Vip 
GER90, Crot GER90, Orth GER05, Pangut GER09, Ther GER99 (Table 3.16) 
representing all genotypes of ferlaviruses known so far were used as PC for testing 
the new primers (Table 3.18). The most successful primer combinations of those 
recently designed (Table 4.3) which resulted in specific size products were; A- F2 in, 
R5 out in the 1st round and F3 in and R4 out in the 2nd round; B- F2 in, R6 out in the 
first round and F3 in and R5 out in the second round; and C F1, R6 in the 1st round 
and F3, R5 in the 2nd round. 
These nested combinations as shown in Figure 7.1 gave positive signals of the 
expected sizes (see in Table 4.3; ~200, ~800, ~900 bp products respectively). The 
rest of the primer combinations (D, E, F, G, H, I) either gave weak signals or failed to 
result in any amplicon. Among all primer combinations, C was the most sensitive as it 
was the only combination that resulted in positive amplicons from all ferlaviruses 
tested (100%) with the expected size product (929 bp). However, weak signals were 
detected for two isolates (324/00 and 1356/90). Primer combinations A and B only 
amplified RNA from some of the nine ferlaviruses tested: combination A amplified 
44% and combination B amplified 66% of the nine isolates. No signals were detected 
for NC for all trials (Figure 7.1). 
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Figure 7.1:  RT PCR targeting a portion of the L gene using primer combinations; A, B and C. 
using RNA from nine ferlaviruses isolates as templates. 
(Primer combinations; see table 4.3) 
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In order to compare the sensitivity of primer combination C with the already 
established RT-PCR described by Ahne et al. (1999) (illustrated in Table 4.2), the 
nested RT-PCR according to Ahne et al. (1999) was performed using the same RNA. 
Positive and strong signals (566 bp products) were obtained for all ferlaviruses as 
shown in Figure 7.2.  
Figure 7.2:  Nested RT PCR targeting a portion of L gene as described by Ahne et al. (1999) 
using RNA from a variety of ferlavirus isolates as templates. 
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5.3: Surface glycoprotein gene amplification 
5.3.1: RT/PCR amplification and sequencing 
Surface glycoprotein gene amplification was attempted for nine ferlavirus isolates 
(see Materials and Methods section 3.7.1 and Table 5.3.1). For the F gene 100% 
coverage was obtained for the following isolates: Orth GER05, Pangut GER09, Crot 
GER03, Igu GER00 and Crot GER90 and Vip GER90. For the rest of the isolates, the 
entire CDS region was obtained. However, the untranslated region located before the 
start codon is missing from these other isolates. Therefore, the coverage of the 
obtained F gene of these isolates are as follows: 98.83% Pyth GER01; 96.82% Var 
GER95; 97.66% Ther GER99 (supplementary data, Figure 2A in Appendix; deduced 
aa sequences of F gene). An overall coverage of 100% was obtained for the HN 
genes for all isolates (see supplementary data, Figure 2B) in Appendix; deduced aa 
sequences of HN genes). 
The obtained sequences were concatenated based on overlapping sequences 
forming one continuous sequence including the F and HN as well as partial L gene 
sequences (supplementary data, Figure 1). The lengths of the concatenated 
sequences were as follows; 5334 bp for Var GER95, 5310 bp for Crot GER90, 5352 
bp for Igu GER00, 5374 bp for Orth-GER05, 5366 bp for Vip GER 90, 5418 bp for 
Pyth GER01, 5430 bp for Crot GER03, 5370 bp for the Pangut GER09 and 5336 bp 
for the Ther GER99. The length of sequence that could be evaluated differed based 
on quality of sequence data of the L gene obtained. Sequence length of 5242 nt was 
used for phylogenetic analyses. 
After importing the sequences into the BioEdit alignment program (Hall 1999), the 
beginning of the gene, start codon, CDS regions, end codon and intergenomic 
regions could be identified for each gene. The non-coding region of the F gene 
located subsequent to the stop codon was 95% conserved within the subgroup B 
isolates. However, this region showed only 67% similarity within subgroup A. For 
Pangut GER09, this region showed 57% similarity to squamate ferlaviruses 
(subgroups A and B) and 46% similarity to the corresponding region in Ther GER99.  
The non coding region located before the start codon of the HN gene was 94% 
conserved within the subgroup B isolates, 70% within the subgroup A isolates. 
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Pangut GER09 (subgroup C) showed 83% similarity with isolates of subgroups A and 
B. However, the tortoise isolate showed only 30% similarity with the other isolates for 
this region. The non coding region located after the stop codon of the HN gene 
showed comparable results with that located after the stop codon of the F gene for all 
isolates. The non coding region located after the start codon of the L gene also 
showed comparable results to those of the HN gene. Gene starts and gene stops 
were 100% conserved among all ferlavirus isolates except for the gene start of the L 
gene in Pangut GER09 which was 88.89% conserved. 
Three nucleotides were predicted to be intergenetic regions between the F, HN and L 
genes of the ferlavirus isolates. These regions usually consisted of CCT for all 
isolates except for the Pangut GER09 and the tortoise isolate which always had CTT 
as an alternative.  
Any sequencing results showing any inconsistency were repeated at least once. All 
primer combinations resulted in the expected size products (see Materials and 
Methods section, Table 4.5). In the case of isolate Pangut GER09, new primers (F C) 
were designed and used for this isolate to amplify problematic regions. The tortoise 
isolate only gave positive results with F-HN primer combinations when Innu long taq 
polymerase (see Materials and Methods section Table 4.4) was used with the 
corresponding PCR conditions. New primer combinations (HN-L tortoise and HN 
tortoise) were designed and used as alternatives to the `HN gene` primers 
(Marschang et al., 2009) and `HN-L` primers which gave positive amplicons for all 
other ferlaviruses. 
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Table 5.3.1: Description of ferlavirus isolates analyzed in this study with the length of F, HN and L gene sequences obtained. 
 
Isolate 
No/ 
year 
Isolate name 
  
Sub 
group 
Host Species common name Length of gene sequences obtained 
F HN L  
3319/95 Var GER95 A Varanus prasinus Emerald tree monitor 1715 nt 1937 nt 1709 nt 
368/01 Pyth GER01 B Python regius Ball python 1772 nt 1937 nt 1709 nt 
9/5/03 Crot GER03 B Crotalus horridus Timber rattlesnake 1793 nt 1937 nt 1700 nt 
324/00 Igu GER00 B Iguana iguana Green iguana 1793 nt 1937 nt 1622 nt 
1356/90 Crot GER90 B Crotalus 
catalinensis 
Santa Catalina Island 
Rattlesnake 
1793 nt 1937 nt 1580 nt 
2766/90 Vip GER90 B Vipera palaestinae Palestine viper 1793 nt 1937 nt 1636 nt 
20/3/05 Orth GER05 B Orthriophis 
taeniurus 
Beauty snake 1793 nt 1937 nt 1644 nt 
tPMV/99 Ther GER99 - Testudo hermanni Hermann’s tortoise 1751 nt 1937 nt 1648 nt 
6/3/09 Pangut GER09 C Pantherophis 
guttatus 
Corn snakes 1793 nt 1937 nt 1640 nt 
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5.3.2: Phylogenetic analyses  
All ferlavirus isolates (Table 3.19) clustered together within the new genus Ferlavirus 
according to all phylogenetic analyses of both individual F (1728 bp) and HN (1937 
bp) genes and the concatenated sequence of these genes with extended portions of 
the L gene (1544 bp) (supplementary data Figure 2 A&B, 1).  
The obtained phylogenetic trees for both the F (Figure 8A) and HN (Figure 8B) genes 
demonstrate the same topology as in previous publications (Marschang et al., 2009; 
Abbas et al., 2011). Phylogenetic analyses using the complete sequence of the F 
gene showed the subgroup C isolate (Pangut GER09) clusters on a separate branch 
supported with high bootstrap values (74-100%) for all methods used. Using the 
UPGAMA method to analyze the HN gene led to the same results with a high 
bootstrap value of 96% for this branch, while the rest of the methods showed this 
isolate clustering with subgroup A isolates supported with lower bootstrap values (64-
72%). 
Phylogenetic analyses were conducted for the concatenated sequence of F, HN, and 
partial L genes. Depending on the methods applied, Pangut GER09 clustered either 
closer to subgroup B isolates (Bootstrap values 57-59%), or as its own subgroup, but 
supported with low bootstrap values (59%) (Figure 8C). Interestingly, when including 
members of other PMV genera in the analysis, Pangut GER09 clearly formed a 
separate subgroup supported with higher bootstrap values (98-100)% (Figure 8D). 
Regarding Ther GER99, all of the trees showed the same topology where this virus 
clustered within the genus as a sister group to the squamate ferlaviruses, supported 
with high bootstrap values (84-100%).  
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Figure 8A: Phylogenetic analysis of the full F gene CDS (1728 bp) using Maximum 
Likelihood analyses in Phylip program version 3.69.  
Bootstrap values indicated on the branches are of both Maximum Likelihood and Neighbour 
Joining analyses which show the same topology and represented the percentage of 100, 
(500 for Neighbour Joining analysis) replicate trees respectively. Values higher than 60% are 
indicated at the branches, while branches supported with lower values are indicated with 
checkerboard lines. Subgroups A, B and C are framed with smaller circles. Ther GER99 is 
printed in bold. Full F gene CDS of FDLV AF251500 and Gono Ger 85 AY725422 were 
included to enhance the classification especially within subgroup A in reptilian PMV. Full F 
gene CDS from paramyxoviruses of different genera also used in the analysis: APMV-
6/15072442, NDV |GI 259879797|gb|FJ772486.1|, Nipah |NV/MGI57282808, Hendra 
|GI29468603, Mumps SBL-1 gi|7672807|gb|AF143395.1|, (SV41) 55770820, Measles  D-V/S 
gi| 162946413, Cetacean morbillivirus gi|520639 Dolphin morbillivirus gi|38490143, Tupaia 
gi|9634968, Sendai gi|11994992, HPIV-1 F gene,Oh-MVC11 gi|516851. 
74/90 
100 
81/93 
81/77 
97/99 
100 
100 
100 
100 
SV41 
Mumps 
Tupaia 
Dolphin 
Cetacean 
Measles 
Hendra 
Nipah
h 
Sendai 
GonoGER95 
`A`   FDLV 
VarGER95 
          
PangutGER09 
                     `C` 
TherGER99 
0.1 
100 
 
 
 
 
 
subgroup`B
` 
73 
 
 
 
 
Figure 8B: Phylogenetic analysis of the full HN gene CDS (1937 bp) by Maximum Likelihood 
analysis in Phylip program version 3.69.  
Bootstrap values indicated on the branches were calculated for 100 replicates and are for 
both ML and Fitch Margoliash analyses respectively. Values higher than 60% are indicated 
at the branches, while branches supported with lower values indicated with checkerboard 
lines. The Ferlavirus genus is framed with a large ovular circle with grey background. 
Subgroups A, B, and C are framed with smaller circles. Ther GER99 is printed in bold. Full 
CDS of FDLV NC_005084 is included. Full CDS of HN genes from paramyxoviruses of 
different genera were used as outgroups; Sendai NC_001552, HPIV1 NC_003461, Hendra  
NC_001906, Nipah NC_002728, Mumps NC_002200, NDV B1 NC_002617.1 
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Figure 8C: Phylogenetic analysis of the concatenated sequence (5242 bp) of F, HN, and a 
large portion of L gene of 9 ferlaviruses. 
The tree was created using the Maximum Likelihood analysis in the Mega 5.05 program. 
Bootstrap values indicated on the branches represent the percentage of 500 replicates with 
the same branches. Values higher than 60% are indicated at the branches, while branches 
supported with lower values are indicated with checkerboard lines 
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Figure 8D: Phylogenetic analysis of the concatenated F, HN, and L gene nt sequences (5242 
bp). 
Phylogenetic analysis of the concatenated F, HN, and L gene nt sequences (5242 bp) of nine 
ferlaviruses by ML method in Mega program version 5.05Bootstrap values above 60% are 
indicated on the branches and represented the percentage of 500 replicates with the same 
topology. Branches of lower values are drawn with checkerboard lines. GenBank accession 
numbers are as follows: Pangut GER09 (AY725422.1, HQ148085.1, HQ148084), Var 
GER91), FDLV (AY141760.2), Igu GER00(GQ277619- GQ277617), Crot-GER03 
(GQ277611), Ther GER99 (GQ277615), Orth GER05 (GQ277620-GQ277616), Pyth GER01 
(GQ277612),  Crot GER90 and Vip GER90, Hendra virus (AF017149), HPIV-1 (AF457102), 
Dolphin Morbillivirus (AJ608288.1), Measles virus (AB016162.1), Mumps virus 
(AB040874.1), Nipah virus (AF212302.2), Sendai (AB039658.1), SV-41=Simian virus 41 
(X64275.1).   
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5.3.3: Sequence identity matrixes 
Sequence identity (ID) values were calculated for complete CDS and the deduced aa 
sequences of both F and HN genes for nine ferlavirus isolates: Var GER95, Pyth 
GER01, Crot GER03, Igu GER00, Crot GER90, Vip GER90, Orth GER05, THer 
GER99, Pangut GER09 (see Materials and Methods section Table 3.19) based on 
ClustalW alignment using the Phylip program package (version 3.69). The highest 
identity values for both genes were found between the squamate subgroup B isolates 
as follows: nt 96.6-99.8% and aa 98.8-100% for F gene (Table 5.3.2) and nt 97.1-
99.8% and aa 99.1-99.8% for HN gene (Table 5.3.3). Identity values for F gene of 
subgroup A isolates showed moderate distances compared to subgroup B isolates 
(nt 78.3-79.1%; aa 91.9-92.1%) and subgroup C isolates (nt 77.1-78.1%; aa 90.8-
91.1%). Comparable results were calculated for the HN genes of subgroup A isolates 
compared to subgroup B (nt 77.2-78.8; aa 90-91.3%) and C (nt 77.5-78.1%; aa 90-
90.4%). For the Pangut GER09, identity values compared to subgroups A and B 
isolates were similar, supporting the classification of Pangut GER09 as the first 
representative of a third cluster within the Ferlavirus genus. ID values for the chelonid 
ferlavirus (Ther GER99) show equivalent distance to each of the squamate ferlavirus 
subgroups (A, B, and C) for both genes. However, these values are a bit higher for 
the F gene (nt 66.9-68.4%; aa 75.2-75.7%) than for the HN gene (nt 64.0- 65.6%; aa 
70-72%).  
ID values were also calculated for partial sequence of the L gene (1544 bp) for 
eleven ferlavirus isolates (Var GER95, Dasy GER00, Pangut GER91, Crot GER03, 
Orth GER05, Vip GER90, Pyth GER01, Crot GER90, Igu GER00, Pangut GER, Ther 
GER99) and found comparable to those found for F gene and higher than those for 
HN gene (Table 5.3.4). The squamate subgroup B had the highest identity values for 
L gene as follows: nt 97.3-99.8% and aa 98.8-100%. Identity values for partial L gene 
sequences among subgroup A isolates showed moderate distances compared to 
subgroup B isolates (nt 78.2-79.5%; aa 92.2-100%) and C isolates (nt 78.1-79%; aa 
90.4-91.6%). ID values for the chelonid ferlavirus (Ther GER99) show equivalent 
distance to each of the squamate ferlavirus subgroups (A, B and C). 
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The U gene in squamate ferlaviruses encodes two ORFs (ORF-1 at position 68 aa 
and ORF-2 at position 87 aa) coding for 82 and 143/144 aa respectively (Papp et al., 
2013 and Abbas et al., 2011). ID values were also calculated for the complete U 
gene CDS region of the nt sequence (246 and 429 bp) and the deduced aa 
sequence (82 and 143 aa) for ten ferlavirus isolates (Orth GER05, Igu GER00, Pyth 
GER01, Crot GER03, FDLV, Gono GER85, Dasy GER00, Xeno USA99, Biti CA98 
and Pangut GER09). In general, nt and aa identity values between ferlaviruses are 
higher for the ORF-2 (77.4-99.5), (72.2-100)% than those for ORF-1 (76.7-100), 
(60.9-100)% respectively. For both, especially the aa ID values are lower than the 
corresponding values for the complete CDS regions of the F and HN genes and the 
partial sequences of the L gene (Table 5.3.5). 
 
Table 5.3.2: Sequence identity matrix of ferlavirus F gene sequences. 
Sequence identity values were calculated for the nucleotide (`Arial` letters) and the deduced 
amino acid sequences (`Times New Romans letters` and Italics) of the complete CDS of F 
gene (1728 bp)  from eight squamate ferlaviruses representing subgroups A, B, and C and 
from the sole chelonid ferlavirus. All values are presented in percentage. 
 
Subgroups  A B 
 
C 
A 
 
84.3 78.3-79.1 77.1-78.1 
94.8 91.9-92.1 90.8-91.1 
B 
 
 96.6-99.8  
 98.8-100  
C 
 
 78.4-78.7  
 91.1-91.5  
Ther GER99 
 
68.6-67.2 66.9-67.5 68.4 
75.2-76.1 75.7-76.4 75.5 
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Table 5.3.3: Sequence identity matrix HN gene 
Sequence identity values were calculated for the nucleotide (`Arial ` letters) and deduced 
amino acid sequences (`Times New Romans letters `and Italics) of complete CDS of HN 
gene (1937 bp) from eight squamate ferlaviruses representing subgroups A, B and C and 
from the sole chelonid ferlavirus All values are presented in percentage. 
Subgroups  A B C 
A 
 
84.4 77.2-78.8 77.5-78.1 
92.9 90-91.3 90-90.4 
B 
 
 97.1-99.8  
 99.1-99.8  
C 
 
 77.5-77.7  
 90-90.6  
Ther GER99 
 
64.4-65.6 64.3-65.0 64 
71.5 71.8-72.0 70.6 
  
 
Table 5.3.4: Sequence identity matrix L gene 
Sequence identity values were calculated for the nucleotide (`Arial ` letters) and deduced 
amino acid sequences (`Times New Romans letters `and Italics) of partial L gene (1544 bp) 
from ten squamatid ferlaviruses representing subgroups A, B and C and from the sole 
chelonid ferlavirus. All values are presented in percentage. 
Subgroups  A B C 
A 
 
86.1-98.5 78.2-79.5 78.1-79 
96.3-99.8 92.2-100 90.4-91.6 
B 
 
 97.3-99.8  
 98.8-100  
C 
 
 78.8-79.8  
 91.8-92.2  
Ther GER99 
 
68.5-68.4 66.5-66.9 68.2 
72.7-73.3 74.1-74.3 73.3 
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Table 5.3.5: Sequence identity matrix U gene 
Sequence identity values were calculated for both ORFs for the complete U gene CDS 
region of the nt sequence (ORF-1 246 and ORF-2 429 bp nt) (`Arial ` letters) and deduced 
amino acid sequences (ORF-1 82 and ORF-2 143 aa) (`Times New Romans letters `and 
Italics) from ten squamate ferlaviruses representing subgroups A, B and C. All values are 
presented in percentage. Normal print is for ORF-1, bold is for ORF-2. 
 
Sub 
groups  
A B 
 
C 
A 
 
88.3-100 87.5-99.5 76.7-79.1 77.4-78.6 85.9-86.7 81.6-83.8 
71.9-100 86.7-100 60.9-67 72.2-75 71.9-75.6 81.2-84 
B 
 
 95.9-100 95.7-100 77.1-77.9 78.1-78.4 
 90.2-100 97.2-100 60.9-64.6 75.6-76.3 
 
 
5.3.4           Fusion and attachment protein analyses 
In order to assess the function of the predicted domains of the F and HN proteins, 
amino acid sequences of these proteins of 10 ferlaviruses including FDLV were 
aligned and compared (supplementary data, Figure 2 A&B).  
 
5.3.4.1          Fusion protein analyses 
Generally, subgroup A and B isolates each had a conserved sequence for each 
motif. However, the sequence motifs of each subgroup differed to some degree from 
those of the other subgroups. Pangut GER09 (subgroup C) revealed inconsistent 
results, occasionally showing the conserved sequence of subgroup A and/ or B.  The 
chelonid ferlavirus revealed as well contradictory results for particular motifs, showing 
individual residues that are different from the sequences of the squamate 
ferlaviruses. 
Signal peptide (SP) is the first motif predicted using the SignalP 2.0 software 
program (Table 3.21), at the N-terminus of the F protein at position 1-19 aa for FDLV 
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and Var GER95 (subgroup A). For all subgroup B and C viruses and the chelonid 
ferlavirus, this peptide was predicted at position 1-18 aa. In general, this motif was 
not conserved and had several hydrophilic residues for all ferlaviruses including 
those at the intermediate hydrophobic region at positions 7 and 8 for the Pangut 
GER09 and subgroup B isolates respectively where hydrophobic residues were 
substituted with hydrophilic ones. 
 
The furin recognition site is the next predicted motif located at position 107-110 
(labelled with a box) (supplementary data, Figure 2A) which consists of four amino 
acids upstream from the cleavage site (from -1 to -4) and one residue +1 
downstream from that site. Fission of the C-terminus of this site would cleave the F0 
into F1 and F2 subunits. This motif is conserved for all ferlavirus subgroups since all 
contain basic residues R, K and R at positions -1, -2, and -4 respectively. Contrary to 
all other ferlavirus isolates, the tortoise isolate has a strongly basic residue R at 
position-6, while members of subgroups A and B have slightly acidic amino acids 
(threonine and serine respectively) at the same position. At position +1 downstream 
from the cleavage site, all subgroups share the conserved hydrophobic and aromatic 
amino acid phenylalanine. In general, this motif is conserved and shows a high 
degree of similarity when compared with corresponding regions of members of the 
genera Rubulavirus, Morbillivirus and Avulavirus. However, henipah- and 
respiroviruses lack the paramyxovirus furin recognition site, instead they have a 
single basic residue at position -1 as illustrated in Figure 9.  
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                                                      Cleavage  
                                                         site 
                 -6  4   -2-1   +1 
FDLV (A)     NKREKR FV 
    Crot GER03(B) SR.... .. 
        Pangut GER09(C)A..G.. .. 
              Ther GER99    RR.K.. .F 
                Mumps       SR.H.. .A 
      SV41        GS.R.. .A 
      Measles     SR.H.. .A 
Cetacean    SR.S.. .A 
Dolphin     SR.S.. .A 
Hendra      LVGDVK LA 
Nipah       LVGDV. LA 
Sendai      DVPQS. .F 
HPIV-1      DVPQS. .F 
NDV         GR.Q.. .I 
 
Figure 9: Furin recognition sites of F proteins of PMVs.  
Deduced aa sequences of F gene of the squamate ferlaviruses (FDLV, Crot GER03, Pangut 
GER09) and the chelonid ferlavirus (Ther GER99) were aligned with corresponding regions 
of other PMVs. Members of the genera Ferlavirus, Avulavirus, Rubulavirus and Morbillivirus 
have identical furin recognition sites (RXKR), compared to members of the genera 
Respirovirus and Henipahvirus which lack this site. 
 
The following motif is the highly conserved fusion peptide (FP) (Lamb & Kolakofsky, 
2001) at position 111-135. As expected, this motif consists mainly of hydrophobic 
residues (V, A, L, I). At positions 112 and 118 (supplementary data, Figure 2A), Ther 
GER 99 has semi-conserved and conserved hydrophobic substitutions (F and I), 
while at position 114 this isolate has a non conserved substitution with an hydrophilic 
(T) residue compared to all other subgroups which have a hydrophobic residue there. 
In general, this motif is identical among all members of the squamate groups and 
shares a high degree of similarity with the corresponding sequences of other genera 
of the Paramyxovirinae (Figure 10). 
 
 
 
 
HENIPAH 
RESPIROVIRUS 
RUBULAVIRUS 
AVULAVIRUS 
MORBILLIVIRUS 
FERLAVIRUS 
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                   111                                135 
                   ....|....| ....|....| ....|....| ....| 
FDLV (A)           FVGIAIAVGA VALATSAQIT AGIALSNTIK NAEAI                                                                                                
Crot GER03 (B)     FVGIAIAVGA VALATSAQIT AGIALANTIK NAEAI                                                                                                
Pangut GER09 (C)   FVGIAIAVGA VALATSAQIT AGIALSNTIK NAEAI                                                                                                
Ther GER99         FFGTAIAIGA VALATSAQIT AGIALSNTIK NAAAI                                                                                                
Tupaia             FWGAIIAGAA LGVATAAAIT AGVALHRAEQ NARNI                                                                                                
Nipah              LAGVIMAGVA IGIATAAQIT AGVALYEAMK NADNI                                                                                                
Hendra             LAGVVMAGIA IGIATAAQIT AGVALYEAMK NADNI                                                                                                
Sendai             FFGAVIGTIA LGVATSAQIT AGIALAEARE AKRDI                                                                                                
HPIV-1             FFGAVIGTIA LGVATSAQIT AGIALAEARE AKRDI                                                                                                
APMV-6             LIGAIIGTAA LGLATAAQVT AALALNQAQD NAKAI                                                                                                
Mumps              FAGIAIGIAA LGVATAAQVT AAVSLVQAQT NARAI                                                                                                
NDV                FIGAVIGSVA LGVATAAQIT AAAALIQANQ NAANI                                                                                                
SV41               FAGVVVGLAA LGVATAAQVT AAVAVVKANA NAAAI                                                                                                
Measles            FAGVVLAGAA LGVATAAQIT AGIALHQSML NSQAI                                                                                                
Cetacean           FAGVVLAGVA LGVATAAQIT AGIALHQSIM NSQSI                                                                                                
Dolphin            FAGVVLAGVA LGVATAAQIT AGVALHQSIM NSQSI                                                                                                    
                                                                                            
Figure 10: Fusion peptide regions of F proteins of several PMVs.  
Deduced aa sequences of each subgroup of the squamate ferlaviruses (FDLV, Crot GER03, 
Pangut GER09) and the chelonid ferlavirus (Ther GER99) were aligned with corresponding 
regions of the FP of other PMV genera which consist mostly of hydrophobic amino acids. 
 
HRA and HRB were predicted for all PMV isolates. These repeats were assumed to 
contain seven residues in the arrangement from (a) to (g) which was found to repeat 
six times at positions 145–186 and 461–502 respectively. A high level of similarity 
was noticed within HRA for all ferlavirus isolates, where it contains mainly 
hydrophobic and/or non-polar residues at positions a & d. At these regions HRB was 
also conserved and/or semi conserved for all ferlaviruses presenting non polar or 
hydrophobic residues with the exception of the tortoise isolate which had a 
hydrophilic serine residue instead of the hydrophobic alanin at position d of the fifth 
repeat. A leusine zipper (LZ) was detected within the HRB from 461~482 using the 
motif scan option and the leusine zipper prediction tools in the GENtle program. This 
motif was mapped to the hydrophobic residues (leucine and/or Isoleucine) at position 
(a) of this motif for all ferlaviruses (supplementary data, Figure 2A). As reported 
previously by Franke et al. (2006), all residue differences at positions other than a & 
d of both repeats were substituted with similar amino acids. 
The last motif is the transmembrane domain TM which was predicted for all ferlavirus 
isolates at position 502-520 at the C- terminus end of the F protein using the 
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TMHMM Server 2.0 (2009). This motif had several changes for all squamate 
ferlaviruses, although most of them retain hydrophobic residues except for the 
chelonid ferlavirus isolate which has two hydrophilic residues (S and T) at positions 
503 and 508. 
Glycosylation site (N-G) detection was done using NetNGlyc 1.0 (2002) for the full 
length sequence of F protein for 10 ferlaviruses, including FDLV (as a reference). 
Three probable N-G positions were predicted for FDLV at locations 102, 436, and 
443 aa. These results correspond with previous findings from Franke et al. (2006) 
when full length sequence of F gene from FDLV and Gono GER85 were analyzed 
and used to predict a model for the F protein of PMV of reptilian origin. The first N-G 
found at position 102 aa for FDLV was not detectable for any other ferlavirus isolates 
(Table 3.19). For Var GER95 (subgroup A), the second and the third N-G positions 
were detected at analogous sites compared to FDLV. For subgroups B, C, and the 
chelonid ferlavirus, these sites were also detected, though moved back to positions 
435 and 442 respectively. The last N-G site predicted at position 442 aa for the 
chelonid ferlavirus did not pass the threshold. Nevertheless, these results are based 
on a computer modeling program and it is not defined whether these sites are truly 
glycosylated. 
 
5.3.4.2 HN protein analysis 
The first predicted motif in the HN protein was the cytoplasmic tail lying at the N-
terminus which spans residues 1-25 aa. This domain was likely to be conserved 
except for the region 12-23 where many non-conserved substitutions were observed.  
The next predicted domain using TMHMM Server 2.0 (2009) represents the 
transmembrane domain (TM) at positions 28 to 50 for all squamate ferlaviruses 
which is in agreement with previously published studies (Kurath et al., 2004). For the 
tortoise isolate, this motive was predicted at positions 31-49 using both TMHMM 
Server 2.0 (2009) and transmembrane prediction tools in the GENtle program. This 
motif was conserved containing hydrophobic residues for all ferlaviruses. For the 
chelonid ferlavirus, non conserved residues were observed at the N terminus of this 
domain, however, all remain hydrophobic. 
84 
 
 
 
According to the predicted model of NDV HN protein (Yuan et al., 2011), the stem 
can be mapped to the residues from 68 to 115. Sequence alignments of the HN 
proteins of several PMVs including nine ferlavirus isolates along with other PMV 
genera (respiro-, morbilli- and rubullaviruses) with the corresponding regions from 
NDV revealed that all substitutions in this region including those mapped to the outer 
surface and the hydrophobic core of the stalk were more conserved within PMV 
genera than between the genera. In general, all residues were conserved within the 
Ferlavirus genus compared to all other genera except for the tortoise isolate (Figure 
11). Some non conserved residues were predicted for the chelonid ferlavirus 
especially at the fusion interaction sites (68, 80, 96) These sites correspond to aa 69, 
81, and 97 of the NDV HN respectively.  
Next to the stem region starting from 127 until the end of the HN protein is the head 
region which was highly conserved except in the chelonid ferlavirus at several 
positions (from 224 to 228, from 271 to 279, and from 345 to 360).  
 
          68                                                   116              
          *...|*..*| ..*.*....| .**.|.*.** |....|.... |....|.... | 
Pangut09  YLVPIKEKSD AIGQDV-QEG VLPRLNLITA ATTTTIPRSI AIQTK-DLSD L                                                                              
Pangut91  YLVPIKEKSE TINQDI-QEG ILPRLNLITA STTTTIPRSI AIQTK-DLSD L                                                                              
Igu GER00 YLIPIKTKSD DISQDV-QEG ILPRLNLITA STTTTIPRSI AIQTK-DLSD L                                                                              
Xenu USA99YLVPIKEKSD TIGQDI-QEG IFPRLNLITA STTTTIPRSI AIQTK-DLSD L                                                                              
FDLV      YLVPIKDKSE SISQDI-QEG IFPRLNLITA ATTTTIPRSI AIQTK-DLSD L                                                                                                      
Vip GER90  YLIPIKTKSD DISQDV-QEG ILPRLNLITA STTTTIPRSI AIQTK-DLSD L                                                                                
Pyt GER01 YLIPIKTKSD DISQDV-QEG ILPRLNLITA STTTTIPRSI AIQTK-DLSD L                                                                                 
Crot GER03YLIPIKTKSD DISQDV-QEG ILPRLNLITA STTTTIPRSI AIQTK-DLSD L                                                                              
THerGER99 QIDLIKDESK VILQDI-QEG ILPRLNLITQ AITTGLPRSI AIQTQ-ELKE T                                                                              
Sendai    LNTSNKEVKE SLTSLIRQEV ITRAANIQS- --SVQTGIPV LLN-KN-SRD-V                                                                               
HPIV1     MNESAKIIKE TITELIRQEV ISRTINIQS- --SVQSGIPI LLN-KQ-SRD-L                                                                                  
Mumps     SATMIASAVG VMN-QV-IHG VTISLPLQI- -EGN-QNQLL STLATICTSK K                                                                                                       
SV41      ITDLLNNILS VAN-QI-IYN SAVALPLQL- -DTL-ESTLL TAIKSLQTSD K                                                                                                      
Canine    VHHQVIDVLT PLFKII-GDE IGLRLPQKLN EIKQFILQKT NFFNPNREFD F                                                                              
Measles   VTNSIEHQVK DVLTPL-FKI IGDEVGLRTP QRFTDLVKFI SDKIKFLNPD R                                                                                                     
NDV       KITSTLGSNQ DVVDRI-YKQ VALESPLALL NTETTIMNAI TSLSYQINGA A                                                                                                       
                            abc defghijkab cdefghijka bcdefgh 
Figure 11: stalk regions of HN protein of several PMVs 
Deduced aa sequences (HN gene) represent the predicted Stalk regions of squamate 
ferlavirus HN proteins (FDLV, Crot GER03, Pangut GER09, Pangut GER91, Igu GER00, 
Xeno USA99, Vip GER90, Pyt GER01) and the chelonid ferlavirus HN protein (Ther GER99). 
This region was aligned with the corresponding regions of other PMVs of other genera. 
Residues that mainly influence the fusion process by interfering with F-HN interaction are 
indicated by an asterisk. Residues a, d and j form the hydrophobic core of the 4HR of the 
NDV stalk region. 
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The subsequent position (246-251 aa) is the sialic acid binding site N-R-K-S-C-S. 
This site was found to be 100% conserved within HN proteins among several 
members of many PMV genera including: Ferlavirus, Respirovirus, Rubulavirus and 
Avulavirus, compared to henipaviruses (G protein) which revealed 40% similarity 
(Figure 12). 
                                             5  
                                    ....|....|  
              FDLV                  RKSCSTVAQG                                                                                                                             
              pangut GER09          RKSCSTVAQG                                                                                                                             
              Var GER95             RKSCSTVAQG                                                                                                                             
              Pyt GER01             RKSCSTVAQG                                                                                                                             
              Igu GER00             RKSCSTVAQG                                                                                                                             
              Crot GER03            RKSCSTVAQG                                                                                                                             
              Orth GER05            RKSCSTVAQG                                                                                                                             
              Vip GER90             RKSCSTVAQG                                                                                                                             
              Crot GER90            RKSCSTVAQG                                                                                                                             
              Ther GER99            RKSCSTVALG                                                                                                                             
              Hendra                IHHCSSTYHE                                                                                                                             
              Nipah                 VYHCSAVYNN                                                                                                                             
              HPIV-1                RKSCSVIAAG                                                                                                                             
              Sendai                RKSCSVVATG                                                                                                                             
              Mumps                 RKSCSIATVP                                                                                                                             
              NDV                   RKSCSVSATP                                                                                                                             
              apmv 1                RKSCSVSATP                                                                                                                             
              apmv 3                RKSCSVTAGA                                                                                                                             
              apmv 2                RKSCSIVASK                                                                                                                             
              apmv 4                RKSCSVAAGS                                                                                                                             
              apmv 5                RKSCSIVATT                                                                                                                             
              apmv 6                RKSCSIIANP                                                                                                                             
              apmv 7                RKSCSIAATG                                                                                                                             
              apmv 8                RKSCSIVATQ                                                                                                                             
              apmv 9                RKSCSISATP                                                                                                                             
 
Figure 12: Putative sialic acid binding sites HN proteins of several PMVs. 
Deduced aa sequences (HN gene) of squamate ferlavirus (FDLV, Crot GER03, Pangut 
GER09, Igu GER00, Vip GER90, Pyt GER01, Var GER95, Orth GER05, Crot GER90) and 
the chelonid ferlavirus (Ther GER99) were aligned to the corresponding regions of PMVs of 
other genera. The putative sialic acid binding sites R-KS-C-S found to be identical for all 
viruses except for the henipahviruses. 
 
 
 
FERLAVIRUS 
HENIPAH 
RESPIROVIRUS 
RUBULAVIRUS 
AVULAVIRUS 
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In the alignment of seven ferlavirus (FDLV, Pangut GER91, Xeno USA99, Igu 
GER00, Vip GER90, Pyt GER01 and Crot GER03) HN proteins with avian PMV 
(apmv) 1-9 HN proteins, a conserved region was noticed within the head structure as 
illustrated in Figure 13. 
 
 
                247 .|....| ....|....| ....| 274 
     FDLV        RKSCSTVAQG RGAYLLCTNV VEDERTDY                                                                                                        
    Pangut GER91 RKSCSTVAQG RGAYLLCTNV IEDERTDY                                                                                                        
     Xeno USA99  RKSCSTVAQG RGAYLLCTNV VEDERTDY                                                                                                        
     Igu GER00   RKSCSTVAQG RGAYLLCTNV IEDERTDY                                                                                                        
     Vip GER90   RKSCSTVAQG RGAYLLCTNV IEDERTDY                                                                                                        
     Pyt GER01   RKSCSTVAQG RGAYLLCTNV IEDERTDY                                                                                                        
     Crot GER03  RKSCSTVAQG RGAYLLCTNV IEDERTDY                                                                                                        
     apmv 1      RKSCSVSATP LGCDMLCSKV TGTEEEDY                                                                                                        
     apmv 3      RKSCSVTAGA GVCWLLCSVV TESESADY                                                                                                        
     apmv 2      RKSCSIVASK YGCDILCSIV IETENEDY                                                                                                        
     apmv 4      RKSCSVAAGS GHCYLLCSLV SEPEPDDY                                                                                                        
     apmv 5      RKSCSIVATT EGCDVLCSIV TQTEDQDY                                                                                                        
     apmv 6      RKSCNIIANP NGCDVLCSLV KQTENEDY                                                                                                        
     apmv 7      RKSCSIAATG FGCDILCSVV TETENDDY                                                                                                        
     apmv 8      RKSCSIVATQ FGCDILCSIV IEKEGDDY                                                                                                        
     apmv 9      RKSCSISATP LGCDLLCAKV TETEEEDY                                                                                                        
 
Figure 13: Deduced aa sequences represent the predicted head structure in the HN protein 
of several PMVs. 
Deduced aa sequences (HN gene) of several ferlaviruses (FDLV, Crot GER03, Pangut 
GER91, Igu GER00, Vip GER90, Pyt GER01, Crot GER03) were aligned to the 
corresponding regions of nine aPMVs. The predicted head structure (HN protein) found to be 
conserved for all viruses.  
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In the aa alignment of the HN proteins of all ferlaviruses with members of the respiro, 
avula-, and rubula viruses, the sequence GAEGR, was conserved, showing 80-100% 
identity for all members except for the henipahviruses that showed only 20% 
similarity (Figure 14).  
                                 5 
                             ....|.... 
                 FDLV        GAEGRIQTL                                                                                                                             
                 pangut GER09.........                                                                                                                             
                 Var GER95   .........                                                                                                                             
                 Pyth GER01  .........                                                                                                                             
                 Igu GER00   .........                                                                                                                             
                 Crot GER03  .........                                                                                                                             
                 Vip GER90   .........                                                                                                                             
                 Crot GER90  .........                                                                                                                             
                 Ther GER99  .....L...                                                                                                                             
                 Orth GER05  .........                                                                                                                             
                 Hendra      .SPSK.YNS                                                                                                                             
                 Nipah       .SPSK.YDS                                                                                                                             
                 HPIV-1      .....LLK.                                                                                                                             
                 Sendai      .....LLK.                                                                                                                             
                 Mumps       .....VLLI                                                                                                                             
                 NDV         ......L.V                                                                                                                             
                 apmv 1      ......L.V                                                                                                                             
                 apmv 3      ...A..YY.                                                                                                                             
                 apmv 2      ...A.LIQV                                                                                                                             
                 apmv 4      ...S..YY.                                                                                                                             
                 apmv 5      .....L.LV                                                                                                                             
                 apmv 6      A....L.LV                                                                                                                             
                 apmv 7      .....LLMI                                                                                                                             
                 apmv 8      A.....IKI                                                                                                                             
                 apmv 9      ...A..M.F                                                                                                                             
Figure 14: Deduced aa sequence GAEGR of HN gene of several PMVs 
Deduced aa sequence of HN gene of several ferlaviruses (FDLV, Pangut GER09, Igu 
GER00, Vip GER90, Pyt GER01 and Crot GER03, Var GER95, Crot GER90, Ther GER99) 
were aligned with the corresponding regions of  PMVs of other genera. The following 
sequence G-A-E-G-R showed a high degree of similarity. 
 
For the prediction of potential N-glycosylation sites, the program NetNGlyc.1.0 was 
used. This led to the detection of two possible N-glycosylation sites for all ferlavirus 
isolates included in this study at positions 128 and 163 and two additional sites for 
the tortoise isolate, at positions 277 and 496. 
 
FERLAVIRUS 
HENIPAH 
RESPIROVIRUS 
RUBULAVIRUS 
AVULAVIRUS 
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6       Discussion 
     6.1       Prevalence of ferlaviruses in diagnostic samples 
     6.1.1    Ferlaviruses infecting snakes 
 
 
The molecular diagnostic tool PCR/RT-PCR has enhanced our capability to identify 
and characterize pathogens. It has also enabled us to optimize diagnostic methods 
and understand specificity and sensitivity of these methods. Sequencing portions of 
viruses has contributed to taxonomic classification of new viruses and to widening 
our understanding of the possible factors involved in viral pathogenicity. It also 
provides the potential for understanding the genetic basis for presence or lack of 
species specificity.  
There are actually a number of different factors that might lead to false negative 
results, including mutations in the primer binding sites and inhibitory substances in 
samples. Due to the possibility of RNA loss starting from the first step of the sampling 
procedure and then more specifically during RNA preparation, the present results 
might not reflect the real virus content. Therefore, the use of internal positive controls 
would be of great importance to examine the occurrence of inhibitory substances and 
to control RNA preparation as has been suggested by Vainionpa and Leinikki (2010) 
In the current study, the infection rate (5.97 %) was low compared with other studies 
(Papp et al., 2010; Pees et al., 2010) which showed infection rates of 23% and 9% 
respectively. This might indicate that there are fluctuations in the infection rates in the 
snake population screened. However, the actual study populations of each study 
were not representative, as each used samples submitted to diagnostic laboratories. 
In the previously mentioned studies, the ultimate diagnosis was also based on RT-
PCR results and not on sequencing results. 
A study using virus isolation in cell culture for the diagnosis of ferlavirus infections in 
snakes showed highest recovery rate of ferlavirus from the lungs of infected snakes 
(Blahak, 1995). Therefore, tracheal washes have been suggested for viral detection 
(Pees et al., 2010). In our study, the lung gave the most reliable positive results from 
the dead positive PMV snakes, followed by intestine which is consistent with the 
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previous results from Papp et al. (2010). The use of several different organs for the 
diagnosis of viral RNA in dead snakes, including lung and intestine, would possibly 
enhance the chances of virus detection. Interestingly, all ferlaviruses isolated in our 
study were from intestine and kidney, while no isolates were obtained from the lung 
compared to reoviruses, which were mainly isolated from lung, intestine and kidney 
of infected snakes.  
Diseased snakes, showing mainly pneumonia and/or CNS signs were often 
documented without detectable ferlaviruses (supplementary data, Table 1) which 
corresponds to the previous findings from Papp et al. (2010). The majority of the 
snake samples tested in our laboratory were from clinically ill snakes that were 
collected by veterinarians and practitioners for analytic examination rather than 
random samples. Pees et al. (2010) has documented no significant correlation 
between the presence of PMV and clinical findings, when screening 100 viperid and 
boid snakes via RT-PCR. Asymptomatic seropositive and RT-PCR positive animals 
were documented in a recent study from Abbas et al. (2012) where healthy bearded 
dragons from a rescue centre in Munich were screened for the presence of 
ferlaviruses. The fact that not all ferlavirus infected squamates are sick could 
theoretically be dependent on several factors including; host species, viral 
pathogenecity factors, immune status, and time post infection. 
 
The effects of sampling bias when screening only diseased snakes should therefore 
be considered when evaluating the prevalence of ferlaviruses in snake populations. 
Consequently, the infection rate obtained in these kinds of studies may not reflect the 
real occurrence of viruses.  
Pees et al. (2010) underlined the significance of screening healthy collections of 
snakes for ferlaviruses and referred to the threat of unobserved contagious disease 
in these collections. A possible method to reduce the degree of sampling bias would 
be to screen both symptomatic and asymptomatic snakes for viruses, which can only 
be achieved by conducting entry examinations and screening for each newly 
established collection or when introducing new snakes into previously established 
groups. 
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In general, ferlavirus infections are clearly associated with respiratory disease in 
snakes, though CNS is also observed. Severe cases are most often doccumented in 
viperid snakes, though ferlaviruses have been detected in several snake families 
(Boidae, Pythonidae, and Colubridae) (Jacobson et al., 2007).  
Koch's postulates, proving a relationship between the pathogen and the disease, 
have only been fulfilled once for ferlavirus infections in reptiles. A transmission study 
was carried out with a PMV in Aruba Island rattlesnakes (Crotalus unicolor) 
associated with pulmonary lesions. Snakes inoculated intratracheally with PMV 
isolated from Aruba Island rattlesnakes also developed disease and the virus could 
be reisolated from the infected animals. Two snakes of the test group in that study 
were found dead on day 19 and 22 post inoculation. Extensive hemorrhage was seen 
in the mouth and lung in one of these snakes (Jacobson et al., 1997). 
In the case of multiple viral infections (PMV, reo and adeno viruses) in a group of 
captive corn snakes (Col-1, Col-1a~f), suspected transmission of ferlaviruses can be 
traced where six live snakes and one dead from a total of thirteen live corn snakes of 
one enclosure were found to be ferlavirus positive with the same sequence pattern 
(Pangut GER09) (Table 5.1.1). The source of the infection in this group might the 
addition of new untested animals to form new population. In the consecutive stock 
after dispersing all animals from the previous one and importing ten new snakes 
(54/09, supplementary data, Table 1), inappropriate disinfection of the terrarium 
could have played a role in transmitting the same types of non enveloped viruses 
(reo and adeno viruses) to the newly introduced animals whereas the 
environmentally less stable PMV was no longer present. In addition, concentrating on 
a particular pathogen (e.g. PMV in snakes) can lead to underestimation of the 
significance of other infectious agents. Multiple viral infections should therefore be 
considered when screening snakes for the presence of viruses (Abbas et al., 2011). 
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6.1.2 Sequencing and phylogenetic analyses 
In the current study, all RT-PCR positive results were further verified by sequencing 
in order to discard all false positive results which indicate the presence of nonspecific 
products (other viruses, bacteria) as will be discussed in the next section (6.2)  
Identical sequences from different snakes from one enclosure (Col-1, 1a~f) & (Pyt-
1a~c) and/or from several organs from one animal (Pyt-5) were obtained as 
previously documented by Ahne et al. (1999), Franke et al. (2001), and Papp et al. 
(2010).  A ferlavirus 97% similar to FDLV Subgroup A (Acc. No: AY141760.2) was 
found in a single case (Pyt-2). This virus differed clearly from all other viruses 
detected in this study. 
Several reports (Ahne et al., 1999; Marschang et al., 2009; Franke et al., 2001) have 
shown that ferlaviruses lack species specificity. In Marschang et al. (2009), 
ferlaviruses from lizards clustered within groups of snake isolates; Papp et al. 
(2010a), detected two ferlaviruses in a leopard tortoise clustered with those of 
squamate origin and did not form a separate cluster. In a recent study from Abbas et 
al. (2012), a ferlavirus was detetected in bearded dragons (Pogona vitticeps) (100% 
identical to Pyth GER01) that was originally isolated from a python. In another case 
from a python (Pyt-5), this snake was infected with a ferlavirus that was 100% 
identical to Igu GER00 which was originally isolated from an iguana indicating no 
species specificity. No signs of host species specificity were obtained when 
conducting phyogenetic analyses based on concatenated sequences of the full F, HN 
(CDC regions) and the extended portion of the L gene, where isolates from lizards 
could be found among both subgroup A and B members mixed with snake ones. In 
addition, the close genetic relation between ferlaviruses from such different hosts 
(snake, lizard, and tortoise) indicates that ferlaviruses may cross species barriers 
quite readily. 
 
Of the PMV positive amplicons, except Pyt-2 (234 bp L gene), which was not 
included in the phylogenetic analyses,  60% (3 of the total 5 amplicons) clustered to 
subgroup B, while the remaining 40% clustered to the newly proposed subgroup C 
within the Ferlavirus genus (Figure 5A). 
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 In one case (Pyt-2), the ferlavirus was 97% similar to FDLV (subgroup A). No other 
cases detected in this study belong to subgroup A despite the fact that viruses from 
both subgroups A and B have been detected in Germany. The only subgroup A 
viruses that have been described so far that orginated outside of Germany are Xeno 
USA99 and FDLV, which were originally found in the US and Switzerland 
respectively.  
None of the detected ferlaviruses clustered in relation to geographical provenance or 
year of detection/isolation. There were also no epidemiological relations among the 
ferlaviruses detected in our study as they were all detected from diverse groups from 
different countries at different intervals. 
In all methods used to analyse the L gene sequences obtained from the diagnostic 
samples, the first two representatives of the subgroup C isolates (Pangut GER09 and 
Hobuc HUN09) clustered together within the Ferlavirus genus supported with good 
bootstrap values (61-83%). These two isolates sometimes clustered close to 
subgroup B isolates or clustered as a seperate branch depending on the method 
applied. A similar inconsistency was noticed when assigning subgroup C isolates as 
in previous publications (Abbas et al., 2011; Papp et al., 2013) in which these viruses 
sometimes clustered with subgroup A or B viruses or in their own subgroup within the 
Ferlavirus genus depending on the gene targeted and the method applied. In 
general, this discrepancy was solved when conducting phylogenetic analyses based 
on the concatenated sequences of the F and HN genes and larger portion of L gene 
(as will be discussed in section 6.3). 
Initially, the sole chelonid ferlavirus isolate was classified in the Ferlavirus genus as 
the first member of a chelonid group based on a portion of L gene sequence 
(Marschang et al., 2009). Unfortunately, in that study, no sequence data could be 
obtained from HN or from U genes of the Ther GER99 isolate which are of particular 
importance to assign the proper position of this isolate in relation with squamate 
PMVs. However, it was clear from the phylogenetic positioning of the partial L gene 
sequence that it clustered as an outgroup to the squamate PMVs within the new 
genus Ferlavirus and was never assigned to any of the existing subgroups. These 
phylogenetic results were further confirmed by later studies from Abbas et al. (2011) 
and Papp et al. (2013). 
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Several attempts have been carried out so far to amplify a portion of the U gene from 
the tortoise isolate, however, all trials gave no signal (Rösler, 2011). The lack of U 
gene amplification products might be attributed to either the lack of this gene in the 
tortoise isolate or to the high sequence differences at primer binding sites due to the 
higher variability in nucleotide sequences of this gene compared with HN and L 
genes as has been shown in our results and which corresponds to the previous 
findings from Marschang et al. (2009). 
It is therefore still not clear whether the tortoise isolate does have the U gene to be 
further classified as the fourth cluster (subgroup D) within the Ferlavirus genus, or not 
and instead forms its own cluster (chelonid PMV) outside of the genus Ferlavirus 
within the subfamily Paramyxovirinae. Additional trials to discover the existence of 
this gene are of great value to reach the proper phylogenetic localization of the 
tortoise PMV in relation to the Ferlavirus genus and its groups. 
 
6.2 Evaluation of the RT-PCR method and optimization trials 
In 1999, Ahne et al. described a nested RT-PCR protocol targeting a portion of the 
conserved L gene of the ferlaviruses (FDLV). Since then, this protocol has been 
established as a standard molecular diagnostic technique for the detection of 
ferlaviruses in reptiles. Usually, this procedure results in amplicons of 566 bp that can 
then be used for subsequent sequencing, which opens possibilities for rapid 
categorization and provides a closer look into their taxonomic relationship and 
epidemiological investigations (Ariel, 2011). Previous studies (Papp et al., 2010; 
Pees et al., 2010) recommended using the previously established protocol for 
detecting ferlaviruses in snake populations due to its high sensitivity. 
This RT-PCR protocol (L gene) was used for detecting PMV in several snake families 
in this study including Boidae, Pythonidae and Colubridae. Sequencing results 
indicate that this protocol is not very specific (29.23% of the apparently positive 
samples showed unspecific products of the expected size but not specific sequence). 
Including results of an RT-PCR targeting a different gene (e.g. the HN gene) as 
previously described (Marschang et al., 2009) as well as results of virus isolation in 
cell culture in addition to the results of this L gene RT-PCR protocol may support the 
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diagnosis. However, sequencing of each RT-PCR positive amplicon remains 
necessary for a final diagnosis. 
Of the animals that tested negative for ferlaviruses by RT-PCR (L gene), unknown 
viruses were isolated on VH2 in two cases (Lab No; 3-2-09 and 106-09). In the first 
case, the snake suffered from pneumonia. Interestingly, of the animals that tested 
positive for ferlaviruses by RT-PCR and revealed no significant results after 
sequencing, unknown viruses were isolated from four of these samples (Lab No; 56-
10, 60-1-10, 60-2-10 and 157-10) where the first animal suffered from CNS signs 
while the last suffered from CNS signs and pneumonia (supplementary data, Table 
1). Of the samples that tested positive for feralvirus L gene by RT-PCR, 49.18% 
could not be sequenced while 19.66% could be sequenced. However, analysis of 
those sequences using BLAST, indicated non specific results (several kinds of 
bacteria/ unknown amplicons).  
Changes in annealing temperature and MgCl2 concentration did not lead to changes 
in the number of unspecific reactions detected. All sets of the degenerate primers 
used targeting partial L gene sequences showed lower sensitivity than the published 
protocol from Ahne et al. (1999). The L-gene RT-PCR described by Ahne et al. 
(1999) therefore remains the most senstivie method for the detection of ferlaviruses 
in reptiles. However, sequencing of PCR products is absolutely necessary to ensure 
the specificity of the reaction. 
 
6.3         Surface glycoprotein amplification and characterization 
6.3.1     Sequences and phylogenetic analyses 
In this study, the full F and HN genes (CDS region) along with a longer portion of the 
L gene of 9 ferlavirus isolates have been successfully sequenced and analyzed to 
investigate their taxonomic relationships and to study sequence differences and their 
impact on viral properties. 
It has been proposed in 2009 by Kurath to expand the subfamily Paramyxovirinae by 
including a new genus ‘Ferlavirus’ with the type species FDLV based on sequence 
analyses of the whole genome and the presence of the unknown U gene (Kurath et 
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al., 2004), which is missing in all other genera of the Paramyxovirinae. Earlier 
publications have characterized many PMV isolates based on sequence analyses of 
partial L and HN gene (Ahne et al., 1999) and L gene (Franke et al., 2001) 
sequences and revealed inconsistent clustering into two groups with intermediate 
isolates (Ahne et al., 1999) or into three groups (Franke et al., 2001). This 
contradiction in nomenclature was resolved in a later study by Marschang et al. 
(2009) by suggesting a revised grouping; a sensu lato A and sensu lato B. A recent 
publication from Abbas et al. (2011) has revealed the first representative of a new 
third PMV cluster C (Pangut GER09) which was equally distant from the other two 
squamate subgroups within the new genus Ferlavirus.  
In the present study, the classification of isolate Pangut GER09 (proposed subgroup 
C) was finally determined only when using the continuous sequences obtained from 
the F, HN, and L genes of all PMV isolates combined with the corresponding 
sequences from members of other PMV genera within the subfamily 
Paramyxovirinae. Pangut GER09 clustered forming its own branch (subgroup C) 
within the monophyletic squamate ferlaviruses. Based on the concatenated 
sequences from all of these genes, subgroups A, B, and C always cluster together in 
all trials, forming single monophyletic groups in the novel genus Ferlavirus within the 
sub family Paramyxovirinae supported with high bootstrap values (98-100%).  
The inconsistency in the clustering of subgroup C viruses within the Ferlavirus genus 
when using partial gene sequence was similar to the discrepant results obtained in 
previous studies (Rösler 2011; Papp et al., 2013; Abbas et al., 2011). In the latter 
study, the Pangut GER09 was compared with other PMVs based on partial L, HN, 
and U gene sequences revealing clustering of this isolate once with subgroup A 
using a portion of L gene sequence, second with subgroup B using a portion of HN 
gene sequence (bootstrap 72, 65% respectively) and third, alone forming its own 
subgroup using partial U gene sequences, although this was supported with lower 
bootstrap values.  
Sequence identity values for this isolate have also revealed moderate distances to 
each subgroup A and B. Therefore, based on the phylogenetic analyses and Identity 
values obtained so far, we propose the taxonomy of the Pangut GER09 as the first 
agent of the third cluster subgroup C within the Ferlavirus genus. 
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By comparing the identity values from the full CDS regions of F, HN and U genes and 
the partial sequence of L (1544bp) of all ferlavirus isolates (Tables; 5.3.2, 5.3.3,  
5.3.4 and 5.3.5), Identity values of F and L gene were comparable to each other and 
higher than those for the HN gene which indicate that the L and F genes are more 
conserved that the HN gene. Interestingly, the U gene was the least conserved gene. 
These findings are consistent with earlier findings from Marschang et al. (2009) in 
which partial U gene sequences were compared to partial sequences of L and HN 
genes of several ferlaviruses. 
Interestingly, this is the first study to effectively augment and further characterize the 
whole F, HN and a large portion of the L genes of the tortoise PMV and several 
squamate PMV isolates (Table 3.19). In all of the trials, the tortoise isolate clustered 
as a sister group to the squamate PMVs, and was never allocated to any of the three 
subgroups predicted so far. In all phylogeny calculations, the tortoise isolate did form 
a larger monophyletic group within the new genus Ferlavirus supported with high 
bootstrap values, which ranged from 84 to 100% and never clustered to any other 
genus of the subfamily (Figures 7A, B, C and D). Furthermore, the identity values of 
the nt sequences of the F, HN and L genes of the tortoise isolate compared to 
corresponding genes of the squamate PMVs showed moderate distance to each 
subgroup. Therefore and despite the fact that no U gene could be detected in this 
isolate yet, all of the taxonomic analyses and identity values obtained so far confirm 
the tortoise PMV isolate to be a member of the Ferlavirus genus. 
6.3.2 Fusion and attachment protein analyses 
The envelope glycolproteins F and HN have an essential role in the viral 
immunogenicity and pathogenecity and they play multiple roles in virus entry and exit 
from the host. Klenk and Garten (1994) have demonstrated the important role of F 
protein in the virulence of mammalian and avian PMV. Lamb and Kolakovfsky (2001) 
have documented the vital role the attachment protein (HN) plays as the main 
antigenic determinant of PMV. Yuan et al. (2011), studied the functions of HN protein 
e.g attachment to sialic acid binding sites, activation of the fusion process and virus 
entry and then hydrolyzation of the sialic acid binding sites setting the progeny virions 
free. Yuan et al., 2011 has underlined the necessity of homotypic F and HN 
interactions in viral entry and the important role the HN protein plays for fusion 
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activation. Previous studies have highlighted the functional domains and important 
sites of F protein of several PMVs (Morrison, 2003; Franke et al., 2006; Lamb and 
Kolakofsky, 2001). Several studies (Lamb and Kolakofsky, 2001, Yuan et al., 2011) 
have revealed the structure of the HN protein which consists of the stalk and globular 
head. Sialic acid binding sites are mapped to the active sites of the neuraminidase 
domains in the head of the protein, while fusion activation residues are mapped to 
the stalk of the HN protein (Yuan et al., 2011).  
As documented for respire- and morbilliviruses (Lamb and Kolakowisky, 2001) 
intergenic regions of three nucleotides long were detected in the current study for all 
ferlaviruses between the gene boundaries of F, HN and L. 
Deduced amino acid sequences of F genes of all ferlavirus isolates contained all of 
the important domains detected by several software programs and predicted by aa 
sequence comparison with the homologous sequences of functional domains of the F 
proteins of reptilian PMV (FDLV and Gono GER85), avian PMV (NDV) and 
mammalian PMV (SV-5) as indicated by Franke et al. (2006); Morrison (2003); Lamb 
and Kolakofsky (2001) respectively.  
The SP was the first domain detected for all ferlaviruses at the N- terminus of the F 
protein. Hunter (2001); Lamb and Kolakofsky (2001) described the important role the 
SP (especially its hydrophobic region) plays in the translocation machinery of the 
nascent synthesized protein to the membrane of the ER. All three regions of this 
motif for all ferlaviruses were not conserved and inconsistent in both length and aa 
composition which is similar to previous results from Von Heijne where a number of 
eukaryotic and prokaryotic signal sequence were studied and compared (1985). Von 
Heijne (1985) indicated that the intermediate region of the signal sequence extends 
from residues -7 to -14 in prokaryotes (Escherichia coli) and consists of highly 
hydrophobic residues. Substitutions of hydrophobic residues for one hydrophilic 
residue can be tolerated. This region remained mostly hydrophobic in all ferlaviruses 
and the single hydrophilic residue detected in this region for some ferlaviruses 
(Pangut GER09 and subgroup B isolates) (supplementary data, Figure 2A) should 
not affect the translocation process of the freshly translated polypeptides. 
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The next predicted region located at the C terminus of the SP is the furin recognition 
site. Klenk and Garten (1995) have documented that the number of basic residues at 
the furin recognition site and the sequence of this site play a role in the virulence of 
the viral strain. The furin cleavage site was conserved in all ferlavirus isolates having 
the basic residues (R-X-K-R) at positions -1, -2, and -4 correspondingly. All of these 
viruses should therefore induce infections that are not restricted to the respiratory 
tract, instead they can induce systemic infection which is in agreement with previous 
findings from Franke et al. (2006). In addition, this site was detected and found 
conserved for all rubula-, morbilli-, and avulaviruses compared to henipa (Hendra 
and Nipah) and respiroviruses (Sendai and HPIV1) which have a single basic residue 
at this site which corresponds to earlier results from Morrison (2003). Interestingly, 
henipah viruses induce infections in humans and horses mostly associated with the 
respiratory tract and the central nervous system (Chua et al., 2000). 
At position -6 upstream from the cleavage site, subgroup A and B isolates shared 
slightly acidic amino acids (threonin and serine) which might decrease the viral 
virulence. Since at least three basic residues were predicted at positions -1,-2 and -4, 
the effect of these acidic residues might be reduced. Regarding the chelonid 
ferlavirus isolate, the basic residue (arginine) at this site might increase the virulence 
of this isolate due to the additive effect of this extra basic aa for cleavage efficiency 
(Watanabe et al., 1992). Interestingly, this site was detected and found conserved for 
all ferla-, rubula-, morbilli-, and avulaviruses compared to henipa and respiroviruses 
(Sendai and HPIV1) which lack this site which corresponds to earlier results (Rawling 
et al., 2011).   
The next domain is the strongly hydrophobic FP which is the closest to the cleavage 
site (Lamb and Kolakofsky, 2001). By studying membrane fusion of influenza viruses 
mediated by HA protein, White (1992) has suggested that the FP inserts into the 
cellular membrane and starts membrane fusion which is important for CPE formation 
after infection (Bosch et al., 1989). For all ferlaviruses, this domain was conserved, 
except for the chelonid ferlavirus isolate where a sole non conserved hydrophilic aa 
(threonine) was detected at position 114. Sergel-Germano et al. (1994) have 
documented that the introduction of non conserved and charged aa in the FP of NDV 
may block the fusion process by interrupting the conformational modifications 
catalyzed by the HN protein.  
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Since all of the substitutions in this region were non charged and remained mostly 
hydrophobic, the fusion process of the chelonid ferlavirus should not be influenced. In 
the current study, this motif was 100% identical within the squamate ferlaviruses and 
shared a high degree of similarity with the chelonid ferlavirus. In general, this domain 
remained hydrophobic and shared a high degree of similarity when compared with 
the analogous sequences of henipa-, respiro-, morbilli-, avula- and rubulaviruses. 
HR1 of NDV was found to be very important in fusion and for the initial folding of the 
protein (Morrison, 2003). Substitution of any leusine residues at position (a) of the 
leusine zipper motif of the F protein of NDV results in a minor decrease in fusion 
activity, while substitution of two or three leusine residues at this site abolishes the 
ability of the protein to induce fusion (Reitter et al., 1995). In that study Reitter et al. 
(1995) suggested that the leusine residues (as individual residues) do not perform a 
particular task, instead the repetitive leusine residues as a collection play a role in the 
fusiogenecity of the protein. In our study, HRA and HRB, especially the non polar 
side of the helix at positions a & d were conserved for all ferlaviruses. Furthermore, 
single residue substitutions on the nonpolar side of the helix should not interrupt the 
biological activities of the protein (Reitter et al., 1995). Therefore, the conserved polar 
residue (serine) at position d (492 aa) in HRB of the chelonid ferlavirus should not 
have a direct effect on membrane fusion. 
Reitter et al. (1995) examined mutations at positions b, g and e of the LZ motif in the 
NDV fusion protein and their effect on fusion activity. All mutants showed fusion 
activity. However, a lower level of fusiogenecity was observed compared to the wild 
type NDV. For this reason the aa substitutions observed for the chelonid isolate on 
the polar side of the helix (positions; b,c,e,f and g) should not abolish the fusion 
activity, though it might decrease this function. 
For all ferlaviruses, positions (a) of the HRB (461, 468, 475, 482, 489, 496 aa) 
constitute the LZ (supplementary data, Fig 1A) with the residues leucine or isoleucine 
which corresponds to earlier findings from Franke et al. (2006). 
A transmembrane domain was detected for all ferlaviruses at the C- terminus of the F 
protein and showed a high degree of similarity within the squamate ferlaviruses. This 
domain remained mostly hydrophobic in the chelonid ferlavirus. The two hydrophilic 
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residues (serine and threonine) at positions 503 and 508 respectively should not 
have a huge effect on the hydrophobicity of this region.  
Surface glycoproteins are post-translationally glycosylated in the rough ER. This 
process affects several characteristics of the glycoproteins including immunogenicity, 
antigenicity, protein folding, solubility and stability and intracellular transport (Olden et 
al., 1985; Panda et al., 2004). In the current study, the F proteins of subgroup A 
isolates displayed conserved N-G sites at positions 436 and 443, but not at position 
102, where an N-G site was detectable only for FDLV. F proteins of subgroups B & C 
squamate ferlaviruses and the chelonid ferlavirus also displayed conserved N-G sites 
that were different in position (shifted back 1 aa) from subgroup A ferlaviruses. Moll 
et al. (2004) have studied the influence of losing N- glycan(s) in the F protein of nipah 
virus on proteolytic cleavage. They found that loss of the N- glycan located at 
position 99 aa of F2 and adjacent to the fusion peptide had little or no effect on 
cleavage efficiency. This site is analogous to the one detected for FDLV at position 
102 aa. In contrast, Klenk and Garten (1994) have documented that N- glycan(s) 
located adjacent to the cleavage site might reduce cleavage efficiency by interrupting 
protease accessibility. Further studies are necessary to find out the real impact of N-
G sites predicted for all ferlaviruses. 
Deduced amino acid sequences of HN genes of all ferlavirus isolates contained all of 
the important domains detected by several software programs and predicted by aa 
sequence comparison to the corresponding sequences of the functional domains of 
HN protein of avian PMV (NDV) and mammalian PMV (SV-5) as indicated by Yuan et 
al. (2011) and Lamb and Kolakofsky (2001) respectively.  
Overall, the HN proteins including their active sites were conserved for all 
ferlaviruses. However, different degrees of similarity were found, especially for the 
chelonid ferlavirus. The first domain detected was the cytoplasmic tail, this domain 
was mainly conserved especially within the squamate ferlaviruses.  
The transmembrane domain was the next detected domain which remained 
hydrophobic for all isolates. A recent study by Yuan et al. (2011) predicted the HN 
structure of NDV and revealed that the hydrophobic core of the stalk region consists 
of four HBs formed by an 11- aa repeat. Residues at positions a, d, and h form the 
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hydrophobic core of the repeats. In the current study, this region was conserved 
among all ferlaviruses.  
The predicted stem was conserved for all squamate ferlaviruses. For the chelonid 
ferlavirus, the non conserved residue predicted at the fusion interaction sites at 
position 80 aa was mapped to the interior core of the corresponding part of the NDV 
stalk. On the other hand, the nonconserved residue at position 96 aa in the same 
virus was mapped to the exterior surface of the of the corresponding part of NDV 
stalk. Yuan et al. (2011) indicated that non conserved residues at these sites should 
affect fusion activation. This may indicate a difference in pathogenicity or specific 
host cells between the chelonid ferlavirus and the squamate ferlaviruses. 
The predicted sialic acid binding site NRKSCS as described by Lamb & Kolakofsky 
(2001) and the conserved region GAEGR (Morrison, 1988) were all conserved within 
ferla-, respiro-, avula-, and rubellaviruses, highlighting the relatedness of the 
ferlaviruses to other PMV genera and the possible value of these regions in the HN 
protein function and structure as suggested previously by Mirza et al. (1994) and 
Morrison (1988). Mirza et al. (1994) found that the motif NRKSCS is part of the 
neuraminidase active site in the HN protein of NDV. This may explain the lack of 
these motifs in the attachment proteins of morbilli- (G) and henipaviruses (H) 
together with the lack of neuraminidase activity in this protein in viruses from those 
genera. 
McGinnes and Morrison (1994) have documented the role the cysteine residues of 
NDV HN play in protein folding and antigenic structure. In the alignment of 
ferlaviruses with several PMVs, all of these sites were totally conserved for respiro- 
and ferlaviruses (data not shown). Since all of these residues are conserved, this 
should not decreas the biological activities of the attachment protein as found by 
McGinnes and Morrison (1994). 
Conserved N-G sites were predicted in HN proteins of all ferlaviruses which 
highlights the significant role they play in the protein functionality. Panda et al. (2004) 
predicted four N-G sites in the HN of NDV at residues 119, 341, 433, and 481. Loss 
of a carbohydrate side chain in these sites depending on their location might change 
virus virulence, fusion efficiency and intracellular protein transport. For instance, the 
loss of a glycan at residue 481 led to reduction in virus virulence and decreased 
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intracellular transport of the protein. Panda et al. (2004) indicated that the loss of N-G 
sites at aa positions 119 and 341 together increased virus fusogenicity, while the loss 
of the glycan at position 481 decreased fusogenicity. Panda et al. (2004) also 
showed that glycosylation probably does not have a significant effect on the 
attachment of NDV since mutant and parental viruses showed similar hemadsorption 
values. Despite the differences between the HN of ferlaviruses and NDV, it can be 
hypothesized that the two extra N-G residues found at positions 277 and 496 for the 
chelonid ferlavirus impair the second step of virus replication (fusion). This might in 
turn explain the slow growth of the chelonid ferlavirus in cell culture. Further studies 
are necessary to investigate the role of each N-G site. 
Several studies have detected antigen binding sites on the F1 or F2 subunits of F 
proteins for several PMVs including HPIV 3, Sendai virus, human respiratory 
syncytial virus and NDV (Portner et al., 1987; Samson et al., 1986). These studies 
documented that the cysteine-rich region between the two HBR A and B of PMVs is 
rich with fusion-inhibiting epitopes. According to a previous study from Franke et al. 
(2006), one linear epitope has been detected for the F gene in ferlaviruses which was 
located within HRB. However, it was not clear if this epitope was associated with 
neutralization. In the current study this region was mostly conserved for all squamate 
felaviruses. For the chelonid ferlavirus, few non conserved residues were detected. 
Therefore antibodies binding to this region may differ among different ferlaviruses. 
Although the attachment protein is the main antigenic determinant of ferlaviruses, no 
studies have examined antibody binding sites in these viruses so far. Thompson and 
Porter (1987) documented that in the HN protein of Sendai virus the region extending 
from 260-280 aa of the head may act as a potential antigenic binding site. The 
analogous region in Sendai virus to that in ferlaviruses is the region extending from 
254-274 aa which was found to be 100% identical among all ferlaviruses and shows 
high similarity when compared with aPMV1-9 (Fig 13). Serological cross-reactivity of 
ferlaviruses with different aPMV serotypes has been frequently detected (Potgieter et 
al., 1987; Blahak, 1995). Therefore, this region might be an antigenic binding site for 
ferlaviruses. Loss of different N-G sites influences the configuration of antigenic 
epitopes (Panda et al., 2004). Therefore, the predicted N-G site at position 277 for 
the chelonid ferlavirus might enhance the functionality of this region as a potential 
antigenic binding site. 
103 
 
 
 
7  Conclusions 
A low infection rate of ferlaviruses in snakes was documented for the last years (from 
the beginning of 2009 until the end of 2011).  Based on previously documented 
prevalence rates for ferlaviruses within Germany, this may indicate a fluctuation in 
the infection rate. Diseased snakes with clinical signs considered typical for ferlavirus 
infection (pneumonia and/or CNS signs) were often found to be ferlavirus negative. 
The presence of PMV in snakes therefore did not correlate with the clinical 
investigations. Screening of both healthy and sick animals is important to understand 
the true prevalence of ferlavirus infection in a population and to avoid bias sampling.  
The genetic diversity of ferlaviruses appears to be relatively high, with a total of 3 
different genogroups documented among the squamate ferlaviruses. A single 
chelonid ferlavirus isolate is genetically distinct from these squamate subgroups and 
analysis of various viral genes and proteins support both phylogenetic differences 
and possible biological differences between these viruses.  
Although the analysis of data on screening of diagnostic samples for the presence of 
ferlaviruses shows that the RT-PCR protocol published by Ahne et al. (1999) has the 
highest sensitivity of the methods tested, this protocol has been shown to be highly 
unspecific. Sequencing of PCR products is therefore necessary to ensure specific 
results.  Extended studies are necessary to establish an alternative and more specific 
diagnostic assay. 
Concentrating on a particular pathogen, for instance ferlaviruses in snakes may lead 
to underestimation of the significance of other infectious agents. Our findings 
therefore emphasize the importance of testing for several pathogens and different 
organs and tissues.  
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8           Summary 
 
PMV are important pathogens for reptiles especially snakes and have been isolated 
from wild and private collections. During a period (2009-2011),  a total of 495 clinical 
samples originating from 251 snakes of several families including Boidae, 
Pythonidae, and Colubridae were screened for the presence of PMV by RT-PCR 
described by Ahne et al. (1999) targeting a partial sequence of the L gene and virus 
isolation on the reptilian cell line viper heart cells (VH2).  
Samples with positive amplicons (566 bp, L gene) were subjected to RT-PCR 
targeting partial sequence of HN as described by Ahne et al. (1999) and Marschang 
et al. (2009) and U gene as described by Marschang et al. (2009). All RT-PCR 
positive amplicons were subjected to sequencing in order to exclude false positive 
results. Phylogenetic analyses using several programs (Phylip 3.36 and Mega 5.05) 
were carried out to explore the associations between the viruses detected and to 
broaden our understanding of their taxonomic relationships. 
Unspecific size products and specific size products with non specific amplicons were 
repeatedly obtained using the previously published protocol. Several trials were 
therefore carried out in an attempt to increase the specificity of the original RT-PCR 
protocol (Ahne et al., 1999) including optimization and sensitivity tests. Several 
concentrations of MgCl2 (1, 1.5, 2, 2.5) mM and different annealing temperatures (45, 
48 and 51) Cº were used in order to eliminate the unspecific size products. Sensitivity 
tests using several ferlavirus isolates were conducted using new degenerate primers 
targeting the conserved L gene. Changes in annealing temperature and MgCl2 
concentration did not decrease the number of unspecific reactions detected. 
Sensitivity tests showed that the RT-PCR protocol described by Ahne et al. (1999) 
has the highest sensitivity. However, this protocol has been shown to be highly 
unspecific. Sequencing of RT-PCR products is therefore necessary to ensure specific 
results. 
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Ferlaviruses were detected in 5.97% of the snakes tested (15 of the 251 snakes 
screened). All ferlavirus positive snakes were from the families Colubridae and 
Pythonidae. The low infection rate might indicate a fluctuation in the infection rate.  
A total of six different partial L gene sequences were obtained from 19 RT-PCR 
products using RT-PCR (L gene) and verified by sequencing. Three of these 
products clustered within subgroup B isolates. The one detected in an Indian python 
was 97% similar to FDLV (AY141760.2) (Subgroup A). Two (Pangut GER09 and 
Hobuc HUN09) were not assigned to subgroup A or B.  However, they clustered 
together forming the first two representatives of the novel subgroup C within the 
Ferlavirus genus extending its classification into three squamate subgroups; A, B and 
C. Concurrent viral infections (PMV, reo and AdV) were detected in a group of corn 
snakes in Germany which highlight the significance for testing for different pathogens 
and different organs and tissues. 
In order to assess the degree of genetic diversity within this group of viruses, 
complete CDS regions of the F and HN genes from nine ferlaviruses were 
sequenced and compared (on both nt and deduced aa sequence levels) with each 
other and with the corresponding sequences of other genera of the Paramyxovirinae. 
Phylogenetic analyses were conducted for each gene separately and for the 
concatenated sequences of F, HN and the extended portion (1544 nts) of L gene.  
On a genomic level, squamate ferlaviruses are closely related; however they are 
distributed into three different genogroups (A, B and C). Deduced animo acid 
sequences of both F and HN genes of all ferlavirus isolates revealed conserved 
domains corresponding to those described for other members of the 
Paramyxovirinae.  However, the chelonid ferlavirus showed for both genes and for 
some motifs some differences to the squamate (snake and lizard) group.   
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9    Zusammenfassung 
 
PMV sind bedeutende Krankheitserreger bei Reptilien und konnten sowohl aus 
wildlebenden als auch in Gefangenschaft gehaltenen Populationen isoliert werden. 
Über einen Zeitraum von drei Jahren (2009-2011) wurden insgesamt 495 klinische 
Proben von 251 Schlangen verschiedener Familien wie Boidae, Phytonidae und 
Colubridae auf PMV untersucht, dabei wurde das Virus mittels RT-PCR nach Ahne et 
al. (1999), die auf das L-Gen des Virus abzielt nachgewiesen und Virusisolation 
durch Vermehrung in VH2 (Viper Herz Zellen) durchgeführt. 
Proben mit positivem PCR-Ergebnis (566 bp, L-Gen) wurden weiterhin in RT-PCRs, 
welche auf die Gene HN und U abzielen, getestet. Alle positiven PCR-Ergebnisse 
wurden sequenziert um falsch-positive Resultate auszuschließen. Die erhaltenen 
Sequenzen wurden des Weiteren phylogenetische Analysen mit unterschiedlichen 
Programmen (Phylip 3.36 und Mega 5.05) unterzogen um die genetischen 
Relationen zwischen den Subtypen weiter zu erforschen und das Verständnis der 
taxonomischen Zusammenhänge zu erweitern.  
Produkte mit unspezifischer Länge und Produkte mit spezifischer Länge aber 
unspezifischen Amplicons Sequencen wurden wiederholt getestet. Dafür wurden 
verschiedene Anpassungen des ursprünglichen Protokolls (Ahne et al, 1999) 
vorgenommen.  Außerdem wurden Sensitivitätstests anhand neuer Primer, welche 
auf das konservierte L-Gen abzielten, durchgeführt. Veränderungen der Annealing 
Temperatur und der MgCl2 Konzentration hatten keinen Effekt auf die Anzahl 
unspezifischer Reaktionen. Sensitivitätstests zeigten, dass das RT-PCR Protokoll 
nach Ahne et al. (1999) die höchste Sensitivität aufweist. Da die PCR nach diesem 
Protokoll jedoch einen hohen Anteil falsch positiver Resultate aufweist, sollten, um 
spezifische Ergebnisse zu erhalten, die Produkte stets sequenziert werden.  
Insgesamt wurden in 5.97% der getesteten Schlangen (15 von 251 Tieren) Ferlaviren 
nachgewiesen, dabei gehörten alle positiv getesteten Tiere den Familien Colubridae 
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und Phytonidae an. Die in der Studie gemessene geringe Infektionsrate könnte durch 
eine Schwankung in der Gesamtinfektionsrate zustande gekommen sein.  
Aus den 19 RT-PCR Produkten wurden sechs unterschiedliche partielle L-Gen 
Sequenzen nachgewiesen. Drei dieser Produkte ließen sich dem Subtyp B 
zuordenen, eines aus einer indischen Phyton wies 97% Homologie zum FDLV 
(AY141760.2), (Subgruppe A), auf. Zwei Isolate (Pangut GER09 and Hobuc HUN09) 
konnten in keines der bestehenden Cluster der Subtypen A oder B eingeordnet 
werden. Sie bildeten zusammen eine eigene Gruppe und sind damit die ersten 
Mitglieder des neuen Subtyps C innerhalb des Genus Ferlavirus, welches nun 
erweitert und in die drei squamaten Subgrupen A, B und C unterteilt werden kann. Es 
wurden multiple Virusinfektionen (PMV, reo und AdV) in einer Gruppe von 
Kornnattern/Kornschlangen in Deutschland entdeckt, was die Bedeutung des 
Testens verschiedener Pathogene  und  unterschiedliche Organe und Geweben 
hervorhebt. 
Um den Grad der genetischen Diversität innerhalb dieser neuen Virusgruppe 
einzuschätzen, wurden die kompletten CDS Regionen der Gene F und HN von neun 
Ferlaviren sequenziert und untereinander und mit entsprechenden Sequenzen 
anderer Mitglieder der Paramyxovirinae verglichen (sowohl auf der Ebene der 
Nukleotidsequenzen als auch der abgeleiteten Aminosäure-sequenz). Die 
phylogenetischen Analysen wurden dabei zum einen für jedes Gen separat und des 
weiteren anhand der aneinandergereiten Sequenzen der Gene F, HN und einem 
erweiterten Anteil des L-Gens (1544 Nuckleotide) durchgeführt. Dabei konnte gezeigt 
werden, dass die squamaten Ferlaviren auf genomischer Ebene eng miteinander 
verwandt sind, sich jedoch in drei verschiedene Genogruppen (A, B und C) 
aufspalten. Hergeleitete Aminosäuresequenzen der F und HN Gene aller 
Ferlavirusisolate in dieser Studie zeigten konservierten Domänen übereinstimmend 
mit denen anderer Mitglieder der Paramyxovirinae,  allerdings konnten in beiden 
Genen und einigen Motiven Unterschiede zwischen dem cheloniden Ferlavirus und 
den squamaten Isolaten (Schlangen und Echsen) nachgewiesen warden. 
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12         Appendix 
 
Supplementary data, Table 1: Diagnostic samples tested negative for ferlaviruses by RT-
PCR and sequencing. 
 Abbreviations: swab§= oral and cloacal swabs were collected together; $= adenovirus (AdV) 
PCR first described in Wellehan et al. (2004); PMV FP: False positive for PMV by RT-PCR; 
SeqR: Sequencing results; NS= not significant results. 
Register  
No. 
 
Species name Tissue tested Case history Comments, 
Further 
findings 
(virus 
isolation, 
other PCRs) 
1/09 common boa 
(Boa constrictor) 
lung, kidney, 
Intestine 
  
3/4/09 common boa 
(Boa constrictor) 
lungs, pancreas, 
kidney, intestine 
  
10//09  4 common boa 
(Boa constrictor) 
four swabs§ respiratory 
problem 
 
11/2/09 common boa 
(Boa constrictor) 
lung, pancreas, 
kidney, intestine 
  
12/09 
 
common boa 
(Boa constrictor) 
throat, tracheal, 
cloacal swab, 
lung, kidney, 
pancreas,  
intestine 
respiratory 
problem 
 
22/09 common boa 
(Boa constrictor)  
swab§ CNS signs  
45/5/09 Common boa 
(Boa constrictor) 
throat, kloakal 
swab 
  
63/09 2  common boa 
(Boa constrictor)  
lungs, kidney, 
intestine 
stock problem  
animals died 
 
63/2/09 common boa 
(Boa constrictor)  
lung, kidney, 
intestine 
stock problem   
72/09 common boa 
(Boa constrictor) 
swab§   
87/09 common boa 
(Boa constrictor) 
throat, kloakal 
swab 
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90/1/09 3  common boa 
(Boa constrictor) 
three swabs§   
92-09 (Boa constricor) lung, kidney, 
intestine, 
pancreas 
snake died  
93-09 common boa 
(Boa constrictor) 
lung, nieren, 
darm, pankreas 
snake died  
94-09 (Common boa) 
Boa constrictor 
lung, nieren, 
darm, pankreas 
snake died  
96/09 
 
common boa 
(Boa constrictor) 
Paraffin cut 
ribbons 
CNS and 
encephalopathy 
 
100/09 5  common boa 
(Boa constrictor) 
Lung, kidney, 
intestine,pancreas 
  
102/09 common boa 
(Boa constrictor ) 
swab§   
106/09 common boa 
(Boa constrictor) 
swab§  unknown virus 
isolated 
112/3/09 common boa 
 (Boa constrictor)  
throat, cloacal 
swab 
  
113/ 09 common boa 
(Boa constrictor)  
5 swabs§   
114/1/09 common boa 
(Boa constrictor)  
throat, tracheal, 
cloacal swab 
  
4/10 
 
common boa 
(Boa constrictor)  
Pancreas, kidney, 
lungs, intestine 
male  
17/1/10 common boa 
(Boa constrictor)  
swab§   
28/10 
 
madagascar 
ground boa (Boa 
madagascariensis) 
lung   
45/10  common boa 
 (Boa constrictor ) 
lung, kidney, 
intestine, 
pancreas 
  
57-10 
 
common boa 
 (Boa  constrictor) 
 female,  8 years 
old  
multiple small, 
dry papilloma 
lesions 
73/10 common boa 
 (Boa constrictor) 
throat, kloakal 
swab 
female, 13 years 
old 
 
82/10 
 
madagascar 
ground boa (Boa 
madagascariensis) 
throat, tracheal 
cloacal swab 
respiratory 
problem 
 
88/10 
 
common boa 
 (Boa constrictor) 
throat, cloacal 
swab 
respiratory 
problem 
 
132/1/10 2 common boa  
(Boa constrictor) 
two throat & 
cloacal swabs 
male and fermale 
of one enclosure 
suffering from 
pneumonia 
PMV FP: 
SeqR: 
Acinetobacter 
baumanni 
147/10 common boa 
 (Boa constrictor) 
throat, tracheal 
cloacal swab 
chronic anorexia, 
emaciation,  
adenovirus 
PCR positive$ 
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mouth mucosa 
15/11 common boa 
(Boa constrictor) 
oral swab CNS signs,  
mortality 
observed in the 
same stock,  
skinning problem, 
anorexia 
 
35-11 common boa 
Boa constrictor 
swab and trachea 
washing 
dermatitis, snale 
mites were 
detected 
adenovirus 
PCR positive$ 
 
74-11  common boa 
Boa constrictor 
swab§   
76-11 common boa 
Boa constrictor 
oral swab   
106-11 5  common boa 
Boa constrictor 
five swabs§ five female  
2/09 royal python  
(Python regius) 
lung,  kidney, 
intestine 
animal died  
3/1/09  indian python 
(Python molurus) 
throat, tracheal, 
kloakal, swab 
respiratory 
problem 
adenovirus 
PCR positive$ 
 
3/2/09 royal python  
(Python regius) 
lung, pancreas, 
kidney, intestine 
respiratory 
problem 
unknown virus 
isolated.  
adenovirus 
PCR positive$ 
from intestine 
3/3/09 green tree python 
 (Morelia viridis) 
lung, pancreas, 
kidney, intestine 
respiratory 
problem 
 
03/5/09 carpet python 
 (Morelia spilota 
variegata) 
lung, pancreas, 
kidney, intestine 
respiratory 
problem 
 
4/1/09   6 royal python 
(Python regius) 
lung, liver, 
intestine, kidney 
 adenovirus 
PCR positive$ 
from lung and 
intestine in 
four snakes 
7/1/09  indian python 
(Python molurus) 
 tracheal 
washing& cloakal 
swab 
 PMV FP in 
tracheal 
washing.  
SeqR: NS  
7/2/10 carpet python 
(Morelia spilota 
variegata) 
brain   
8/1/09  indian python 
(Python molurus) 
lungs, kidney, 
intestine 
animal died PMV FP in 
lung. SeqR: 
NS  
8/2/09 royal python 
(Python regius) 
lungs, kidney, 
intestine 
animal died  
11/1/09 
 
indian python 
(Python molurus) 
throat, tracheal 
cloatal swab 
respiratory 
problem 
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18/09 carpet python 
(Morelia spilota 
variegata) 
throat, cloacal 
swab 
 PMV FP. 
SeqR: NS 
32-09 tieger python brain, kidney, liver stock PMV 
problem 
PMV FP. 
SeqR: NS 
44/09 
 
carpet python 
(Morelia spilota 
variegata) 
lung, intestine, 
kidney, pancreas 
  
45/09 4 indian pythons 
(Python molurus) 
intestine, kidney, 
pancreas of four 
snakes 
 PMV FP in 
lung of one 
snake. SeqR: 
NS 
Same group 
as Pyt-1c 
13/10 
 
carpet python 
(Morelia spilota 
variegata) 
Throat &cloacal 
swab 
  
47/09 
 
green tree python  
(Morelia viridis) 
lung, kidney, 
intestine, 
pancreas 
 adenovirus 
PCR positive$ 
from lung, 
intestine and 
pancreas 
64/09 
 
angolan python  
(Python anchietae) 
lung, liver, kidney sub adult female 
with pneumonia, 
the animal is part 
of a group with 
chronic 
respiratory 
disease 
Snake from 
international 
zoo veterinary 
UK 
65/09 
 
indian python 
(Python molurus) 
throat, tracheal 
kloakal swab 
CNS 
 
 
67/09 
 
indian python 
(Python molurus) 
intestine, kidney, 
pancreas, lung, 
swab§ 
  
70/1/09 
 
2 indian python 
(Python molurus) 
two throat & 
kloakal swabs 
 PMV FP in 
one snake. 
SeqR: NS. 
Adenovirus 
PCR  positive$ 
in the same 
snake  
109/09 
 
children's Python 
(Antaresia 
childreni) 
skin skin problem, 
change the skin 
each 2 weeks 
adenovirus 
PCR positive$ 
110/09 
 
tiger python 
(Python molurus) 
3 tracheal 
washing 
respiratory 
problem 
PMV FP. 
SeqR: NS 
112/09 
 
2 indian python 
(Python molurus) 
two Throat & 
Kloakal swabs 
  
114/2/09 indian python 
(Python molurus) 
lung, kidney, 
intestine, 
 PMV FP in 
lung, kidney 
120 
 
 
 
pancreas and intestine. 
SeqR: NS  
114/3/09 indian python 
(Python molurus) 
throat & cloacal 
swab 
  
5/10 
 
green tree python  
(Morelia viridis) 
lung, intestine, 
kidney 
  
6/10 
 
carpet python 
(Morelia spilota 
variegata) 
lung, kidney   
7/10  indian python 
(Python molurus) 
intestine, lung, 
kidney 
  
8/1/10 
 
8 carpet python 
(Morelia spilota 
variegata) 
eight swabs  PMV FP in two 
snakes. SeqR: 
NS 
9/1/10 
 
indian python 
(Python molurus) 
throat, tracheal 
cloacal swab 
  
17/2/10 monty python swab§   
18/10 
 
royal python  
(Python regius) 
throat & cloacal 
swab 
female noticed 
with respiratory 
problems and 
CNS  
microbiological 
investigations 
from tracheal 
washing 
revealed the 
prevelence of  
klebsiella 
pneumonia 
and  
psudomonas 
aeroginosa 
23/1/10 
 
5 indian pythons 
(Python molurus) 
lung, kidney, 
pancreas, 
intestine 
 PMV FP in 
three snakes 
from lung, 
kidney and 
intestine. 
SeqR: NS  
25/10 
 
indian python 
(Python molurus) 
throat, tracheal 
cloacal swab 
  
27/10 
 
green tree python 
 (Morelia viridis) 
throat, cloacal 
swab 
  
34/10  indian python 
(Python molurus) 
throat, cloacal 
swab 
  
39/10 
 
bismark ringed 
python 
(Bothrochilus boa)  
lung, kidney, 
intestine 
  
56/10 
 
royal python  
(Python regius) 
throat, kloakal 
swab 
CNS signs PMV FP. 
SeqR: NS. 
Unspecified 
virus isolated 
60/10 
 
2 indian python 
(Python molurus) 
lung, kidney, 
pancreas, 
intestine 
 PMV FP in 
both snakes. 
SeqR: NS. 
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Unknown virus 
isolated from 
from both 
snakes 
86/1/10 
 
8 royal pythons  
(Python regius) 
lung, kidney, 
intestine of 1 
snake and 7 
swabs§ 
  
103/10  tiger python 
(Python molurus) 
swab§   
123/10 
 
Royal python  
(Python regius) 
swab§ stock respiratory 
problem, 
 adenovirus 
PCR positive$ 
132/3/10 royal python  
(Python regius) 
swab§ 662g, male with 
respiratory 
problem 
 
138/10 royal python  
Python regius 
lung, Intestine, 
kidney, pankreas 
 PMV FP. 
SeqR: NS 
139/10 8  royal python  
Python regius 
8 swabs§   
150/10 indian python 
(Python molurus)  
lungs, kidney, 
pancreas, 
intestine 
 adenovirus 
PCR positive$ 
from intestine 
151/10 royal python 
(Python regius) 
throat, Cloakal 
swab 
 adenovirus 
PCR positive$ 
157/10 royal python 
(Python regius) 
throat, tracheal 
cloacal swab 
CNS, Respiratory 
problem 
PMV FP. 
SeqR: NS. 
Unknown virus 
isolated 
160/10 royal python 
(Python regius) 
trachea washing  PMV FP. 
SeqR: NS 
1/1/11 Python 
brongersmai 
lung, trachea, 
kidney, liver, 
swab 
 adenovirus 
PCR positive$ 
in swab 
1/2/11 Python 
brongersmai 
lung,trachea, 
kidney, liver, 
swab 
 adenovirus 
PCR positive$ 
in kidney 
1/3/11 royal python 
(Python regius) 
lung, trachea, 
kidney, liver,  
kidney,  swab 
 
 adenovirus 
PCR positive$ 
in lung 
6/4/11 royal python 
(Python regius) 
heart, head group of python 
of about 40 
snake died of 
fatal pneumonia. 
the group was 
treated with 
Gentamycin that 
had no effect. 
Septicaemia was 
found after 
adenovirus 
PCR  positive$ 
in head 
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dissection 
10/11 royal python 
(Python regius) 
pancreas, 
intestine, kidney 
  
11/11 royal python 
(Python regius) 
oral, cloacal swab   
12/11 royal python 
(Python regius) 
oral, cloacal swab   
13/11 royal python 
(Python regius) 
oral, cloacal swab  PMV FP. 
SeqR: NS 
14/11  7  royal python 
(Python regius) 
7 head,   adenovirus 
PCR positive$ 
in one snake. 
Same group 
as 6/11 
17 & 
18/11 
 
2  royal python 
(Python regius) 
 two swabs§  PMV FP in 
both snakes 
SeqR: NS 
19 & 
20/11 
2  red albino blood 
python 
(Brongersmai 
albino) 
 
two swabs§   
21/111/11 indian python 
(Python molurus) 
lung, Kidney, 
Intestine, 
Pancreas 
Brain 
 adenovirus 
PCR  positive$ 
in intestine in 
one snake 
23/11 royal python 
(Python  regius) 
 
lung, kidney, 
intestine  
 adeno virus 
isolated. 
adenovirus 
PCR positive$ 
25/11 royal python 
(Python regius) 
Intestine, kidney animal died, 
Enteritis noticed 
 
26/11 reticulated python 
(Python 
reticulatus) 
brain, lung, 
kidney, intestine 
animal died 
enteritis 
 
31/11 5  royal python 
(Python regius) 
five swabs 
 
 adenovirus 
PCR  positive$ 
in one snake  
55/11 blutpython 
(Python 
brongersmai) 
swab§   
60/11 python, unknown 
species 
swab§  adenovirus 
PCR positive$ 
41/11 royal python 
(Python regius)  
swab§   
101/11 python burmese 
(Python bivittatus) 
 
lung Male with CNS,  PMV FP in 
brain, kidney 
and lung.  
SeqR: NS 
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(Acinetobacter 
aceti ) in all 
tested organs 
107/11 2 python Burmese 
(Python bivittatus) 
 
two swabs§  same animals 
as 101-11 
112/11 royal python 
(Python regius) 
swab§ anorexia, 
parasitosis, 
emaciation 
 
113/11  3 carpet python 
(Morelia spilota 
variegata) 
three swabs§   
115/11 royal python 
(Python regius) 
20 swabs§   
6/1/09 corn snake 
(Elaphe guttata) 
lung,  kidney,  
intestine 
  
6/2/09 corn snake 
(Elaphe guttata) 
lung,  kidney,  
intestine 
  
14/09 6 corn snake 
(Elaphe guttata 
six swabs§  reovirus 
isolated from 
three snakes 
17/1/09 
 
2 garter snake 
(Thamnophis 
sirtalis) 
2 swabs§  PMV FP. 
SeqR: NS 
33/09 
 
garter snake 
(Thamnophis 
sirtalis 
 CNS signs, 
Animal died  
problem in single 
animal 
 
42/09 corn snake 
(Elaphe guttata) 
Tracheal swab pneumonia  
54/09 10 corn snake 
(Elaphe guttata) 
Ten Throat, 
Kloakal swab 
 adenovirus 
positive$ PCR 
in three 
snakes.  
Reovirus 
isolated in two 
snakes. 
This group is 
the 
consequtive 
group to the 
captive corn 
snakes (Col-1, 
Col-1a~f) 
which was 
established 
after 
dispersing the 
first group of 
snakes. Both 
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groups belong 
to the same 
owner. 
55/09 
 
aesculapian 
Snake (Elaphe 
longissima) 
lung, kidney 
intestine pancreas 
  
59/09 
 
corn snake 
(Elaphe guttata) 
lung, kidney, 
intestine 
 adenovirus 
PCR positive$ 
60/09 
 
corn snake 
(Elaphe guttata) 
lung, kidney, 
intestine 
animal died 
suddenly 
PMV FP in 
lung and 
kidney. SeqR: 
NS. 
adenovirus 
PCR positive$ 
in lung and 
kidney 
66/09 
 
2 corn snake 
(Elaphe guttata) 
two Throat, 
cloacal swabs 
 adenovirus 
PCR positive$ 
in 66-1-09 
86/09 
 
unknown lung   
95/09 garter snake 
(Thamnophis 
sirtalis) 
lung, kidney, 
intestine, 
pancreas 
animal died 
suddenly 
 
142/10 dice snake  
(Natrix tessellata) 
lung and liver   
95/09 garter snake 
(Thamnophis 
sirtalis) 
lung, kidney, 
intestine, 
pancreas 
animal died 
suddenly 
 
101/09 
 
2 corn snake 
(Elaphe guttata) 
two swabs§  PMV FP in 
one snake. 
SeqR: NS, 
Salmonella 
spp 
29/10 
 
corn snake 
(Elaphe guttata) 
lung, kidney, 
intestine 
stock  problem, 
snake died 
 
95/09 garter snake 
(Thamnophis 
sirtalis) 
lung, kidney, 
intestine, 
pancreas 
animal died 
suddenly 
 
101/1/09 
 
2 corn snake 
 (Elaphe guttata) 
two swabs§  PMV FP in 
one snake. 
SeqR: NS 
97/2/09 
 
 swab§  adenovirus 
PCR positive$ 
42/10 
 
corn snake 
(Elaphe guttata) 
small intestine stock of animals 
died,Trichomonas 
and enteritis 
observed 
 
70/10 
 
corn snake 
(Elaphe guttata) 
throat swab and 
cloacal swab 
male  
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84/10 
 
corn snake 
(Elaphe guttata) 
throat, tracheal 
cloacal swab 
CNS signs  
152/10 corn snake 
(Elaphe guttata) 
throat, tracheal 
cloakal swab 
respiratory 
problem 
adenovirus 
PCR positive$ 
154/10 corn snake throat and cloacal 
swab 
emaciation, 
parasitosis, 
vomitus, and 
bacterial infection 
noticed. This 
snake represents 
a single case 
within established 
stock 
 
155/10 corn snake 
(Pantherophis 
guttatus) 
throat and cloacal 
swab 
CNS, vomits, 
high amount of 
Flagella in cloaca 
flashing. This 
snake represents 
a single case 
within established 
stock 
 
54/11 corn snake 
(Pantherophis 
guttatus) 
swab§ emaciation, 
enteritis were 
observed 
 
61/11 corn snake 
(Pantherophis 
guttatus) 
 male, CNS signs PMV FP. 
SeqR: NS, 
Pseudomonas 
putida 
67/11 corn snake 
(Pantherophis 
guttatus) 
swab§ 8 years old, CNS  
24/11 corn snake 
(Pantherophis 
guttatus) 
lung, intestine, 
kidney 
enteritis   
30/11 corn snake 
(Pantherophis 
guttatus)  
lung, kidney, 
intestine 
4 years old male, 
stock problem 
adenovirus 
PCR positive$ 
in lung 
104/11 5 corn snake 
(Pantherophis 
guttatus) 
five swabs§ 
 
 PMV FP in 
four snakes 
(104-1,2,4,5-
11). SeqR: 
NS, 
Enterobacter 
cloaca. 
adenovirus 
PCR  positive$ 
in three 
snakes (104-
1,4,5-11) 
136/1/10 4 eyelash Viper four throat,  adenovirus 
126 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 (Bothriechis 
schlegelii) 
kloakal 
swab 
PCR positive$ 
In two snakes 
116/11 horned viper 
(Vipera 
ammodytes) 
kidney, lung, 
intestine 
stock problem  
121/11 Dinnik's viper 
(Vipera dinniki) 
cloacal swab respiratory 
problem 
 
52/09 
 
ground rattlesnake 
(Sistrurus 
miliarius) 
intestine, kidney, 
lungs, pancreas, 
brain 
  
16/1/11 unspecified 
species 
Brain Trachea 
Lung Heart Liver 
Kidney Pancreas 
Intestine Colon 
 PMV FP in 
brain, lung and 
heart. SeqR: 
NS adenovirus 
PCR positive$ 
in liver 
80/11 unspecified 
species 
swab§   
122/11 
 
 swab§, Brain, 
Lung, Pancreas, 
kidney, intestine 
  
97/1/09 
 
unspecified 
species 
lung  PMV FP in 
lung. SeqR: 
NS.  
adenovirus 
positive$ PCR 
in kidney, 
intestine and 
pancreas 
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Supplementary data, Figure 1: Deduced amino acid sequences of L gene of twelve ferlaviruses.  
Deduced amino acid sequences of L gene of twelve ferlaviruses (FDLV, Var GER95, Crot GER03, Igu GER00, Orth GER05, Pyth GER01, 
Pangut GER09, Ther GER99, Vip GER90, Crot GER90, Dasy GER00, Pangut GER91). Identity shading refers to 80% among ferlaviruses. Dots 
indicate identical letters to that of the reference sequence (FDLV) 
 
                     10        20        30        40        50        60        70        80        90       100       110       120                     
            ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
FDLV        MDPKDILYPECHLDSPIVLGKVIRLHYLLDLTVEYDIKDSSILRNLDYNAKSGRLSNRDRELVKHKDILRKEGFVRSGYRGIDYPRGNKELFRLVIPNLTKPLECLLKQSNKVFDRIESG                          
Var GER95   ...R..........................................................I................................................R........  
Dasy GER00  ...R..........................................................I.......R........................................R........  
Pangut GER91...R..........................................................I.......R........................................R........  
Crot GER03  ...R...........................................................R...................................S....S.............P.  
Orth GER05  ...R...........................................................R...................................S....S.............P.  
Vip GER90   ...R...........................................................R...................................S....G.............P.  
Pyth GER01  ...R...........................................................R...................................S....S.............P.  
Crot GER90  ...R...........................................................R...................................S....S.............P.  
Igu GER00   ...R...........................................................R...................................S....S.............P.  
Pangut GER09...R..........................................................I....................................S...........R......P.  
Ther GER99  .......................K................A......H...T..F....K.IMT.RHL........N.................SV.SFY.T..D......R.YE...P.  
 
                    130       140       150       160       170       180       190       200       210       220       230       240            
            ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
FDLV        LRDTFLASANKISGKGKEVFTEQNLTESGMAGVSRSIHNNGWNQPFMTWFTIKKEMRKLKKDYRKNAKSTGMTRLASHHERYSLYIHSDFVLISDHVLEVYHLLTDDMVLGFCDVVEGRL                           
Var GER95   ....................IK.....G........V....................................K......................TS......................  
Dasy GER00  ..............R............G........V....................R...........A...K......................IS......................  
Pangut GER91..............R............G.............................R...........A...K......................IS......................  
Crot GER03  ..NM..T.........R...ID.....Q......N.V.T......................E.......A.L.K......................T.......................  
Orth GER05  ...M..T.........R...ID..I..Q......N.V.T......................E.......A.L.K......................T.......................  
Vip GER90   ...M..T.........R...ID.....Q......N.V.T......................E.......A.L.K......................T.......................  
Pyth GER01  ..NM..T.........R...ID.....Q......N.V.T......................E.......A.L.K*.....................TW......................  
Crot GER90  ...M..T.........R...ID.....Q......N.V.T......................E.......A.L.K......................T.......................  
Igu GER00   ...M..T.........R...ID.....Q......N.V.T......................E.......A.L.K......................T.......................  
Pangut GER09...M..T.........R...V......A..H...N.......HK.........R...R...........A.LAKVS....................TS..........I...........  
Ther GER99  .QKM.TTATE.L..HRCGHGVRGAEEPDRQTK..TVM.E....KS.....S..R.......E.FR.S.QGIA..MVH.DG................EN......S...............  
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                    250       260       270       280       290       300       310       320       330       340       350       360            
            ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
FDLV        MVSAVASMDPNYVNIGIRGEQLWSLIDSLFILLGNKVYDVVGMLEPLALSYIQLRDPIKEIRGAFLYYNLSELDQLLKEDTILSTGEVKDFIELISEIINMGSVSEISEIFSFFRSFGHP                          
Var GER95   .I...............K...................................................................................D..................  
Dasy GER00  .................K...................................................................S..................................  
Pangut GER91.................K...................................................................S..................................  
Crot GER03  .I...S......A..SVK............V......................................M..............VD..N.............N.................  
Orth GER05  .I...S......A...VK............V......................................M..............VD..N.............N.................  
Vip GER90   .I...S......A...VK............V......................................M..............ID..N.............N.................  
Pyth GER01  .I...S......A...VK............V......................................M..............VD..N.............N.................  
Crot GER90  .I...S......A...VK............V......................................M..............VD..N.............N.................  
Igu GER00   .I...S......A...VK............V......................................M..............VD..N.............N.................  
Pangut GER09.I...............K.......................................L...........M....H......L..AE..H........L...DN.................  
Ther GER99  .I..TSEL....TQ..L......G......TIM..Q.....................VA.V.........N...V..R.N.M.TNE..S...QAL.N.V..DK.................  
 
 
                    370       380       390       400       410       420       430       440       450       460       470       480            
            ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
FDLV        VLEAVTAADKVRDHMCKPKVLDYETLQKGHAVFCSMIINGFRERHGGSWPPCFLPDYASSELKAVMANHAAIPYELSVNNWESFIGFKFDKFEEVNLDEDLTIFMKDKALSPIRAEWDTV                          
Var GER95   ...................I....I....................................I..................................................V.......  
Dasy GER00  ...................I....I...........................S........I..........................................................  
Pangut GER91...................I....I...........................S........I..........................................................  
Crot GER03  I..................I..........................................................S........R..........................S.....  
Orth GER05  I..................I..........................................................SS.......R..........................S.....  
Vip GER90   I..................I..........................................................S........R..........................S.....  
Pyth GER01  I..................I..........................................................S........R.................R........S.....  
Crot GER90  I..................I..........................................................S........R..........................S.....  
Igu GER00   I..................I..........................................................S........R..........................S.....  
Pangut GER09I..................I....V...........................S......P.....A.............H....V..R.........................KS.....  
Ther GER99  I..................I...K.I.Q........................I..EH..ADI..I.V..S....DIC.RD.........E.......................KS.....  
 
                    490       500       510   
            ....|....|....|....|....|....|.... 
FDLV        YPQENMQYSPGRSSTSRRLVDVFLEDMEFNPQDI                                                                                                                  
Var GER95   ...........K.......I..............                                                                                        
Dasy GER00  ..................................                                                                                        
Pangut GER91..................................                                                                                        
Crot GER03  ...........K......................                                                                                        
Orth GER05  ...........K......................                                                                                        
Vip GER90   ...........K......................                                                                                        
Pyth GER01  ...........K......................                                                                                        
Crot GER90  ...........K......................                                                                                        
Igu GER00   ...........K......................                                                                                        
Pangut GER09...........K......................                                                                                        
Ther GER99  ........PT.KG..............D.D.NN.                       
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Supplementary data, Figure 2: Deduced amino acid sequence of F and HN genes (CDS region) of ten ferlaviruses. 
 Deduced amino acid sequence of F and HN genes (CDS region) of ten ferlaviruses (FDLV, Var GER95, Crot GER03, Igu GER00, Orth 
GER05, Pyth GER01, Pangut GER09, Ther GER99, Vip GER90, Crot GER90) and the important motifs. Threshold for shading with dark and 
light grey is 80%. Dark grey refers to identical residues among all ferlaviruses. Light grey refers to similar substitutions. Dots indicate identical 
letters to that of the reference sequence (FDLV). Abreviations for the consensus sequence: * = identical or conserved residues among all 
ferlaviruses,: = indicates conserved substitutions, . = indicates semi-conserved substitution. 
Supplementary data, Figure 2A: Deduced amino acid sequence of F gene (CDS region) 
 
 
 
                            10        20        30        40        50        60        70        80        90     100         110      120                     
                   ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|.X..|....| 
FDLV (A)           MTRITILQIILTLTLPVMCQVSFDNLEQVGVMFDKPKFLKITGPASTATMIIKLIPTLGTMESCGTSAVNEYKKTLDTILVPLRDTINKLSTDITVVEGTSNISNKREKRFVGIAIAVGA  
Var GER95 (A)      ..KTI.F..V...AA.A................................I..............................I....................KV.T...............  
Crot GER03(B)      .-KV.T.L...I.ITSIL..I...........................................................I...............L...PKTLSR..............  
Igu GER00 (B)      .-KV.T.L...I.ITSIL..I...........................................................I...............L...PKTLSR..............  
Crot GER90(B)      .-KV.T.S...I.IT.TL..I...........................................................I...............L...PKTLS...............  
Vip GER90 (B)      .-KV.T.S...I.IT.IL..I...........................................................I...............L...PKTLSR..............  
Orth-GER05(B)      .-KV.T.P...I.ITSIL..I...........................................................I...............L...PKTLSR..............  
Pyth-GER01(B)      .-KV.T.L...I.ITSIL..I...........................................................I...............L...PKTLSR..............  
pangut GER09(C)    .-SGAMPY.VVV.AV.T...I...S..........................................................K...D........L...LKTPA..G............  
Ther GER99         .-EK...LFLWGFIIS.SG.I...Q...I..VY.R...........K............A.A...N...Q...S..E...G......D.IK...S.I...RLSNRR.K...F.T...I..  
Consensus          *       ::  :  .   *:***.***:**::*:***********.**:*********:* ***.***:***.**:*** **:***:*:.***:*:***     :* ***.* ***:** 
 
 
                           130       140       150       160       170       180       190       200       210       220       230       240            
                   ....|....|....|....|....abcdefg abcdefg abcdefg abcdefg abcdefg abcdefg...|....|....|....|....|....|....|....|....|....| 
FDLV(A)            VALATSAQITAGIALSNTIKNAEAIESIKSS IQASNQA IQKVIDA QGRTVTV INGIQDH INSVINPALNQLGCDVAKNTLAISLTQYFSKLSLLFGPNLRNPVEQPLSVQAIAGLMDGDI  
Var GER95(A)       ............................... ....... ....... ....... .....................................................................  
Crot GER03(B)      ...............A...........L... .....K. ....... ....... .....................................................................  
Igu GER00(B)       ...............A...........L... .....K. ....... ....... .....................................................................  
Crot GER90(B)      ...............A...........L... .....K. ....... ....... .....................................................................  
Vip GER90(B)       ...............A...........L... .....K. ....... ....... .....................................................................  
Orth-GER05(B)      ...............A...........L... .....K. ....... ....... .....................................................................  
Pyth-GER01(B)      ...............A...........L... .....K. ....... ....... .....................................................................  
pangut GER09(C)    ...........................L... .....K. ....... ....... .....................................................................  
Ther GER99         ......................A....L.A. ....... ....... .....I. ........................................A.I..........................  
Consensus          ***************:****** ****:*:* *****:* ******* *****:* ****************************************:*:**************************  
 
 
      Signal peptide 
RXKR 
Furin recognition 
site Fusion peptide 
      Heptad Repeat A Fusion peptide 
F1 F2 
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                           250       260       270       280       290       300       310       320       330       340       350       360            
                   ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
FDLV(A)            NAVVSQLGYTQSDLLDLLSTESIVGTVTAIDMVNYMIQIEMSFPQYITIPDTKVLEGHKITFNDKGSEWQTQVPSTIAVRDILIAGVDPDGCSITSTSYICKNDPTYAMSEVLTNCFRGN  
Var GER95(A)       .........................................................................................E.............................K  
Crot GER03(B)      ..........P..................V............................R.....R............................V..........................  
Igu GER00(B)       ..........P..................V............................R.....R............................V..........................  
Crot GER90(B)      ..........P..................V............................R.....R.........G..................V..........................  
Vip GER90(B)       ..........P..................V............................R.....R............................V..........................  
Orth-GER05(B)      ..........P..................V............................R.....R............................V..........................  
Pyth-GER01(B)      ..........P..................V............................R.....R............................V..........................  
pangut GER09(C)    ..........P..........................................I.................................N.....V..........................  
Ther GER99         .S.......SS.................GV..R....................I.........NA.....A................NSE.....P............L...M.E..K.R  
Consensus          *:*******: *****************.:** ********************:****:****: *****:***.************:.:***:*.************:***:*:**:*.  
 
 
 
                           370       380       390       400       410       420       430       440       450       460       470       480            
                   ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|abcdefg abcdefg abcdef 
FDLV(A)            TQECPRARITSTFATRFAIARSTVIANCVAAVCLCGDPGIPVVQKAEVTLTAMTLDQCSLITVDGLQIKPSKSIANVTANFGNITLGPVVSVGDLDLSAELTKVQSD LKEAQDK LDESNA  
Var GER95(A)       .......................................T.......I..........N........................................................  .....  
Crot GER03(B)      .......................................T.................................L................................. ......R .....S  
Igu GER00(B)       .......................................T.................................L................................. ......R .....S  
Crot GER90(B)      .......................................T.................................L................................. .....GR .....S  
Vip GER90(B)       .......................................T.................................L................................. .....GR .....S  
Orth-GER05(B)      .......................................T.................................L................................. ......R .....S  
Pyth-GER01(B)      .......................................T.................................L................................. ......R .....S  
pangut GER09(C)    .......................................T....................V.I.........N......D........................... .....E. ......  
Ther GER99         .EN...........N...VV..I........S.........I.....K..S..VTND.G...........G.FLG.I.S....VS...II..DS...........QE ..T..SY ..K..G  
Consensus          *::***********.***:.** ******** ******* *:***** **:**. ::*.*:*:*******.* :.*:*::***::***::**..***********.: ** **   **:**. 
 
  
 
                              490       500       510       520       530       540            
                   G abcdefg abcdefg abcdefg..|....|....|....|....|....|....|....|....| 
FDLV(A)            I LQGINNK ILTAPTS IALIVVSVVVILLIIGMISWLVWLTKAVRRSNTRSERVTPSAYNNLGFIK  
Var GER95(A)       . ....... ....... .........IV.....I....IF..R..K..SI........T........  
Crot GER03(B)      . ....... ....... ........IIV.I...I....A......K..SI....I..NT........  
Igu GER00 (B)      . ....... ....... ........IIV.I...I....A......K..SI....I..NT........  
Crot GER90(B)      . ....... ....... ........IIV.I...I....A......K..SI....I..NT........  
Vip GER90(B)       . ....... ....... ........IIV.I...I....A......K..SI....I..NT........  
Orth-GER05 (B)     . ....... ....... ........IIV.I...I....A......K..SI....I..NT........  
Pyth-GER01 (B)     . ....... ....... ........IIV.I...I....A......K..SI....I..NT........  
pangut GER09(C)    . ....... ..S.... .......II.V.F....VV......R..K..S.....I...T........  
Ther GER99         . .NNL..Q ..KSSV. ....IFLSIA..T..CL.L......R.IK.I.QKP..I...T......L.  
 Consensus         * *:.:**: **.:..* ****:.  : :* ** :: ** :**:*::* . :.**:**.:******:*  
 
      Heptad Repeat B 
Tansmembrane anchor 
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Supplementary data, Figure 2B: Deduced amino acid sequence of HN gene (CDS region) 
 
 
 
 
                            10        20        30        40        50        60        70        80        90       100       110       120                     
                   ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
FDLV(A)            MDPKSYYCNEDLRSDGGEKSPGGDLYKGIILVSTVISLIIAIISLAFIIDNKINIQSLDPLRGLEDSYLVPIKDKSESISQDIQEGIFPRLNLITAATTTTIPRSIAIQTKDLSDLIMNR  
Var GER95(A)       .......SS...KK.D.D..S...I...L.............V..G.....R..........S..........E..DT.G................S.......................  
Pyth GER01(B)      .......SSD...K.ND.R.S.......LV....IV.........G.V....V.....G..KE..N...I...T..DD....V....L........S.......................  
Igu GER00(B)       .......SSD...K.ND.R.S.......LV....IV.........G.V....V.....G..KE..N...I...T..DD....V....L........S.......................  
Crot GER03(B)      .......SSD...K.ND.R.S.......LV....IV.........G.V....V.....G..KE..N...I...T..DD....V....L........S.......................  
Vip GER90(B)       .......SSD...K.ND.R.S.......LV....I..........G.V....V.....G..KE..N...I...T..DD....V....L........S.......................  
Crot GER90(B)      .......SSD...K.ND.R.S.......LV....I..........G.V....V.....G..KE..N...I...T..DD....V....L........S.......................  
Orth GER05(B)      .......SSD...K.ND.R.S.......LV...............G.V....V.....G..KE..N...I...T..DD....V....L........S.......................  
pangut GER09(C)    .......GSD...KSDES..SESG.....V........V..V...G.....R..........D..S.......E..DA.G..V...VL................................  
Ther GER99         ..SRN..SS..V.PEFSQG.KQKS.LEISRFII.L...L..LV..GLLV.S.GWV..TNYKEDISKKQIDL...E.KV.L.......L.......Q.I..GL........QE.KETVK..  
Consensus          **.:.** .:*:: .  . *   .: :   :: *::**:**::**.:::*.:  :** .  . :... :  ** :*. * **:***::******* : ** :********::*.: : **  
 
 
 
 
 
                           130       140       150       160       170       180       190       200       210       220       230       240            
                   ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
FDLV(A)            CYPSVVNNDTSCDVLAGAIHSNLFSQLDPSTYWTCSSGTPTMNQTVKLLPDNSQIPGSTYSTGCVRIPTFSLGSMIYSYSHNVIYEGCNDHSKSSQYWQLGYISTSKTGEPLQQVSRTLT  
Var GER95(A)       ...................................P..S.I.........................................IV.....................G.N............  
Pyth GER01(B)      .....A...............SS............P..S.V................................N........I......................G.N............  
Igu GER00(B)       .....A...............SS............P..S.V................................N........I......................G.N............  
Crot GER03(B)      .....A...............SS............P..S.V................................N........I....................R.G.N............  
Vip GER90(B)       .....A................S............P..S.V................................N........IV.....................G.N............  
Crot GER90(B)      .....A................S............P..S.V................................N........IM.....................G.N............  
Orth GER05(B)      .....A................S............P..S.V................................N........I..G...................G.N............  
pangut GER09(C)    .....A...............SS............P..S...........................................IV....D................D.S.G..........  
Ther GER99         ................T.V.GAK.K...........T...V..R.IRM............T............D........I..S.....A..A........DENNL...I........  
Consensus          *****.********** *:*.  *.**********.:*:* **:*:::************:************.********::* **:**:**:********  .: * *:********  
 
  Cytoplasmic tail 
Signal – Anchor 
Transmembrane domain   Presumptive stem region 
  Presumptive head region 
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                           250       260       270       280       290       300       310       320       330       340       350       360            
                   ....|....:....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
FDLV(A)            LNNGLNRKSCSTVAQGRGAYLLCTNVVEDERTDYSTEGIQDLTLDYIDIFGAERSYRYTNNEVDLDRPYAALYPSVGSGTVYNDRILFLGYGGLMTPYGDQAMCQAPECTSATQEGCNSN  
Var GER95(A)       ..........................................V.................S.................................V............R......DD....  
Pyth GER01(B)      ..D.......................I.................................S...................I..............K..............T.........  
Igu GER00 (B)      ..........................I.................................S...................I..............K..............T.........  
Crot GER03 (B)     ..........................I.................................S...................I..............K..............T.........  
Vip GER90(B)       ..........................I.................................S...................I..............K..............T.........  
Crot GER90(B)      ..........................I.....................V...........S...................I..............K..............T.........  
Orth GER05(B)      ..........................I.................................S...................I..............K..............T.........  
pangut GER09(C)    ..........................................I.....V.....N.........................I....V........V............G.P........N.  
Ther GER99         ..D.I.........L.........H.I...V...RSN.T.........L..THK....SDR.INF...............I.............IS........N..L.PTVN.DD..R.  
Consensus          **:*:********* *********:*:*** *** ::* *** *****:**:.:.***:: *:::***************:****:********:.********:** *.:..*:.** *  
 
 
 
                           370       380       390       400       410       420       430       440       450       460       470       480            
                   ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
FDLV(A)            QLIGYFSGRQIVNCIIEIITVGTEKPIIRVRTIPNSQVWLGAEGRIQTLGGVLYLYIRSSGWHALAQTGIILTLDPIRISWIVNTGYSRPGNGPCSASSRCPAQCITGVYTDIFPLSQNY  
Var GER95(A)       .................V................................................................K.........R..P......V.................  
Pyth GER01(B)      ....W.........................K...................................................E.........N...........................  
Igu GER00 (B)      ....W.........................K...................................................E.........N...........................  
Crot GER03(B)      ....W.........................K...................................................E.........N...........................  
Vip GER90(B)       ....W.........................K...................................................E.........N..P........................  
Crot GER90(B)      ....W.........................K...................................................E.........N...........................  
Orth GER05(B)      ....W.........................K...................................................E.........N...........................  
pangut GER09(C)    ....W..............K........K.....................................................E.........S..P......V.................  
Ther GER99         .F........V...L..V.II.....L.K.T..............L........I..............M............E.........E..P......S.......N....I....  
Consensus          *:**:*****:***:**:* :*****:*:* **************:********:**************:************ ********* **.****** *******.****:****  
 
 
 
 
                           490       500       510       520       530       540       550       560              
                   ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
FDLV (A)           GYLATVTLLSGVDRVNPVISYGTSTGRVADSQLTSSSQVAAYTTTTCFTFNQKGYCYHIIELSPATLGIFQPVLVVTEIPKICS-  
Var GER95 (A)      ...........I..I........P...........P................................................-  
Pyth GER01(B)      ............N......................A............I...................V......A.....V..-  
Igu GER00 (B)      ............N......................A............I...................V......A.....V..-  
Crot GER03(B)      ............N......................A............I...................V......A.....V..-  
Vip GER90(B)       ............N......................A............I...................V......A.....V..-  
Crot GER90(B)      ............N......................A............I...................V......A.....V..-  
Orth GER05(B)      ............N......................A............I...................V......A.....V..-  
pangut GER09(C)    ................................................I..........................A.....V..-  
Ther GER99         .Q.........NT....T.....P......K.I.TAE......M....VLAER.F.............L......A.......QP  
Consensus          * *********  *:**.*****.******.*:*:..****** **** : ::*:*************:******.*****:*.
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